Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADIPOQ,Adiponectin,24961,-0.183376861430704,0.00457993435933921,-0.192353532775009,-0.174400190086399,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGRP,Agouti-related protein,29781,0.229955500970098,0.0034352480985748,0.223222414696891,0.236688587243305,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,29213,0.0907623178157149,0.00200719316413052,0.086828219214019,0.0946964164174107,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL23,C-C motif chemokine 23,29576,0.12424222192443,0.00280570347594178,0.118743043111584,0.129741400737276,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL27,C-C motif chemokine 27,29473,0.196779603856728,0.0041190734868757,0.188706219822451,0.204852987891004,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN1,CCN family member 1,29296,0.302484201611651,0.00495890100882402,0.292764755634356,0.312203647588946,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29344,0.0885894007966432,0.00215635540340477,0.0843629442059698,0.0928158573873165,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,29378,0.102767385145768,0.00199494854484335,0.0988572859978754,0.106677484293661,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CES1,Liver carboxylesterase 1,29484,0.240679305570975,0.00544618514781131,0.230004782681265,0.251353828460685,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRIP2,Cysteine-rich protein 2,29213,0.106259048426101,0.00245302978919914,0.10145111003927,0.111066986812931,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,29689,0.163095725900697,0.0041304889505298,0.154999967557659,0.171191484243736,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,29344,0.233207986532257,0.00590295052467303,0.221638203503897,0.244777769560616,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FURIN,Furin,29561,0.0913119834893779,0.00227354963556103,0.0868558262036783,0.0957681407750775,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCG,Pro-glucagon,28792,0.33395774877285,0.00845810685801404,0.317379859331142,0.350535638214557,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPR37,Prosaposin receptor GPR37,28911,0.20286009087081,0.00446510734196713,0.194108480480554,0.211611701261065,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,24840,0.24208186529902,0.00511479094394137,0.232056875048895,0.252106855549145,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29720,0.100565113709359,0.00231364710502401,0.0960303653835119,0.105099862035206,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LDLR,Low-density lipoprotein receptor,29495,0.367920559753508,0.00298223240604059,0.362075384237669,0.373765735269348,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPL,Lipoprotein lipase,29473,-0.143964798882087,0.00317020095747503,-0.150178392758738,-0.137751205005436,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29095,0.128838137969024,0.00321991195290472,0.122527110541331,0.135149165396718,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFGE8,Lactadherin,29438,0.16666247030077,0.00289993759353945,0.160978592617432,0.172346347984107,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",28769,0.150361713548747,0.00357677320127871,0.143351238074241,0.157372189023254,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPY,Pro-neuropeptide Y,29720,0.257374191019146,0.00434081001632091,0.248866203387158,0.265882178651136,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,29438,0.0955503776898701,0.00214972680941039,0.0913369131434258,0.0997638422363145,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLTP,Phospholipid transfer protein,29697,-0.134300822716691,0.00237723043163162,-0.138960194362689,-0.129641451070693,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,24933,0.11392659817129,0.00276351723799913,0.108510104384812,0.119343091957768,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTH,Parathyroid hormone,24190,0.237749537448162,0.00547724440010834,0.22701413842395,0.248484936472375,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,29623,0.151617685663416,0.00317002712667068,0.145404432495142,0.157830938831691,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBP5,Retinol-binding protein 5,29344,0.149272347205232,0.00381637209089702,0.141792257907073,0.15675243650339,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,29720,0.109983932405597,0.00219875077136442,0.105674380893722,0.114293483917471,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29589,0.122239972455921,0.00287729254681845,0.116600479064156,0.127879465847685,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,29344,0.192500162484382,0.00461075047733136,0.183463091548813,0.201537233419952,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGSF9,Protein turtle homolog A,24917,0.217292939121079,0.00563033354364568,0.206257485375534,0.228328392866625,1.11253693723101e-308
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS9,Galectin-9,29448,0.0832049919875084,0.00216988272366156,0.0789520218491317,0.087457962125885,1.11253981263571e-308
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,29328,-0.163599718865672,0.00429249686767947,-0.172013012726324,-0.155186425005021,1.12728910782959e-308
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,29576,-0.0730429906859218,0.00193017153247382,-0.0768261268895705,-0.0692598544822731,4.57692780796298e-306
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,29374,0.138341993869911,0.00367405014791794,0.131140855579992,0.14554313215983,4.62742052709292e-303
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29689,0.133588993409512,0.00355357479495648,0.126623986811398,0.140554000007627,3.48804198063426e-302
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28911,0.140604831590497,0.00374745175758869,0.133259826145624,0.147949837035371,7.23472491226704e-301
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPY30,Protein dpy-30 homolog,29599,0.152559449469433,0.00407160168076248,0.144579110175138,0.160539788763727,3.08638168265019e-300
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGRN,Agrin,29576,0.0874176066299079,0.00234536274268632,0.0828206956542427,0.092014517605573,3.49994367104089e-297
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,28792,0.206846484874161,0.00560148291897881,0.195867578352962,0.217825391395359,1.09994537260061e-291
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F7,Coagulation factor VII,29539,0.0767142223663927,0.00208767861725055,0.0726223722765816,0.0808060724562038,4.39745715710176e-289
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28911,0.209373467679043,0.00570692166290955,0.19818790121974,0.220559034138346,4.71218135649895e-288
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,29473,0.0761346171769148,0.00207860154079781,0.0720605581569511,0.0802086761968785,2.89993674289095e-287
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GHR,Growth hormone receptor,24376,0.0718582030381687,0.00196116710584539,0.0680143155107117,0.0757020905656256,3.73391645300424e-286
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,29561,0.0546860593604511,0.00150535184593979,0.0517355697424091,0.0576365489784931,9.90165054824966e-283
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,29031,0.36457045189577,0.0100528817070931,0.344866803749868,0.384274100041673,1.11965776607667e-281
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APCS,Serum amyloid P-component,24721,0.0857697666857102,0.00236655954981739,0.0811313099680682,0.0904082234033523,2.82995925423898e-280
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GUSB,Beta-glucuronidase,29599,0.146960461920653,0.00407103563131691,0.138981232083271,0.154939691758034,2.72314716600562e-279
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL16,Pro-interleukin-16,29781,0.101633352728479,0.00281964628997135,0.0961068460001353,0.107159859456823,1.64049260841551e-278
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOMO1,Nodal modulator 1,29438,0.0577737307657829,0.0016058275397827,0.0546263087878088,0.060921152743757,1.94906814291533e-277
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNCA,Alpha-synuclein,24376,0.282768895972283,0.00791676531351774,0.267252035957788,0.298285755986778,2.20107668498087e-272
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,29781,0.184117018111005,0.00524722880758077,0.173832449648146,0.194401586573863,2.48369430418522e-264
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HGF,Hepatocyte growth factor,29781,0.0822842358672832,0.00234959086206701,0.0776790377776319,0.0868894339569345,2.43579937983821e-263
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KYNU,Kynureninase,29781,0.106929703512894,0.00310085205434411,0.10085203348638,0.113007373539409,1.50441415118861e-255
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,24376,-0.0716599299705432,0.00209722612616567,-0.0757704931778279,-0.0675493667632585,5.5342375904716e-250
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLUL1,Clusterin-like protein 1,29430,-0.105243478826527,0.0030867100890626,-0.11129343060109,-0.0991935270519642,6.32066974519393e-250
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,29576,0.155574035743636,0.00456866367022736,0.14661945494999,0.164528616537282,2.47678037682327e-249
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFH,Complement factor H,23688,0.0545303367556444,0.00159788861222165,0.05139847507569,0.0576621984355988,3.22886580054127e-249
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,29554,0.0544507611745987,0.00159947887064192,0.0513157825881405,0.0575857397610569,3.42081392359382e-249
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,29344,0.245020071532407,0.00723508468940934,0.230839305541165,0.25920083752365,1.2165256384129e-246
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST3,Cystatin-C,29525,0.0655774140195751,0.00194045294610167,0.0617741262452158,0.0693807017939343,1.13950963602682e-245
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24917,0.166331693838765,0.00496099496205978,0.156608143713128,0.176055243964402,4.31758102404172e-241
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFP,Properdin,24961,0.0526734261791084,0.00157741034422324,0.0495817019044309,0.055765150453786,3.25732401134358e-239
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,29731,0.0466342534496717,0.00140218458734879,0.0438859716584681,0.0493825352408754,3.63322776116864e-238
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29561,0.0814515797278605,0.00245644915921127,0.0766369393758064,0.0862662200799146,9.4787046053879e-237
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPM,Carboxypeptidase M,29579,0.0776660368498033,0.00234477502772735,0.0730702777954577,0.0822617959041489,2.90808730995056e-236
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMBP,Protein AMBP,29678,0.0454542766944987,0.00137778785972462,0.0427538124894384,0.0481547408995589,1.91636518313802e-234
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL16,C-C motif chemokine 16,29815,0.117394673870546,0.00357895186951696,0.110379928206292,0.124409419534799,7.52116497648386e-232
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,29365,0.045355126479687,0.00138615283044275,0.0426382669320192,0.0480719860273548,1.13370455963106e-230
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,29650,0.0701453893162299,0.00215020412433222,0.0659309892325387,0.0743597893999211,2.24853868863402e-229
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,P4HB,Protein disulfide-isomerase,29308,0.0863686884165148,0.00265270038373426,0.0811693956643957,0.091567981168634,1.86895555047353e-228
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF21,Fibroblast growth factor 21,29669,0.263913043503806,0.00811832551399973,0.248001125496366,0.279824961511245,8.1717112692048e-228
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA3F,Semaphorin-3F,29473,0.058694635163265,0.00180657695181111,0.0551537443377152,0.0622355259888148,1.57025077033818e-227
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,29486,0.0884894720996547,0.00272630284149451,0.0831459185303255,0.0938330256689839,4.23412946027123e-227
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFI,Complement factor I,24961,0.0442779534585248,0.00136548662583555,0.0416015996718871,0.0469543072451625,5.68543511802292e-226
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,29781,0.0726993303518099,0.00224750365196721,0.0682942231939542,0.0771044375096656,1.25307199274951e-225
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28926,0.0970103967704643,0.00300717088662138,0.0911163418326864,0.102904451708242,2.45583046083824e-224
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28792,0.139908879533275,0.00434472467973104,0.131393219161002,0.148424539905548,1.54257711287637e-223
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLAT,Tissue-type plasminogen activator,29731,0.110765772972056,0.00344115990981996,0.104021099548809,0.117510446395303,1.77175231244795e-223
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCS1,Neuronal calcium sensor 1,29720,0.0630680300327931,0.00196118605419143,0.0592241053665779,0.0669119546990083,4.57674358536305e-223
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL22,C-C motif chemokine 22,29164,0.113311025981651,0.0035391921545011,0.106374209358829,0.120247842604473,4.42103663928587e-221
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,29781,0.0919890364464572,0.00287714517390354,0.0863498319056063,0.0976282409873082,1.43221792843019e-220
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTA1,Glutathione S-transferase A1,29421,0.184501011234157,0.00577254365702312,0.173186825666392,0.195815196801923,2.19695277022178e-220
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,29678,0.0752667974855493,0.00235908251958851,0.0706429957471558,0.0798905992239428,1.17737098235363e-219
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,28926,0.12055162882054,0.00378324655826614,0.113136465566339,0.127966792074742,5.10355673589577e-219
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUCB2,Nucleobindin-2,29647,0.0813727098738494,0.00255570704075485,0.0763635240739698,0.0863818956737289,8.95904170554341e-219
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,29158,0.158803576814338,0.00498879986949875,0.149025529070121,0.168581624558556,1.30091780220908e-218
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,29344,0.173461493607014,0.00545306163912436,0.16277349279433,0.184149494419697,2.43468192828136e-218
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMPRSS15,Enteropeptidase,29344,0.19644310369153,0.00619631558929042,0.184298325136521,0.20858788224654,6.46721292001904e-217
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RTN4R,Reticulon-4 receptor,29720,0.0733014841313389,0.00231994180756026,0.0687543981885208,0.077848570074157,1.54492462151312e-215
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,29438,0.0596597261482968,0.00189238811601988,0.0559506454408978,0.0633688068556957,1.42141018036073e-214
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGR3,Anterior gradient protein 3,28759,0.128617339808607,0.00408225728833494,0.12061611552347,0.136618564093743,3.13702901274198e-214
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,28792,0.237782712363812,0.00755629080935544,0.222972382377475,0.252593042350149,9.96661441690223e-214
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UPB1,Beta-ureidopropionase,24917,0.197623888518908,0.00627390849253702,0.185327027873535,0.20992074916428,1.37411800462446e-213
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGF,Placenta growth factor,29781,0.0565217406781433,0.00179950452324893,0.0529947118125754,0.0600487695437112,4.52336184367253e-213
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,28792,0.127376963226472,0.00406111667744469,0.11941717453868,0.135336751914264,2.29560500399724e-212
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INHBC,Inhibin beta C chain,29438,0.0880594481531629,0.00283454099106985,0.082503747810666,0.0936151484956598,1.60086383195377e-208
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KITLG,Kit ligand,29473,-0.0795583846102027,0.0025635397977332,-0.0845829226137597,-0.0745338466066456,4.15415283522561e-208
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,29296,0.0550217755129552,0.00177362431785556,0.0515454718499583,0.0584980791759521,6.30482775573998e-208
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29213,0.156503065078802,0.00505319533046317,0.146598802231094,0.16640732792651,2.99182698330288e-207
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",29815,0.106112668671898,0.00342739509933219,0.0993949742772071,0.112830363066589,3.56866044564384e-207
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24376,0.105319472339912,0.00340194867043337,0.0986516529458622,0.111987291733961,1.93883930557158e-206
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPPC,C-type natriuretic peptide,29429,0.101396265342126,0.00328165433367589,0.0949642228481216,0.107828307836131,2.54225214092061e-206
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STC1,Stanniocalcin-1,29689,0.0919027867835661,0.00298139583478734,0.0860592509473829,0.0977463226197493,2.08570900874994e-205
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,29430,0.0669453979370286,0.0021721926376968,0.0626879003671428,0.0712028955069143,2.6731488372181e-205
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELN,Elastin,24917,0.0742540093923135,0.00241149127276956,0.0695274864976851,0.0789805322869418,2.28915460151371e-204
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTYMK,Thymidylate kinase,24917,0.144499999027954,0.00469777912492608,0.135292351943099,0.153707646112809,6.010179923642e-204
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24800,0.0582386524324233,0.0018944103739463,0.0545256080994885,0.061951696765358,1.03148040824318e-203
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSG2,Desmoglein-2,29438,-0.056750897928593,0.00185423941342063,-0.0603852071788975,-0.0531165886782886,1.531400574058e-202
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,29531,0.0697944865428404,0.00228418629408399,0.0653174814064358,0.0742714916792451,6.70215960110499e-202
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD72,B-cell differentiation antigen CD72,24376,0.0902189633542968,0.00294821664185199,0.0844404587362669,0.0959974679723267,7.77594341782625e-202
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSD,Cathepsin D,27437,0.0852146533956743,0.00279562449220429,0.0797352293909539,0.0906940774003947,1.02753692829467e-200
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDHR2,Cadherin-related family member 2,29344,0.151464365861611,0.00497999982981986,0.141703566195165,0.161225165528058,4.53948601652784e-200
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,24224,0.178413997757872,0.00586996507880572,0.166908866203413,0.189919129312331,3.58778144997498e-199
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACY1,Aminoacylase-1,29473,0.128361592666695,0.00423495984341435,0.120061071373603,0.136662113959787,9.58941084339998e-199
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,29438,0.0597378885689618,0.00197297888095655,0.055870849962287,0.0636049271756366,2.47587239408299e-198
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS8,Prostasin,29342,0.0849819818077783,0.00281693501335207,0.0794607891816082,0.0905031744339483,6.34392114342634e-197
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,29429,0.0780331437355347,0.00259601394064273,0.0729449564118749,0.0831213310591944,1.52503963468925e-195
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29492,0.0629936943555021,0.00209864139322044,0.05888035722479,0.0671070314862141,5.18255067608647e-195
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTA3,Glutathione S-transferase A3,28792,0.157240349424808,0.00526219853473598,0.146926440296726,0.167554258552891,3.11223448256937e-193
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",29344,0.16525185605596,0.00558591842041278,0.154303455951951,0.17620025615997,1.48398579275908e-189
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PROC,Vitamin K-dependent protein C,29540,0.0524870156191589,0.00177705116907402,0.0490039953277738,0.055970035910544,5.59594328523767e-189
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,28590,0.0398531605255801,0.00134931960947044,0.037208494091018,0.0424978269601421,6.93282679755492e-189
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,24840,0.0749628226339457,0.00253812501167362,0.0699880976110654,0.079937547656826,1.87441632044857e-188
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,29364,0.0394906774887145,0.00133949784874947,0.0368652617051656,0.0421160932722635,2.75961707218883e-188
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH2,Cadherin-2,29473,0.0717603952456599,0.00243505645522746,0.0669876845934141,0.0765331058979057,3.80397421133972e-188
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,24639,0.064436140966536,0.00218892732723249,0.0601458434051603,0.0687264385279117,3.19965316704926e-187
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDHR5,Cadherin-related family member 5,29473,0.0785080584561876,0.00267543180683905,0.073264212114783,0.0837519047975921,1.38290544394502e-186
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,24574,0.0528444356074156,0.00179896137238904,0.0493184713175331,0.0563703998972981,1.92084389883772e-186
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F9,Coagulation factor IX,29540,0.0364824260223687,0.00124930126816958,0.0340337955367563,0.0389310565079811,7.74112871185618e-185
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPL,N-acetylneuraminate lyase,24917,0.0900424035946313,0.00308559021982503,0.0839946467637742,0.0960901604254883,4.1689097270178e-184
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,28962,0.0880421389382499,0.00302297718719297,0.0821171036513517,0.0939671742251481,7.95289869227842e-184
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24106,0.136788677519596,0.00469116428074964,0.127593995529326,0.145983359509865,1.00265061831229e-183
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARB2,Lysosome membrane protein 2,28757,0.0636225696647856,0.00218634908624694,0.0593373254557416,0.0679078138738296,1.65618946628555e-183
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29815,0.0581928424470552,0.00200318579946217,0.0542665982801093,0.062119086614001,5.47157225613068e-183
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,29429,0.080121267150721,0.00276028720579248,0.0747111042273678,0.0855314300740743,1.15390192135181e-182
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLA,Alpha-galactosidase A,24324,0.0752080645102463,0.00259238871358309,0.0701269826316235,0.0802891463888692,5.99853692753595e-182
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29213,0.111991449526727,0.00386634687912292,0.104413409643646,0.119569489409808,6.68384620240662e-182
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,29449,0.055351124442878,0.00191260902614907,0.0516024107516258,0.0590998381341301,1.31208520603584e-181
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCLY,Selenocysteine lyase,29627,0.0959451426831258,0.00333125775635038,0.0894158774806791,0.102474407885573,6.24711146012065e-180
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29302,0.206856703771523,0.00720721915226993,0.192730554233074,0.220982853309972,1.09767375405187e-178
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CREG1,Protein CREG1,29074,0.0751383323869207,0.00261781656848197,0.0700074119126961,0.0802692528611454,1.10438368663291e-178
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28792,0.133432238486987,0.00466569509291415,0.124287476104875,0.142577000869099,2.12799842432396e-177
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300LG,CMRF35-like molecule 9,29438,-0.0738173709066853,0.00258321831849949,-0.0788804788109443,-0.0687542630024263,3.55353523127863e-177
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EZR,Ezrin,29689,0.0471196446864291,0.00165175297515734,0.0438822088551207,0.0503570805177375,1.31464157370084e-176
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,29531,0.101948445940883,0.00357670641108694,0.0949381013751528,0.108958790506614,2.60764930579915e-176
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEG1,Protein HEG homolog 1,24376,0.0536312694384253,0.00188019161249212,0.0499460938779407,0.0573164449989099,4.57151547359781e-176
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAXX,Protein PAXX,24376,0.0900756786346583,0.00315860942826197,0.0838848041552648,0.0962665531140517,5.52460707554849e-176
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,28926,0.166467058671462,0.00585604555252488,0.154989209388513,0.17794490795441,2.46245754289863e-175
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28792,0.161101583316866,0.005682517323857,0.149963849362107,0.172239317271626,2.07343939798178e-174
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F11R,Junctional adhesion molecule A,29438,0.109278953935127,0.00386483913156565,0.101703869237259,0.116854038632996,1.46743683795265e-173
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,29344,0.131710273617829,0.00465864624106558,0.122579326985341,0.140841220250318,1.61837737282801e-173
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24800,0.0585198967922024,0.00206858073066399,0.0544654785601009,0.0625743150243038,2.61052293128134e-173
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24360,0.0922187358857974,0.00325940733691795,0.0858302975054382,0.0986071742661565,2.67340557641549e-173
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GOLM2,Protein GOLM2,29689,0.0438543836960312,0.00155430362972504,0.0408079485817701,0.0469008188102923,7.39748890043733e-173
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,23820,0.0624997666830768,0.00221224842177965,0.0581637597763887,0.0668357735897649,9.58878910464032e-173
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGA5,Integrin alpha-5,29438,0.0485922872891012,0.00172333800082498,0.0452145448074843,0.0519700297707182,1.27526214061809e-172
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24225,0.075513981886322,0.00268787975610854,0.0702457375643493,0.0807822262082947,6.34798717500934e-171
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS1,Galectin-1,29473,0.0661173859014886,0.00236077220353905,0.061490272382552,0.0707444994204251,2.30805804995862e-170
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24800,0.270702110359212,0.00965437718929505,0.251779531068194,0.289624689650231,2.45613395420639e-170
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,24799,0.164494358989839,0.00587303978126156,0.152983201018566,0.176005516961111,5.69745424528594e-170
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRP1,Neuropilin-1,29623,-0.0533926405862966,0.00191312586425606,-0.0571423672802385,-0.0496429138923547,3.26564572819401e-169
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL18,Interleukin-18,29331,0.0882956620106098,0.00316599815895042,0.082090305619067,0.0945010184021526,5.89007790002948e-169
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUMB,Protein numb homolog,24224,0.161006232382538,0.00576573074048977,0.149705400131178,0.172307064633898,6.35663890232735e-169
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,29429,-0.0669931914743105,0.00240657808904534,-0.0717100845288393,-0.0622762984197816,2.32953353875048e-168
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM20A,Pseudokinase FAM20A,24917,0.0543963797238491,0.00195310521361672,0.0505682935051603,0.0582244659425379,3.92760408344145e-168
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29344,0.0856274442516052,0.00308102068942698,0.0795886437003283,0.091666244802882,8.14943903691521e-168
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOA1,Apolipoprotein A-I,24961,-0.0527073200712802,0.00189472082873235,-0.0564209728955956,-0.0489936672469648,9.54786768380704e-168
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29492,0.0647552579610136,0.00233445768376937,0.0601797209008256,0.0693307950212016,3.34387059600737e-167
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUOM,Fucose mutarotase,24376,0.122011066984104,0.00439797481517341,0.113391036346364,0.130631097621844,8.38234488028384e-167
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,29815,-0.0650231305895836,0.00234721187547198,-0.0696236658655087,-0.0604225953136585,8.54057672079625e-167
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",28911,0.175101370867976,0.00632604235275101,0.162702327856584,0.187500413879368,1.83808263765369e-166
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,29815,0.0751354533964162,0.00271778659049097,0.0698085916790539,0.0804623151137785,3.92563117333565e-166
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA4,Kallistatin,24552,0.0453856115131971,0.00164368839761542,0.0421639822538709,0.0486072407725233,2.68108365491801e-165
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,29669,0.0799670490834798,0.00290208820631652,0.0742789561990994,0.0856551419678602,4.64355401449004e-165
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MVK,Mevalonate kinase,28926,0.151030048023236,0.00548023186506627,0.140288793567706,0.161771302478766,4.69911836883635e-165
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFNA4,Ephrin-A4,29164,0.0583485919977713,0.002119506154513,0.0541943599349259,0.0625028240606168,1.00446472211428e-164
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,29344,0.0680649196376232,0.00247281310077315,0.0632182059601078,0.0729116333151386,1.08716401646502e-164
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,29344,0.235095248119891,0.00854624122310338,0.218344615322608,0.251845880917173,1.70187970991673e-164
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,29429,0.100887469425918,0.00366999753736883,0.0936942742526754,0.108080664599161,2.78245541897468e-164
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE4,Ribonuclease 4,24189,0.0522901231920977,0.0018996506714979,0.0485668078759618,0.0560134385082335,2.90823214220792e-164
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,29429,0.120497225010553,0.00438939047595893,0.111894019677673,0.129100430343432,7.68180612324797e-164
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,29213,-0.111586055545154,0.00406491638576651,-0.119553291661256,-0.103618819429051,8.15031036527207e-164
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,29429,0.106446217534233,0.00387853694798598,0.0988442851161803,0.114048149952285,9.2632746885206e-164
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAB2,Stabilin-2,24933,0.0532312943925304,0.0019413262689322,0.0494262949054233,0.0570362938796375,4.16857939616719e-163
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGLN1,Egl nine homolog 1,29429,0.102123461294108,0.00373859281295635,0.0947958193807139,0.109451103207503,2.90885363957733e-162
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FETUB,Fetuin-B,29540,0.0620305521070655,0.00227346413373039,0.0575745624049539,0.066486541809177,6.60789134199865e-162
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,24946,0.0418772365735788,0.0015337697514779,0.0388710478606821,0.0448834252864755,9.23988378929081e-162
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,29755,0.0717305016137738,0.002638009399224,0.0665600031912947,0.0769010000362528,7.68700176893818e-161
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28638,0.103010918542934,0.00378994860468598,0.0955826192777497,0.110439217808119,1.22856332253043e-160
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCN2,Ficolin-2,29376,0.0767668375490628,0.0028269588408108,0.0712259982210737,0.082307676877052,2.11000549667783e-160
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP5,Fatty acid-binding protein 5,29619,0.127103245869078,0.0046817671690366,0.117926982217767,0.13627950952039,2.42986975426916e-160
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,24788,0.130063630297053,0.00478977651368561,0.120675668330229,0.139451592263876,4.9446903405227e-160
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELOA,Elongin-A,29344,0.0976093563816388,0.00360180961599127,0.0905498095342959,0.104668903228982,9.15190864202568e-160
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,24788,0.0982201017757096,0.00362102974730146,0.0911228834709988,0.10531732008042,1.07759336455021e-159
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29213,0.0612291629908166,0.00226335984198328,0.0567929777005293,0.0656653482811038,3.30178133149401e-159
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,24788,0.148504265927646,0.00549555124304604,0.137732985491275,0.159275546364016,1.59235933796931e-158
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,24604,0.0592972955079526,0.00219967226510279,0.0549859378683511,0.0636086531475541,9.19044817158166e-158
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MLN,Promotilin,29429,0.164679522984607,0.00612725075388001,0.152670111507003,0.176688934462212,3.27989667332155e-157
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,29699,0.151342227367969,0.00563318763740452,0.140301179598657,0.162383275137282,4.14449490470384e-157
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GZMA,Granzyme A,29781,0.0641373402384888,0.0023882091400472,0.0594564503239963,0.0688182301529813,5.37525589882739e-157
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OCLN,Occludin,24863,0.0815165171234526,0.00303301070272327,0.075571816146115,0.0874612181007902,7.24485225889966e-157
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPIND1,Heparin cofactor 2,24909,0.0522572505377952,0.00194524249404055,0.0484445752494757,0.0560699258261147,9.90130471856839e-157
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD83,CD83 antigen,29429,0.0628480393553998,0.0023428697867738,0.0582560145733231,0.0674400641374764,1.26186988011734e-156
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL3,C-C motif chemokine 3,29429,0.111632977743422,0.00416646566568712,0.103466705038675,0.119799250448169,2.92119971758176e-156
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,29561,0.168462819478035,0.00628916086051733,0.156136064191421,0.180789574764649,3.44217590510745e-156
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,29815,0.0410664148529683,0.00153462411173611,0.0380585515939655,0.0440742781119711,6.60972011772549e-156
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,29669,0.0520775395130651,0.00195035556027633,0.0482548426149235,0.0559002364112067,3.10138961523524e-155
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCD5,Programmed cell death protein 5,29689,0.106380933972022,0.00398432332549728,0.0985716602540469,0.114190207689996,3.23197323610187e-155
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN3,Contactin-3,29438,0.0593133234788329,0.00222387266905221,0.0549545330474905,0.0636721139101752,7.07863701943362e-155
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,24376,0.0692375576893186,0.00259278556514106,0.0641556979816421,0.0743194173969951,7.1841110195474e-155
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,29576,0.0533124260018132,0.00200201459516275,0.0493884773952942,0.0572363746083322,2.06330544104321e-154
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EEF1D,Elongation factor 1-delta,24917,0.167622507660161,0.00629564669873184,0.155283040130647,0.179961975189676,4.9783441813074e-154
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SORD,Sorbitol dehydrogenase,29590,0.124542563809672,0.00469083316718378,0.115348530801992,0.133736596817352,1.61463227735785e-153
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL7,C-C motif chemokine 7,29429,0.107231632979316,0.0040423680817991,0.09930859153899,0.115154674419642,3.02020947677275e-153
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,29473,0.0586375970951812,0.00221148242268348,0.0543030915467216,0.0629721026436408,4.08425065416957e-153
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,24917,0.120597903849828,0.00454654297013624,0.111686679628361,0.129509128071295,6.61474139674885e-153
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,24800,0.109129046457046,0.00411999104333187,0.101053864012115,0.117204228901976,1.78116768389625e-152
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24235,0.154482406467082,0.00583136371796721,0.143052933579866,0.165911879354298,1.79896986105675e-152
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SYAP1,Synapse-associated protein 1,24376,0.10528201365227,0.00397604921602744,0.0974889571888566,0.113075070115684,2.41915057739671e-152
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,29429,0.101754291224841,0.00385780809891583,0.0941929873509657,0.109315595098716,1.49243323679538e-151
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,29187,0.0673759043333592,0.0025563173428793,0.0623655223413158,0.0723862863254026,2.55527656327885e-151
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,24917,0.102722384140414,0.00389737546325489,0.0950835282324345,0.110361240048394,5.05712540263575e-151
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MENT,Protein MENT,24376,-0.0413435794269804,0.00156869305464141,-0.0444182178140776,-0.0382689410398833,5.81349135591035e-151
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD63,CD63 antigen,29164,0.0928700131323008,0.00353784693196337,0.0859358331456526,0.099804193118949,3.94013803148864e-150
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,23400,-0.20083644408246,0.00764287643320948,-0.215816481891551,-0.18585640627337,5.20291644553647e-150
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRP,Gastrin-releasing peptide,24235,0.0978338014300026,0.00372527366802093,0.0905322650406816,0.105135337819324,6.51456716179594e-150
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24235,0.10383363582136,0.00395450050833855,0.0960828148250163,0.111584456817703,7.42168353315263e-150
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,29429,0.077439401582552,0.00295684542783884,0.0716439845439879,0.0832348186211161,1.79835576845424e-149
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HJV,Hemojuvelin,24863,0.0799379508277578,0.00305856085951092,0.0739431715431164,0.0859327301123992,1.45568577937833e-148
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,29164,0.160599544452684,0.00616240205777954,0.148521236419436,0.172677852485932,4.99946735795711e-148
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DKK1,Dickkopf-related protein 1,29689,0.106251844057518,0.00408631444157126,0.098242667752038,0.114261020362997,2.11801043839407e-147
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29356,0.0483322674056205,0.00186205118435506,0.0446826470842846,0.0519818877269564,7.0141282322043e-147
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOST,Sclerostin,29428,0.0692552506518984,0.0026698974527188,0.0640222516445696,0.0744882496592273,1.07509554511484e-146
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP20,Centrosomal protein 20,28792,0.13273896861014,0.00512687268828746,0.122690298141097,0.142787639079184,3.99214074177372e-146
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RTBDN,Retbindin,29344,0.0529103513734952,0.00204571941061979,0.0489007413286804,0.05691996141831,7.34653625783655e-146
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,29689,0.0617143052371436,0.00239135672425124,0.0570272460576111,0.066401364416676,2.95422591752664e-145
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29344,0.0592269915939526,0.0022964655984029,0.0547259190210829,0.0637280641668223,4.70619478117053e-145
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PENK,Proenkephalin-A,24376,0.0551859863469699,0.00213883550068735,0.0509938687656227,0.0593781039283171,7.45501586276112e-145
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29428,0.202771017616062,0.00788016861867903,0.187325887123451,0.218216148108673,2.04724504584458e-144
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCHE,Cholinesterase,24523,0.0499215554213912,0.00194098115572806,0.0461172323561642,0.0537258784866182,5.7144626948913e-144
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KHK,Ketohexokinase,24235,0.113719294634444,0.00442521884314047,0.105045865701889,0.122392723566999,1.03755596382502e-143
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,29369,0.057933439300985,0.00226422207843497,0.0534955640272524,0.0623713145747175,7.95967388861676e-143
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,29385,0.0886801563678043,0.00346959113352004,0.081879757746105,0.0954805549895036,1.57089901469805e-142
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNF,Tumor necrosis factor,28863,0.0674460543734446,0.00264180472671272,0.0622681171090877,0.0726239916378015,3.45599853689949e-142
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29344,0.0697287483549035,0.00273230782056072,0.0643734250266045,0.0750840716832025,4.20581524485998e-142
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNCG,Gamma-synuclein,29213,0.117621917551766,0.00460957803392178,0.108587144605279,0.126656690498253,4.63342481529521e-142
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,29720,0.224809481073226,0.00883300796135321,0.207496785468973,0.242122176677478,2.25566382926774e-141
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,29689,0.116943029659508,0.00459920847965649,0.107928581039381,0.125957478279634,4.14874853961277e-141
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,24840,0.0552953949711157,0.00217342672610784,0.0510354785879443,0.0595553113542871,5.60628710815362e-141
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29344,0.0771155177280534,0.00304100283486117,0.0711551521717255,0.0830758832843813,2.35732042157178e-140
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,29344,0.104119174365869,0.00410685292751484,0.0960697426279403,0.112168606103799,2.73881460019514e-140
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29781,0.0675482147060061,0.00267951552314875,0.0622963642806345,0.0728000651313776,9.11484998098609e-139
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,24190,0.211301420026046,0.00837829262932981,0.194879966472559,0.227722873579532,1.49099358749165e-138
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,29168,0.049336037809317,0.00195994238815802,0.0454945507285273,0.0531775248901067,2.43193469310726e-138
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OGFR,Opioid growth factor receptor,29344,0.0567008978922365,0.00225610966254624,0.0522789229536459,0.0611228728308272,6.39648494856404e-138
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,29561,0.058199576253046,0.00231704800492364,0.0536581621633957,0.0627409903426963,8.85099542466173e-138
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NT5E,5'-nucleotidase,29561,0.0972312603741343,0.00387280018857207,0.089640572004533,0.104821948743736,1.18339014578821e-137
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TTR,Transthyretin,24702,0.0439344637534271,0.0017529894554756,0.0404986044206949,0.0473703230861593,6.553609516906e-137
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYH9,Myosin-9,24933,0.195256791159482,0.00779457272835111,0.179979428611914,0.21053415370705,8.53150796548173e-137
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,29386,0.0496670441963509,0.00199075451341144,0.0457651653500645,0.0535689230426374,5.73729523720152e-136
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,29561,0.0436342875184876,0.00175085526574879,0.04020261119762,0.0470659638393552,1.09371977089608e-135
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MME,Neprilysin,29344,0.138054266565424,0.00553999426046602,0.12719587781491,0.148912655315937,1.1796468323654e-135
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BECN1,Beclin-1,24235,0.103701827354024,0.00416481959197013,0.0955387809537623,0.111864873754285,3.77501013838526e-135
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29344,0.0748724915409831,0.00301455002126322,0.0689639734993072,0.080781009582659,8.83972274539502e-135
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,29781,0.0951681374315053,0.00383521878371035,0.087651108615433,0.102685166247578,1.46953974465804e-134
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,24376,0.130039591434294,0.0052351138522131,0.119778768283956,0.140300414584632,1.57044519742037e-134
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,24235,0.124472458516895,0.00501195366632262,0.114649029330902,0.134295887702887,1.80204433317488e-134
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,29429,0.0977038923247847,0.00393974883268172,0.0899819846127285,0.105425800036841,2.18352961520997e-134
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FYB1,FYN-binding protein 1,29395,0.157229909194144,0.00634396447691426,0.144795738819392,0.169664079568896,3.18341004109256e-134
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,29213,0.0586125216384117,0.00236547487736876,0.0539761908787689,0.0632488523980545,3.74141661473838e-134
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,29627,0.124000285836416,0.00501145568365149,0.114177832696459,0.133822738976373,8.37299975702052e-134
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HNMT,Histamine N-methyltransferase,29077,0.0804399844007371,0.00325231827493879,0.0740654405818571,0.0868145282196171,1.13824936448985e-133
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,29678,0.0983791287623762,0.00398184330837388,0.0905747158779634,0.106183541646789,2.01624590287454e-133
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29599,0.0987822565501454,0.00399811041142483,0.0909459601437527,0.106618552956538,2.0178660108334e-133
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENO3,Beta-enolase,24235,0.10287713111261,0.00416099377380651,0.0947215833159492,0.111032678909271,2.64290031400147e-133
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SORT1,Sortilin,29428,0.0633405117954077,0.00257094845027443,0.0583014528328698,0.0683795707579456,1.12448177003235e-132
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HLA_E,,29429,0.0492614580820944,0.00200301491112687,0.0453355488562858,0.0531873673079031,3.20549250415665e-132
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL12A_IL12B,Interleukin-12,29344,0.131923451830106,0.00536502978224503,0.121407993456905,0.142438910203306,3.57410122824415e-132
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AFM,Afamin,24961,0.0330068534383875,0.00134700579375486,0.030366722082628,0.035646984794147,4.7609272240411e-131
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAB2,Disabled homolog 2,29720,0.186694589112907,0.00762815159202163,0.171743411992545,0.201645766233269,5.49861441109303e-131
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCXR,L-xylulose reductase,29561,0.090491882106474,0.0037013284127385,0.0832372784175066,0.0977464857954415,1.04141638801648e-130
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,28769,0.0471844929667182,0.00193044612337325,0.0434008185649066,0.0509681673685297,1.31120187634987e-130
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24840,0.0677872359796475,0.00277177433477767,0.0623545582834832,0.0732199136758117,1.51413725691798e-130
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PXN,Paxillin,28769,0.0867379185521187,0.00355506085196418,0.0797699992822689,0.0937058378219685,3.74913487924766e-130
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTDH,Protein LYRIC,24224,0.157276923630749,0.0064439362240232,0.144646808631663,0.169907038629834,5.37237090559026e-130
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,29438,0.0895376045241911,0.00367603519025337,0.0823325755512945,0.0967426334970877,9.41354056587994e-130
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BID,BH3-interacting domain death agonist,29429,0.111816302221666,0.0045973531359873,0.102805490075131,0.120827114368201,2.18657194421045e-129
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFA,Protransforming growth factor alpha,29429,0.0783845325745723,0.00322639521509547,0.0720607979529852,0.0847082671961595,4.17696579773363e-129
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",29344,0.101463654746215,0.00418397500374714,0.0932630637388706,0.109664245753559,1.20878537945631e-128
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,24235,0.0531029348732931,0.00218901757444087,0.048812460427389,0.0573934093191972,1.82157202184703e-128
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OXT,Oxytocin-neurophysin 1,29689,0.232349732342686,0.00959540675177924,0.213542735109199,0.251156729576173,2.7445703982348e-128
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24235,0.0768029947628411,0.00317672192186539,0.0705766197959849,0.0830293697296973,1.2700904224454e-127
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,24788,0.0953246486175211,0.0039492911411261,0.0875840379809139,0.103065259254128,3.00419849481427e-127
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,29752,-0.103443259943764,0.0042945799134074,-0.111860636574043,-0.0950258833134858,5.65262220442902e-127
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THOP1,Thimet oligopeptidase,29338,0.0513490892593064,0.0021324337240176,0.0471695191602319,0.0555286593583809,6.9189058971057e-127
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,29781,0.12568654483717,0.00522127261193403,0.11545285051778,0.135920239156561,8.0239096862583e-127
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSO,Cathepsin O,29781,0.0503400009713873,0.00209491699703731,0.0462339636571942,0.0544460382855804,2.18668115114505e-126
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29473,0.0466347740952592,0.00194080541355575,0.04283079548469,0.0504387527058285,2.30528162971513e-126
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,29438,0.0388669931092127,0.00162087836236893,0.0356900715189696,0.0420439146994558,7.44978034598884e-126
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,24106,0.10357646461947,0.00431785103976242,0.0951134765815354,0.112039452657404,1.10599876626887e-125
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C9,Complement component C9,24946,-0.0883215142485554,0.00368278640759239,-0.0955397756074365,-0.0811032528896743,1.13009889147521e-125
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINH1,Serpin H1,24440,0.213661105700415,0.00891523125055036,0.196187252449336,0.231134958951494,1.7753671943014e-125
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,28911,0.0854948330577161,0.00357352990634418,0.0784907144412815,0.0924989516741507,2.82272137386308e-125
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,24863,0.0959767372431599,0.00400846585112925,0.0881201441749465,0.103833330311373,2.83519478813718e-125
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CES3,Carboxylesterase 3,29344,0.115251434194893,0.00481990934292346,0.105804411882763,0.124698456507023,3.67266899164235e-125
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,28911,0.120418269221578,0.00504224877346173,0.110535461625593,0.130301076817563,7.67842180536499e-125
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOD,Apolipoprotein D,23783,-0.0720104869030322,0.00301231537916774,-0.0779146250462009,-0.0661063487598634,8.01258206187026e-125
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PALM2,Paralemmin-2,24840,0.0626201511053845,0.00262288662745505,0.0574792933155727,0.0677610088951964,1.43006311712e-124
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28792,0.0840096793074985,0.00352395896099572,0.0771027197439469,0.0909166388710502,2.09237208545668e-124
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,24224,0.131523549583943,0.00551292441660997,0.120718217727387,0.142328881440498,2.31785660853933e-124
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,29286,0.0501461954087049,0.00210742840913173,0.0460156357268067,0.0542767550906031,5.67442198822995e-124
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,29689,0.111323964987584,0.00468058232455569,0.102150023631454,0.120497906343713,7.03679555616391e-124
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,29344,0.138891132912293,0.00583958957064585,0.127445537353827,0.150336728470758,7.2268574945784e-124
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COCH,Cochlin,24917,0.0761474400280994,0.00319947390651132,0.0698764711713372,0.0824184088848616,8.06756324373275e-124
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUS,RNA-binding protein FUS,28760,0.0649727676051762,0.00273250662082259,0.0596170546283639,0.0703284805819885,8.91868267096787e-124
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,29576,0.0443742057204227,0.00186693472266437,0.0407150136640005,0.0480333977768448,1.02662724964872e-123
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELP,P-selectin,29589,0.0930737459243568,0.00392204241065144,0.08538654279948,0.100760949049234,2.46366180558552e-123
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEP,Leptin,29473,0.110194850764345,0.00464421610958841,0.101092187189552,0.119297514339138,2.70777629017077e-123
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29781,0.0622626034207757,0.00262432696891349,0.0571189225617052,0.0674062842798461,2.77122648349732e-123
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD6,T-cell differentiation antigen CD6,29755,0.086231022929175,0.00363547154818391,0.0791054986947345,0.0933565471636155,3.18133374948952e-123
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,24204,0.092931516914249,0.00393588836832579,0.0852171757123304,0.100645858116168,7.05557902650201e-122
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FST,Follistatin,29531,0.0822723042127175,0.00349109048064749,0.0754297668706485,0.0891148415547866,1.13661794238787e-121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATRN,"Attractin, Isoform 2",24961,0.0271317256056504,0.00115042841435569,0.0248768859135132,0.0293865652977875,1.20633156500661e-121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSZ,Cathepsin Z,29482,0.0514116691481212,0.00218234591025495,0.0471342711640215,0.0556890671322209,1.38601780540124e-121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24376,0.0357314833374084,0.00151602486273998,0.032760074606438,0.0387028920683787,1.82660172974355e-121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,29689,0.128080829441734,0.00544061675099305,0.117417220609787,0.13874443827368,1.98972378706918e-121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD22,B-cell receptor CD22,29781,0.0680502955660973,0.00289074245382664,0.0623844403565971,0.0737161507755975,2.0126836901803e-121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,28911,0.0564817984022723,0.00240059498541063,0.0517766322308675,0.0611869645736771,2.9009985931221e-121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24863,0.0783235443817856,0.00333005990014055,0.0717966269775101,0.0848504617860611,5.32969823323616e-121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL17,C-C motif chemokine 17,29409,0.147528598977246,0.00627813630290919,0.135223451823544,0.159833746130948,5.48633902498889e-121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMOX2,Heme oxygenase 2,28769,0.0757910390583874,0.00322611301868292,0.0694678575417689,0.0821142205750059,6.63719275553352e-121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BST2,Bone marrow stromal antigen 2,29689,0.0851929791632838,0.00362756468284748,0.0780829523849028,0.0923030059416649,7.3838168165411e-121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,29344,0.184381052796663,0.00785924714747247,0.168976928387617,0.199785177205709,1.33871516086496e-120
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,24840,0.175623233407078,0.0074804184101932,0.160961613323099,0.190284853491057,1.42001172783069e-120
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,28769,0.0837067813649846,0.00356864533614393,0.0767122365061425,0.0907013262238267,1.55195276671808e-120
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24376,0.0469049988213597,0.00199878650819236,0.0429873772653027,0.0508226203774167,1.93513409873358e-120
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIAE,Sialate O-acetylesterase,29490,0.0754281370850322,0.00321971279421072,0.0691175000083792,0.0817387741616852,2.85684081017635e-120
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TALDO1,Transaldolase,24883,0.0721829216909905,0.00307857803687895,0.0661489087387077,0.0782169346432732,2.87442457837802e-120
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24800,0.132083976781096,0.00563626264787894,0.121036901991253,0.143131051570939,3.83909860742034e-120
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29781,0.159668391044232,0.00683116229401725,0.146279312947958,0.173057469140506,9.54027821241887e-120
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29213,0.0626051460279731,0.00269189935865945,0.0573290232850006,0.0678812687709456,1.45259738160629e-118
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,29561,0.039822847402387,0.00171324413743626,0.0364648888930119,0.0431808059117621,1.88912021414139e-118
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD302,CD302 antigen,29344,0.0490963604731814,0.00211224895259279,0.0449563525260995,0.0532363684202633,1.94420969726521e-118
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBP1,Guanylate-binding protein 1,24811,0.104059301017937,0.00447737052350709,0.0952836547918629,0.112834947244011,3.20879523158935e-118
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24800,0.166471183346636,0.00717114048113269,0.152415748003616,0.180526618689657,5.95821851476603e-118
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24235,0.156192964517736,0.00672921886674753,0.143003695538911,0.169382233496561,6.8010628531122e-118
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,29429,0.0593473244759686,0.00255942097845309,0.0543308593582005,0.0643637895937366,6.91316361695725e-118
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24735,0.175543255827045,0.00756434293620456,0.160717143672084,0.190369367982006,7.09931936656165e-118
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA6,Carbonic anhydrase 6,29367,-0.101388594981957,0.00437307833579558,-0.109959828520116,-0.0928173614437976,7.45307257630931e-118
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,24840,0.0758945389169069,0.00327791291158372,0.0694698296102028,0.082319248223611,2.35924580445712e-117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,29689,0.103773217190935,0.00448823744189825,0.0949762718048144,0.112570162577056,3.0902105017788e-117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSS,Cathepsin S,23386,0.0389808488192467,0.00168474223079596,0.0356787540468867,0.0422829435916068,4.01710310877795e-117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,29438,0.0817313795421955,0.00353807098211377,0.0747967604172525,0.0886659986671385,5.03747367394944e-117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,29561,0.0887114566940563,0.0038433422438331,0.0811785058961434,0.0962444074919692,7.62852046699129e-117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300E,CMRF35-like molecule 2,29637,0.0650788119184253,0.00281964280864277,0.0595523120134855,0.0706053118233651,7.81616686596724e-117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,29473,0.0575955023170156,0.00249737143218938,0.0527006543099244,0.0624903503241067,1.19348298033275e-116
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SRPK2,SRSF protein kinase 2,29429,0.133325898403892,0.00578696666467261,0.121983443741133,0.14466835306665,2.03894086601777e-116
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,28792,0.0787111965018893,0.00342028266299643,0.0720074424824163,0.0854149505213623,3.8639103295818e-116
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,QDPR,Dihydropteridine reductase,29340,0.068569592710436,0.00298047485990019,0.0627278619850316,0.0744113234358404,4.31078259331143e-116
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTBS,Di-N-acetylchitobiase,24648,0.0434944041672208,0.00189088673239172,0.039788266171733,0.0472005421627085,7.38503656473936e-116
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,29689,0.0728738877004677,0.00317382362138066,0.0666531934025616,0.0790945819983738,1.17004666249775e-115
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,29576,0.206071779559398,0.00897602597248248,0.188478768653333,0.223664790465464,1.26012242055286e-115
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAG1,Dystroglycan,29576,0.07511682140886,0.00327678455012097,0.0686943236906229,0.0815393191270971,2.72030371247773e-115
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NIT2,Omega-amidase NIT2,24808,0.1180662246936,0.00515238474820932,0.10796755058711,0.128164898800091,5.17652715780392e-115
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTN1,Dynactin subunit 1,29720,0.102657469429474,0.00448600938927804,0.0938648910264887,0.111450047832459,6.63379695539404e-115
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXLNA,Alpha-taxilin,29213,0.140111232628275,0.00612308269193762,0.128109990552077,0.152112474704473,7.12892679197205e-115
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD2AP,CD2-associated protein,29473,0.100449899194692,0.0043932604672194,0.0918391086789422,0.109060689710442,1.04582943789862e-114
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSTB,Cystatin-B,29025,0.0671841207697961,0.0029389016427162,0.0614238735500724,0.0729443679895199,1.19223357115652e-114
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARSB,Arylsulfatase B,29344,0.0870922498950279,0.00381327146554875,0.0796182378225523,0.0945662619675034,1.86613951724433e-114
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARF6,ADP-ribosylation factor 6,24800,0.169397612840619,0.00741540639686069,0.154863416302772,0.183931809378466,2.54252707332858e-114
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MUC13,Mucin-13,28769,0.0812223326454851,0.00355866216731049,0.0742473547975566,0.0881973104934137,2.76081104026041e-114
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,24840,0.0998622107387291,0.00437454361737025,0.0912881052486834,0.108436316228775,3.62164448169254e-114
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,29344,0.132865720576222,0.00583295130408735,0.121433136020211,0.144298305132233,7.30474868392399e-114
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24917,0.121409072100737,0.00533008738605376,0.110962100824072,0.131856043377403,1.09887232260986e-113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,24863,0.0997365722710152,0.00438015317090336,0.0911514720560447,0.108321672485986,1.32020903356132e-113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29438,0.0470139937334312,0.00206700373325498,0.0429626664162515,0.051065321050611,1.53566656380087e-113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,29438,0.0380666703094622,0.00167504860524777,0.0347835750431766,0.0413497655757478,2.36482056853627e-113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A4,Protein S100-A4,29561,0.0893942190994289,0.00393689515378244,0.0816779045980153,0.0971105336008425,3.57827737990653e-113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24840,0.064092103034586,0.00282068861962342,0.0585635533401241,0.069620652729048,3.86127084085589e-113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL5,C-C motif chemokine 5,29589,0.157391301757802,0.00693760480560749,0.143793596338811,0.170989007176792,5.59475973432841e-113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,29014,0.0351306875876994,0.00154883836127726,0.0320949643995959,0.0381664107758028,6.4953008050222e-113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLIN1,Perilipin-1,28769,0.0546643866109335,0.00241023006413196,0.0499403356852349,0.0593884375366322,6.89262811049378e-113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23716,0.0778744524178971,0.00343606613245483,0.0711397627982856,0.0846091420375085,1.60032211487776e-112
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERBIN,Erbin,29344,0.160109135132841,0.00708055750516803,0.146231242422712,0.173987027842971,2.98093723386931e-112
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,24815,0.170802250499016,0.00755612108501206,0.155992253172393,0.18561224782564,5.30455642652211e-112
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C3,Complement C3,23774,0.0729015350787789,0.00322516376298263,0.0665802141033329,0.0792228560542248,6.00406201212827e-112
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,24799,0.0921053353041432,0.00407949253344422,0.0841095299385926,0.100101140669694,9.63654746252475e-112
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBKS,Ribokinase,28790,0.0775515256999904,0.00344383348627349,0.0708016120668944,0.0843014393330865,2.48463019235465e-111
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,28769,0.122876350974467,0.00545955722930886,0.112175618805021,0.133577083143912,3.26877562390394e-111
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX15,Sorting nexin-15,24376,0.0845366571051293,0.0037533576624343,0.077180076086758,0.0918932381235005,3.38092490937735e-111
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,29213,0.0899610805706183,0.00399957736959293,0.0821219089262162,0.0978002522150204,4.31232299528913e-111
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24863,0.131289541078156,0.00583473597683618,0.119853458563557,0.142725623592755,5.17838427377402e-111
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,29429,0.0782701946108937,0.00348237221596113,0.0714447450676099,0.0850956441541775,6.12178079793831e-111
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,29429,0.0516237514820196,0.00229838953954323,0.0471189079845149,0.0561285949795244,8.58476355645909e-111
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COLEC12,Collectin-12,29449,0.0409593597795605,0.00182421337447711,0.0373839015655854,0.0445348179935357,1.01584514497136e-110
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN2,CCN family member 2,29473,0.0885263615310701,0.00394449858588493,0.0807951443027357,0.0962575787594046,1.26978667362326e-110
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEFTY2,Left-right determination factor 2,29669,0.0805506982590552,0.00358959806218125,0.0735150860571799,0.0875863104609304,1.33692640461829e-110
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XCL1,Lymphotactin,29720,0.0861413754277788,0.0038392073788106,0.0786165289653101,0.0936662218902476,1.41567209250475e-110
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EREG,Proepiregulin,29158,0.124365809509782,0.00554664682491174,0.113494381732955,0.135237237286609,2.07503692334776e-110
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29213,0.0827584733283925,0.00369821930837096,0.0755099634839855,0.0900069831727996,5.44175078645621e-110
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24917,0.0986311996045525,0.00441027797475346,0.0899870547740357,0.107275344435069,1.06354776244641e-109
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYDGF,Myeloid-derived growth factor,24917,0.154674389871945,0.00691658726401036,0.141117878834485,0.168230900909405,1.09010096827991e-109
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TREML2,Trem-like transcript 2 protein,29438,0.0524367848602716,0.0023484211136154,0.0478338794775854,0.0570396902429578,1.58934021816759e-109
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,29448,0.077028790320429,0.00345103759815046,0.0702647566280541,0.0837928240128039,1.89608103408547e-109
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDCP1,CUB domain-containing protein 1,29213,0.0803960551656979,0.00360189418298846,0.0733363425670405,0.0874557677643553,1.92705036537911e-109
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IDUA,Alpha-L-iduronidase,29720,0.0711595768507508,0.00318895969459521,0.0649092158493442,0.0774099378521575,2.1284529743301e-109
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS2,Trypsin-2,29589,0.0825214457472518,0.00370144775124286,0.0752666081548158,0.0897762833396878,3.33247153636523e-109
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EHBP1,EH domain-binding protein 1,24917,0.115307191224474,0.00517291726596837,0.105168273383176,0.125446109065772,5.31860290949767e-109
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NECTIN2,Nectin-2,29428,0.0459501964020616,0.00206454393576416,0.0419036902879639,0.0499967025161594,7.68304859695083e-109
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL12B,Interleukin-12 subunit beta,29781,0.0838033130386502,0.00376686031013086,0.0764202668307937,0.0911863592465067,9.19596808466577e-109
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29561,0.14622567704385,0.00657469064683241,0.133339283376058,0.159112070711642,1.08432567952884e-108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29213,0.0885534543293856,0.00398167141126304,0.08074937836331,0.0963575302954611,1.12122224277809e-108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,28769,0.0940607726721254,0.00423304069322892,0.0857640129133967,0.102357532430854,1.77998520218092e-108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,24376,0.12809323776794,0.00576112028555149,0.116801442008259,0.139385033527621,1.92894597426797e-108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,29815,0.102747402283358,0.00463047266038326,0.093671675869007,0.111823128697709,3.2767215505844e-108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R9B,Neurabin-2,29781,0.144497348567386,0.00651562555844221,0.131726722472839,0.157267974661933,4.30233992324627e-108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK10,Kallikrein-10,29461,0.0613149474938585,0.00276673433011182,0.0558921482068394,0.0667377467808777,6.1772021791454e-108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,29755,0.0787317951394685,0.00355284955588903,0.071768210009926,0.085695380269011,6.23063767785379e-108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FN1,Fibronectin,24961,0.0409833737527614,0.00185467630256587,0.0373482081997323,0.0446185393057905,3.58183075674627e-107
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,29678,0.0960982002489148,0.00435609968358437,0.0875602448690894,0.10463615562874,5.48738100423417e-107
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTSS1,Protein MTSS 1,24800,0.170067164972123,0.00770672568105053,0.154961982637264,0.185172347306982,6.9655182117806e-107
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHBG,Sex hormone-binding globulin,24946,-0.0789610039705096,0.00357929832291135,-0.0859764286834158,-0.0719455792576034,7.97959499741283e-107
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,29110,0.055114396372314,0.00250596553661147,0.0502027039205555,0.0600260888240725,2.45924590335033e-106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24863,0.14895410072559,0.0067680755695981,0.135688672609178,0.162219528842002,2.48691857568565e-106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMSB10,Thymosin beta-10,29438,0.11548411639445,0.0052512942491813,0.105191579666055,0.125776653122846,2.49735885281336e-106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PYY,Peptide YY,24106,0.148292418269274,0.00673928231835524,0.135083424925297,0.16150141161325,2.92524616706071e-106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MINK1,Misshapen-like kinase 1,24840,0.141624910020439,0.00643760321156709,0.129007207725768,0.154242612315111,3.00856684636659e-106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,28792,0.097410532952081,0.00443189475875913,0.0887240192249131,0.106097046679249,3.3928296316591e-106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29213,0.0670142831658622,0.0030491618548689,0.0610379259303191,0.0729906404014052,3.40548099704336e-106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,29561,0.0403375963719105,0.00183623471195301,0.0367385763364826,0.0439366164073384,4.16637698572107e-106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPD52L2,Tumor protein D54,24376,0.16530846929752,0.00752113487651535,0.15056704493955,0.18004989365549,4.88938060632911e-106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29213,0.143398471308665,0.00654939761662997,0.13056165198007,0.156235290637259,2.05087640667716e-105
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,29344,0.0493502324183121,0.00225572882883514,0.0449290039137952,0.053771460922829,2.94558159341032e-105
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,29576,0.189273745855699,0.00865181960213107,0.172316179435522,0.206231312275876,2.96334154378892e-105
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD244,Natural killer cell receptor 2B4,29781,0.0408177807407062,0.00187214247855528,0.0371483814827379,0.0444871799986746,1.44133275171154e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24440,0.170730746802714,0.0078252794785791,0.155393199024699,0.186068294580729,1.56541829507658e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,24800,0.116065706137441,0.00532104122623567,0.105636465334019,0.126494946940863,1.69530966888378e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CES2,Cocaine esterase,29344,0.0824301304811057,0.00378366207438582,0.0750141528153095,0.0898461081469019,2.13115383750514e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,28792,0.100549073537581,0.00461625515873205,0.0915012134264659,0.109596933648696,2.42256081424623e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,29576,0.158918542858987,0.00729836461823104,0.144613748207254,0.17322333751072,2.67471014403431e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA4D,Semaphorin-4D,29689,0.0451125414384393,0.00207189543903321,0.0410516263779342,0.0491734564989444,2.71226275518691e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,29429,0.0417704630445979,0.00191966402018591,0.0380079215650335,0.0455330045241623,3.74824256284435e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,29438,0.0862846145486846,0.00396712160961339,0.0785090561938423,0.0940601729035268,4.57609283280416e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE6,Ribonuclease K6,24823,0.0464328249207745,0.00213363488096496,0.0422509005540832,0.0506147492874659,4.96793270270091e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBPL,FK506-binding protein-like,24800,0.089416007391877,0.00410891448423674,0.081362535002773,0.097469479780981,5.06881280225513e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MARCO,Macrophage receptor MARCO,29473,0.0396571052372263,0.00182377431385708,0.0360825075820664,0.0432317028923861,5.12715377604682e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH3GLB2,Endophilin-B2,24840,0.100293462049187,0.00461299345368941,0.0912519948799558,0.109334929218418,7.73941462282496e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,29815,0.0525998968918748,0.0024221461838929,0.0478524903714447,0.0573473034123049,9.20328654022284e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL18BP,Interleukin-18-binding protein,29589,0.0463712308566125,0.00213802671048509,0.0421806985040617,0.0505617632091632,1.67925175508012e-103
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,29576,0.0580178232130091,0.00267757536042455,0.052769775506577,0.0632658709194412,2.619447119869e-103
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,29379,0.170476622739278,0.00787148272026112,0.155048516607566,0.18590472887099,3.32216215231602e-103
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSL,Cathepsin L1,29473,0.0365076649867511,0.00168662133830142,0.0332018871636804,0.0398134428098219,4.27259818368532e-103
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,24840,0.135789909399422,0.00627013661279832,0.123500441638337,0.148079377160507,4.7378844234556e-103
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLA2,Src-like-adapter 2,24863,0.157247520375254,0.00726413670979331,0.143009812424059,0.171485228326449,5.78952851800442e-103
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,24800,0.0601582312716606,0.00278297697969943,0.0547035963914497,0.0656128661518715,1.11630335647163e-102
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,24800,0.136142107811337,0.00629845172529706,0.123797142429755,0.14848707319292,1.14839052727837e-102
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDT,D-dopachrome decarboxylase,24933,0.0611307551976315,0.00282904447629457,0.0555858280240941,0.0666756823711689,1.31463806278446e-102
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28911,0.143332999539709,0.00663769426380492,0.130323118782651,0.156342880296767,1.33169456738246e-102
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24235,0.103848211724762,0.00480756881937281,0.0944253768387918,0.113271046610733,1.63242859005062e-102
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,24133,0.074989160692059,0.00347611486346559,0.0681759755596664,0.0818023458244515,3.00343004144593e-102
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USO1,General vesicular transport factor p115,29344,0.133968339227796,0.00621681303251273,0.121783385684071,0.146153292771521,3.33578566914831e-102
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,29599,0.0487150498664996,0.00226685902281965,0.0442720061817731,0.0531580935512261,1.15560266772103e-101
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29213,0.0622124628862436,0.00289493467141979,0.0565383909302609,0.0678865348422264,1.18302130173353e-101
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300A,CMRF35-like molecule 8,24376,0.0447018700692136,0.00208444636298232,0.0406163551977682,0.0487873849406589,4.33670080566782e-101
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,29689,0.142075170264771,0.00663070253040388,0.129078993305179,0.155071347224362,4.38650446992016e-101
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,METAP2,Methionine aminopeptidase 2,29669,0.0850604679694694,0.00397469074476456,0.0772700741097308,0.0928508618292079,7.66278928853481e-101
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASET2,Ribonuclease T2,29692,0.0393306831669707,0.00183798128725862,0.0357282398439438,0.0429331264899976,7.92824335380452e-101
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,29781,0.068701853214047,0.00321064241084568,0.0624089940887894,0.0749947123393045,8.00198279546582e-101
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFC,Platelet-derived growth factor C,28792,0.0427882247647936,0.00200316291635757,0.0388620254487328,0.0467144240808544,1.8861716528978e-100
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300C,CMRF35-like molecule 6,29689,0.0510506871319211,0.00239394940617086,0.0463585462958262,0.055742827968016,3.77184234940724e-100
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,29381,0.0955085052140496,0.0044834349468261,0.0867209727182705,0.104296037709829,6.14548906676539e-100
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,24863,0.0897442238882382,0.00421197231289852,0.0814887581549571,0.0979996896215193,7.66310819140253e-100
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,29576,0.126098722465246,0.00592297908979796,0.114489683449242,0.13770776148125,7.94898774224914e-100
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,29344,0.201879821614815,0.00950837563911375,0.183243405362152,0.220516237867478,2.71877338065883e-99
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,24424,0.0648591997273723,0.00305545472424275,0.0588705084678565,0.0708478909868881,4.2032858513805e-99
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ISM1,Isthmin-1,29429,0.057614788764872,0.00271814704374094,0.0522872205591398,0.0629423569706043,5.68264698124329e-99
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,29473,0.113182659116286,0.00534199239123969,0.102712354029456,0.123652964203116,6.84234672584938e-99
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,24863,0.167341031021103,0.00791598357975984,0.151825703204774,0.182856358837433,2.52525054208e-98
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,24917,0.040308020167887,0.00190986694950512,0.036564680946857,0.0440513593889171,5.152134791459e-98
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29755,0.0556156112105251,0.00263714108630313,0.0504468146813709,0.0607844077396792,5.20622234140016e-98
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28792,0.113670276664314,0.00539050199893412,0.103104892746403,0.124235660582224,5.75900321663497e-98
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,24165,0.124259057995097,0.00588841786152247,0.112717758986513,0.135800357003681,5.81063819095743e-98
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,24224,0.129191027443426,0.00612836654233767,0.117179429020444,0.141202625866408,9.02657850747682e-98
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FMNL1,Formin-like protein 1,28769,0.0895292405076676,0.00425123099948989,0.0811968277486674,0.0978616532666678,1.02254244329709e-97
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,29673,0.0395796028167291,0.00188204116457112,0.0358908021341697,0.0432684034992885,1.79164845583851e-97
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,24224,0.0723457090704285,0.00343850072871958,0.0656062476421382,0.0790851704987189,2.10835460795396e-97
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCD1,Programmed cell death protein 1,29656,0.0624140849466958,0.00297395770416911,0.0565851278465244,0.0682430420468673,4.40082300632619e-97
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24917,0.0897831145632986,0.00427653428692653,0.0814011073609226,0.0981651217656746,5.11996765073283e-97
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,24800,0.13962703952703,0.00665966048629307,0.126574104973896,0.152679974080164,9.26584475658732e-97
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29429,0.0492974574665043,0.00235296543677776,0.0446856452104199,0.0539092697225887,9.32708703477207e-97
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,24800,0.124093954852661,0.0059288801004781,0.112473349855724,0.135714559849598,1.93405875761842e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL15,C-C motif chemokine 15,29815,0.0637104899510486,0.00304733657928185,0.0577377102556562,0.069683269646441,2.28061317439544e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,24376,0.0332035259521395,0.00158792872086641,0.0300911856592413,0.0363158662450377,3.04689165448435e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,28926,0.056886587015341,0.00272273866352782,0.0515500192348265,0.0622231547958555,3.18230168288157e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29720,0.0906349164081807,0.00433900894629566,0.0821304588734412,0.0991393739429201,3.36161687152945e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,24235,0.148874690894035,0.00712398325243518,0.134911683719262,0.162837698068807,3.9675095396621e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GMPR,GMP reductase 1,29781,0.0716954199974106,0.00343384024836375,0.0649650931106176,0.0784257468842035,4.06048096344287e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,29531,0.10238963099213,0.00490669157990471,0.0927725154955167,0.112006746488743,5.24095123825758e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,29158,0.0341123265900758,0.00163508395489552,0.0309075620384806,0.037317091141671,5.88094502352552e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AAMDC,Mth938 domain-containing protein,24235,0.0772773550025159,0.00370298907602927,0.0700194964134985,0.0845352135915333,7.16730211427858e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,28769,0.096788350764539,0.00464119969421595,0.0876915993638758,0.105885102165202,7.16978881473924e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,29731,0.0470488951785541,0.00225807468858706,0.0426230687889234,0.0514747215681847,9.92148020229837e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29429,0.104151585892718,0.00500585838697516,0.0943401034542471,0.11396306833119,1.86487324757433e-95
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29344,0.0548696767030769,0.00263864279102001,0.0496979368326777,0.0600414165734761,2.36197612938984e-95
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,24376,0.103417325238541,0.00498162135736647,0.0936533473781032,0.11318130309898,6.6388868708575e-95
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,24917,0.0492237076992576,0.00237277600289209,0.0445730667335891,0.0538743486649261,8.58742340580753e-95
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,24800,0.0680696825188069,0.00328500160922135,0.0616310793647331,0.0745082856728807,1.40970842159946e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD59,CD59 glycoprotein,28272,0.0330101830231741,0.00159488801721886,0.0298842025094251,0.0361361635369231,1.83423470043377e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP43,Centrosomal protein 43,28700,0.0998227579020877,0.00482389044113289,0.0903679326374673,0.109277583166708,1.94672513588023e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MDK,Midkine,29450,0.0728483435551283,0.00352179860936078,0.0659456182807812,0.0797510688294754,2.22186863545524e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29344,0.0399858228289615,0.00193577176706789,0.0361917101655084,0.0437799354924146,4.01586672546515e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TJAP1,Tight junction-associated protein 1,29561,0.118339125720853,0.00572923455012824,0.107109826002601,0.129568425439104,4.04937453881684e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHISA5,Protein shisa-5,24933,0.0363118993968648,0.0017568673140229,0.0328684394613799,0.0397553593323497,4.09783861254025e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29344,0.126267366529048,0.00611659522997372,0.114278839878299,0.138255893179796,5.22082634438093e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24800,0.0734004124541793,0.00355411877463645,0.0664343396558918,0.0803664852524667,5.77028534863532e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24863,0.111037303087674,0.00537791007728679,0.100496599336192,0.121578006839156,6.39640226341243e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH9,Protocadherin-9,24800,0.048601688993227,0.00235489193877251,0.0439861007932328,0.0532172771932211,7.61020153017953e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,28792,0.102028756318101,0.00494929711993864,0.0923281339630216,0.111729378673181,9.62990656715851e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLK1,Protein delta homolog 1,29815,0.0794011969915329,0.00385629551676387,0.0718428577786758,0.0869595362043901,1.51242480523856e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTSS2,Protein MTSS 2,24788,0.142090069924494,0.00689609685208438,0.128573720094409,0.15560641975458,1.52577639621089e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B2M,Beta-2-microglobulin,24961,0.0444787502825048,0.00215945784716146,0.0402462129020683,0.0487112876629412,1.74545833261717e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPT,Dermatopontin,29815,0.0375592061414038,0.00182495127909526,0.033982301634377,0.0411361106484305,1.81937143751813e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24235,0.0372904576046734,0.00181111195509421,0.0337406781726888,0.0408402370366581,2.13747781385796e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,29403,0.050471286329057,0.00245333056447584,0.0456627584226844,0.0552798142354297,2.20259257571121e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,28911,0.107872890627534,0.0052467269074947,0.0975893058888443,0.118156475366224,2.91432867133211e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,28792,0.050960890987693,0.00248215007243633,0.0460958768457178,0.0558259051296682,5.29269296683776e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IST1,IST1 homolog,24631,0.141890384337254,0.00690737274768873,0.128351933751784,0.155428834922724,5.48413851944381e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL8,C-C motif chemokine 8,29678,0.0860078079970132,0.00419010984317061,0.0777951927043988,0.0942204232896276,5.5479857345237e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMN,Protein amnionless,28926,0.0674035805579746,0.00328564525359531,0.0609637158609278,0.0738434452550214,7.32612968111398e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ST13,Hsc70-interacting protein,24376,0.0795935472911461,0.00388199468895289,0.0719848377007984,0.0872022568814937,1.21981833666256e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,24946,0.0371299851469128,0.00181235281658178,0.0335777736264125,0.040682196667413,1.62092219896791e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM3C,Protein FAM3C,29428,0.042559188060825,0.00208069662314564,0.0384810226794595,0.0466373534421905,2.41849862284436e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,24863,0.102751718287357,0.00502384649477326,0.0929049791576013,0.112598457417112,3.26224145432052e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,24510,0.0193438432654257,0.000945804761528197,0.0174900659328304,0.0211976205980209,3.38117412511963e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29438,0.0652085116024135,0.00319071517372555,0.0589547098619114,0.0714623133429156,3.43163605870495e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,28533,0.17263822186928,0.00845352101543456,0.156069320679028,0.189207123059532,4.85643063024969e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29531,0.121802151498001,0.00596907734499217,0.110102759901817,0.133501543094186,6.44250071491448e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24106,0.105404054987504,0.00516422048408461,0.0952821828386986,0.11552592713631,8.07943328971834e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNMBP,Dynamin-binding protein,29213,0.0862769074763376,0.00423220517989483,0.0779817853237438,0.0945720296289315,9.73940651238727e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,28911,0.0584175126065198,0.00286692868770955,0.0527983323786091,0.0640366928344306,1.19656958938865e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29344,0.137337948540893,0.00674206237457093,0.124123506286734,0.150552390795052,1.32184092982551e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBXN1,UBX domain-containing protein 1,24376,0.0977521539644851,0.00479652228615704,0.0883509702836173,0.107153337645353,1.46701630169187e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,24106,0.0957045591136329,0.0046984533593134,0.0864955905293786,0.104913527697887,1.8440741601058e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL18,C-C motif chemokine 18,29161,0.0988843866456761,0.00486547520547133,0.0893480552429523,0.1084207180484,3.40720166077702e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,24917,0.127676740587473,0.00628178271565444,0.11536444646479,0.139989034710156,4.24893064553951e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,28769,0.119458442633178,0.00588527604028173,0.107923301594226,0.13099358367213,5.83659978443602e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,28792,0.0898891139168914,0.0044293868431402,0.0812075157043366,0.0985707121294462,6.32233281977105e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24917,0.0415863352346755,0.00204885756771619,0.0375705744019518,0.0456020960673992,7.3839432530055e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOF,Apolipoprotein F,24946,-0.0352495104432394,0.00173826490038421,-0.0386565096479925,-0.0318425112384864,1.07278243391443e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAMBP,STAM-binding protein,29158,0.0896894569935508,0.00442552636150666,0.0810154253249978,0.0983634886621039,1.07547979274899e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,24800,0.0746813828924938,0.00368546005679469,0.0674578811811762,0.0819048846038114,1.45551193886821e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL1,Fc receptor-like protein 1,29473,0.0637205109605369,0.00315088616885391,0.0575447740695832,0.0698962478514906,2.52223567883172e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,29429,0.15702732843833,0.00776794244092681,0.141802161254113,0.172252495622546,2.98094527901233e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,29576,0.0930519912165964,0.00460582433208976,0.0840245755257005,0.102079406907492,3.73822064053411e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP12,Macrophage metalloelastase,29461,0.0743447354427936,0.00368057532402147,0.0671308078077115,0.0815586630778757,4.06285672924261e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,28926,0.0970906427405367,0.0048068864764804,0.0876691452466351,0.106512140234438,4.25113356757042e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDC1,Syndecan-1,29473,0.0562944274693095,0.00278963918014893,0.0508267346762176,0.0617621202624014,5.9800653606803e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAX,Protein max,28769,0.146812148650194,0.00728666789424255,0.132530279577479,0.161094017722909,1.16548470751205e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,29531,-0.114305245499807,0.00567607899052729,-0.125430360321241,-0.103180130678374,1.37100218453214e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,29439,0.0791293961508759,0.00393226614972754,0.0714221544974099,0.0868366378043419,1.85459587412404e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BSG,Basigin,29755,0.0286283818111921,0.0014233766478134,0.0258385635814778,0.0314182000409063,2.23439426932607e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASC3,Protein CASC3,24190,0.0588166755944338,0.00292277104475808,0.0530880443467079,0.0645453068421596,2.47366802551456e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNPY4,Protein canopy homolog 4,29344,0.104374467143589,0.00519240804644506,0.0941973473725567,0.114551586914621,2.87058153288555e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,28792,0.0749679205429831,0.00372938991664733,0.0676583163063544,0.0822775247796119,2.91425884332065e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEC31A,Protein transport protein Sec31A,24235,0.107298503390754,0.00533681809982494,0.0968383399150973,0.117758666866411,3.54272305662291e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL11,Eotaxin,29781,0.0523785959723182,0.00260744432930994,0.0472680050868707,0.0574891868577656,3.66179249329137e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29438,0.0508972208298444,0.00253512170483293,0.0459283822883719,0.0558660593713169,4.65226342476968e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL4,C-C motif chemokine 4,29493,0.0906677253706853,0.00451840949442225,0.0818116427616177,0.0995238079797529,5.72069057686915e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,24235,0.103789245415633,0.0051688584656221,0.0936582828230137,0.113920208008252,5.88421610770152e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALCA,Calcitonin,29158,0.0862540664381135,0.00430548305466958,0.0778153196509611,0.0946928132252659,1.11232494142708e-88
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',24840,0.0580744003467156,0.00289933202407864,0.0523917095795215,0.0637570911139098,1.50362343953856e-88
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD46,Membrane cofactor protein,29326,0.0396930330811104,0.00198443249826529,0.0358035453845104,0.0435825207777103,2.05216917472212e-88
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29344,0.106312949886048,0.00531545513122012,0.0958946578288565,0.116731241943239,2.11159805469418e-88
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,29438,-0.0557430233367258,0.00279056478130666,-0.0612125303080869,-0.0502735163653647,3.4594894676986e-88
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,24946,0.0373404711550586,0.00186899556164708,0.0336772398542303,0.0410037024558869,4.11664788884203e-88
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,29389,0.0415238804626742,0.00208134404709221,0.0374444461303734,0.0456033147949749,5.68260222880798e-88
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1S,Complement C1s subcomponent,24961,0.0289911557821203,0.00145239552382634,0.0261444605554207,0.0318378510088199,5.8607254393712e-88
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24800,0.123367925445778,0.00619010774780045,0.111235314260089,0.135500536631467,1.09126937367737e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPB2,Carboxypeptidase B2,24909,0.0312648849441679,0.00156912662539651,0.0281893967583907,0.034340373129945,1.19173790880273e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6AP2,Renin receptor,28792,0.0560296093605365,0.00281380392841781,0.0505145536608376,0.0615446650602354,1.2379549293794e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AXIN1,Axin-1,29429,0.131032941687094,0.00658136712008252,0.118133462131732,0.143932421242455,1.26857456271604e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F10,Coagulation factor X,24946,0.0381013469028187,0.001913568541634,0.0343507525612161,0.0418519412444214,1.56177637929123e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTNB,Dystrobrevin beta,24747,0.0601539533076184,0.00302202236220953,0.0542307894776878,0.0660771171375491,1.77746157474601e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24917,0.103600227035337,0.00520834487521443,0.0933918710799169,0.113808582990758,2.31497717605855e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFF3,Trefoil factor 3,29421,0.063780807550584,0.00321142244605717,0.057486419556312,0.0700751955448561,3.33204072223457e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFNA1,Ephrin-A1,29385,0.0389274878081241,0.00196074060352287,0.0350844362252192,0.0427705393910289,3.84049855893919e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,24224,0.0723351715808045,0.00364421113930747,0.0651925177477618,0.0794778254138471,5.49704902556457e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29438,0.0697984111230338,0.00351919212657867,0.0629007945549397,0.076696027691128,5.65332356779384e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLB1,Beta-galactosidase,29213,0.0574719791749988,0.00289994698678861,0.0517880830808931,0.0631558752691045,7.71748270070658e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCTN3,Tectonic-3,24917,0.0409985288890106,0.00206767042152342,0.0369458948628247,0.0450511629151965,7.93175708945205e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24840,0.0954350236373316,0.0048148378391121,0.0859979414726719,0.104872105801991,9.20050326695827e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C2,Complement C2,29540,0.0320499276757409,0.0016183939551993,0.0288778755235503,0.0352219798279316,1.01563419957593e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100P,Protein S100-P,28911,0.0735442786790691,0.003717511620285,0.0662579559033105,0.0808306014548277,1.55532924224331e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCOF1,Treacle protein,24917,0.0429688990919197,0.0021725809624797,0.0387106404054595,0.0472271577783799,2.13061661675578e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24800,0.201767938623698,0.0102035461870963,0.181768988096989,0.221766889150406,2.29835701041182e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,24863,0.104431089066501,0.00528212472406328,0.0940781246073365,0.114784053525665,2.45790218990137e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL20,C-C motif chemokine 20,29781,0.12001186771081,0.00608134217960059,0.108092437038793,0.131931298382827,3.88410635250963e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,29164,0.0340591352806124,0.00172689610696327,0.0306744189109644,0.0374438516502604,5.01133147845524e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,24840,0.121173628424397,0.00614436477300574,0.109130673469306,0.133216583379488,6.46655504849688e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,29213,0.0559079369008738,0.00283758064469055,0.0503462788372804,0.0614695949644673,7.39628587074037e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DOK2,Docking protein 2,29473,0.166076522159783,0.0084332020840662,0.149547446075013,0.182605598244553,8.80183160449975e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,24863,0.103486935776067,0.00525451248229539,0.0931880913107685,0.113785780241366,1.07569136781326e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28590,0.117950643469209,0.00599744091231443,0.106195659281073,0.129705627657346,1.52835576773239e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,23901,0.0730077276275987,0.00371179543981534,0.0657326085655606,0.0802828466896367,1.88337793795808e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLNK,B-cell linker protein,24224,0.0545419344038328,0.00277425505121622,0.049104394503449,0.0599794743042166,2.20075565603253e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELE,E-selectin,29815,0.0684992167918318,0.0034871595819796,0.0616643840111518,0.0753340495725118,2.29184633853548e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29449,0.0529545065686307,0.00269951383673728,0.0476634594486256,0.0582455536886357,3.92899389797516e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPB1,Carboxypeptidase B,29815,0.0799836753173734,0.00408919493352959,0.0719688532476554,0.0879984973870914,1.15838063336456e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL13,C-C motif chemokine 13,29727,0.0934143107866735,0.00477889506751003,0.0840476764543538,0.102780945118993,1.48075300394531e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,28792,0.0757089950745214,0.0038755111334336,0.0681129932529916,0.0833049968960513,1.94380270763881e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,29720,0.0499783396726157,0.0025608323005601,0.0449591083635179,0.0549975709817135,2.68767896177092e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,24863,0.0915943188018446,0.00469384899541869,0.082394374770824,0.100794262832865,3.58658385970514e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,29815,0.0430330784802232,0.00220703742930927,0.0387072851187771,0.0473588718416694,3.81413316104453e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,24840,0.0899397750825059,0.00461181201470529,0.0809006235336836,0.0989789266313283,4.49440980313077e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNM3,Dynamin-3,24863,0.0743750084842634,0.00381627370382609,0.0668951120247643,0.0818549049437625,5.78028803406582e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,29576,0.0356637293317446,0.00183412781489002,0.0320688388145602,0.0392586198489291,1.08221299468232e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WASHC3,WASH complex subunit 3,24840,0.101919172644572,0.00523990182457857,0.091648965068398,0.112189380220746,1.2092306715337e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEPTIN9,Septin-9,29344,0.0383005468187151,0.0019704365588382,0.0344384911633922,0.0421626024740379,1.24816651358528e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB8,Serpin B8,29781,0.0757752864675936,0.00390312375452289,0.0681251639087287,0.0834254090264584,1.93017566231466e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28792,0.0599449862731998,0.00308942192755173,0.0538897192951984,0.0660002532512012,2.46905146457024e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IMMT,MICOS complex subunit MIC60,24788,0.0600977981069217,0.00309599334966935,0.0540296511415698,0.0661659450722736,2.56904543674103e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WDR46,WD repeat-containing protein 46,24788,0.0486365897981993,0.00250668323108046,0.0437234906652816,0.053549688931117,3.03572687521196e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PROS1,Vitamin K-dependent protein S,24961,0.0343820627171608,0.00177225607913341,0.0309084408020593,0.0378556846322623,3.15980186519909e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD207,C-type lectin domain family 4 member K,28830,0.0519153757722077,0.00267991104179863,0.0466627501302823,0.057168001414133,4.49010240978204e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOXO1,Forkhead box protein O1,29429,0.114618709927471,0.00591728127072333,0.103020838636853,0.126216581218088,4.54254247670705e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,24440,0.0718359474401372,0.0037065708032159,0.064571068665834,0.0791008262144404,4.72566029483924e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALB2,Calretinin,28769,0.0410218931213108,0.00211838054996268,0.036869867243384,0.0451739189992377,5.17874141290441e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,29344,0.114780924918593,0.0059299733920995,0.103158177070078,0.126403672767108,5.97312839615742e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,27934,0.0536324965609842,0.00277387652109054,0.0481956985796467,0.0590692945423217,9.51511184349993e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,24917,0.14388542338838,0.00744734005004512,0.129288636890292,0.158482209886468,1.45682078431386e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29421,0.0819532883827737,0.00424625065173007,0.0736306371053828,0.0902759396601647,1.73578468941749e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS8,Galectin-8,29689,0.0810035539997717,0.0041996084720172,0.072772321394618,0.0892347866049254,2.15174223356696e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AP2B1,AP-2 complex subunit beta,24190,0.0656063034823293,0.00339959431298329,0.058943098628882,0.0722695083357765,2.31438834374413e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KAZN,Kazrin,24800,0.139865059317791,0.0072506850467706,0.125653716626121,0.154076402009461,2.62161306619908e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,24920,0.0261341227745082,0.00135522538968979,0.0234778810107163,0.0287903645383002,2.91646681945294e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PARK7,Parkinson disease protein 7,29438,0.0697363471077821,0.00361971549789469,0.0626417047319086,0.0768309894836557,3.3489274711504e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP2,Microtubule-associated protein 2,24840,0.0619550046954602,0.00321467775598624,0.0556542362937271,0.0682557730971932,3.64161392933306e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",24863,0.0836209046435478,0.00434885538930583,0.0750971480805084,0.0921446612065873,8.44324566272252e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GMPR2,GMP reductase 2,24376,0.0896650458115796,0.00467686926257421,0.0804983820569342,0.0988317095662251,2.52018329873813e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESYT2,Extended synaptotagmin-2,24840,0.109594941871165,0.00572203507885247,0.0983797531166138,0.120810130625716,3.51247257343588e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24376,0.077366232259346,0.00404277973810704,0.0694423839726562,0.0852900805460358,4.89931642254809e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,24917,0.0968566399651423,0.00506210015538459,0.0869349236605885,0.106778356269696,5.05405203228179e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",24235,0.115616340124488,0.00604887696462261,0.103760541273828,0.127472138975148,7.654939553466e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,29815,0.0540280941199891,0.00283008860671475,0.0484811204508282,0.05957506778915,9.18411132578124e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,24224,0.103012653268149,0.00539310221528029,0.0924421729261993,0.113583133610098,9.76593726287533e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29438,0.0559575340238315,0.00293541312361158,0.0502041243015528,0.0617109437461102,1.57166608256041e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CETN3,Centrin-3,24800,0.102983151411092,0.00539955602952861,0.0924000215932155,0.113566281228968,1.61364082589909e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29589,0.0567353535181448,0.00297733823661434,0.0508997705743807,0.0625709364619089,1.78986451955575e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD27,CD27 antigen,29561,0.0549670151455452,0.00288603247942759,0.0493103914858671,0.0606236388052233,2.15793524469545e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29344,0.0916102350146241,0.00481158944568427,0.0821795197010829,0.101040950328165,2.4538038198885e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24788,0.0956378646733193,0.00502123062542196,0.0857962526474922,0.105479476699146,2.62619678888497e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,29589,-0.0438742963606421,0.00230572931185463,-0.0483935258118772,-0.0393550669094071,2.99822343022329e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,29076,0.047736652894018,0.00251087217132543,0.0428153434382202,0.0526579623498158,4.16337602035399e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GH1,Somatotropin,29428,-0.233853419300139,0.012305118238071,-0.257971451046758,-0.20973538755352,4.72397984761492e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DBI,Acyl-CoA-binding protein,29324,0.103275956383844,0.00543480314022535,0.0926237422290019,0.113928170538685,4.91146057381556e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,24235,0.119177212187108,0.00626790846951877,0.106892111586851,0.131462312787365,5.01586674271668e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,24764,0.115751969196617,0.00609288073587411,0.103809922954303,0.12769401543893,6.58047895731107e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX4,Syntaxin-4,29344,0.0781011490246119,0.00411532236554454,0.0700351171881446,0.0861671808610792,7.7910710996263e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,24783,0.0569922201846154,0.0030026469065041,0.0511070322478674,0.0628774081213634,9.08633625222306e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28926,0.0947421443682162,0.00499558687523797,0.0849507940927498,0.104533494643683,1.00993324623953e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FSTL3,Follistatin-related protein 3,29346,0.0419599368315876,0.00221333775899536,0.0376217948239567,0.0462980788392185,1.14236064943165e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC1,Sialoadhesin,29576,0.0558424448920325,0.00294585199582626,0.050068574980213,0.0616163148038519,1.1643855008006e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29344,0.0317834363517867,0.00167798342576378,0.0284945888372896,0.0350722838662837,1.55188391788874e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",28911,0.122062628152449,0.00644675531811451,0.109426987728945,0.134698268575954,1.81509024573676e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRY2,Protein sprouty homolog 2,28926,0.121016198357179,0.00640385181906998,0.108464648791802,0.133567747922557,3.59838059946418e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",24800,0.115428193453311,0.00610554870349586,0.103461317994459,0.127395068912163,3.71144907509374e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCR,Breakpoint cluster region protein,29429,0.119720022861962,0.00634131543594985,0.107291044607501,0.132149001116424,4.9502390103702e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,29448,0.123049160895631,0.00651893918609247,0.11027204009089,0.135826281700373,5.30381260257133e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,24376,0.0704141040546741,0.00373013302728838,0.0631030433211889,0.0777251647881593,6.44268773468611e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,24917,0.0360466435939884,0.00191086153694293,0.0323013549815802,0.0397919322063965,7.98838310956049e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,28792,0.0827470817517984,0.00438879513049695,0.0741450432960244,0.0913491202075725,8.11740084515459e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",28769,0.066584205774924,0.0035315664631276,0.0596623355071939,0.0735060760426541,8.1477953429962e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGAL,Integrin alpha-L,24224,0.0572057571737172,0.0030327297421144,0.051261606879173,0.0631499074682615,8.48112298709706e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANG,Angiogenin,29430,0.0440232897377566,0.00233655761974571,0.039443636803055,0.0486029426724582,1.01219553815007e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXNA4,Plexin-A4,29429,0.106351508559825,0.00565074661172453,0.0952760452008448,0.117426971918805,1.47835893796182e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,24961,0.0223607939426836,0.00118780543272151,0.0200326952945495,0.0246888925908178,1.64169703085754e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,24376,0.0485683044316023,0.00258103404986303,0.0435094776938708,0.0536271311693338,1.95982346122828e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABHD14B,Protein ABHD14B,29116,0.0747188396608869,0.0039754157584442,0.0669270247743363,0.0825106545474375,2.40757638854373e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,24190,0.090472094584048,0.00481095735020641,0.0810426181776434,0.0999015709904525,2.47178922330458e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,28926,0.049297989161913,0.00262460794498696,0.0441537575897386,0.0544422207340875,3.0445116537431e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GDF15,Growth/differentiation factor 15,29815,0.0578457991680134,0.00308109033093558,0.0518068621193797,0.0638847362166471,3.45698637142104e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RWDD1,RWD domain-containing protein 1,29689,0.0824947863993709,0.00439638450501126,0.0738778727695489,0.091111700029193,4.19945217899561e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTD,Biotinidase,24961,0.0269994454331678,0.00143850069376788,0.0241799840733828,0.0298189067929529,4.66112823249479e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29438,0.0497964528954178,0.00265582836745802,0.0445910292952,0.0550018764956355,5.53255662689121e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24224,0.0583088002553376,0.00310986632728914,0.0522134622538509,0.0644041382568243,6.95150558458957e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24235,0.0689696741086015,0.00367980362484211,0.061757259003911,0.0761820892132921,7.88881549826415e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],28821,0.0626429121409888,0.00334661652324064,0.0560835437554371,0.0692022805265404,1.01688376019984e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28926,0.0551777566842154,0.00294840118203897,0.049398890367419,0.0609566230010118,1.08726290780011e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COMMD1,COMM domain-containing protein 1,24235,0.0796749229159414,0.00425756943800889,0.071330086817444,0.0880197590144388,1.35073135936516e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,29689,0.0847332960094232,0.00453302058412047,0.0758485756645471,0.0936180163542993,1.59149892006842e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29650,0.0396496071938198,0.00212264001924258,0.0354892327561043,0.0438099816315352,2.03025739622688e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPY,Pancreatic prohormone,29395,0.131716691794925,0.007052800509373,0.117893202796554,0.145540180793296,2.18873562380273e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",29576,0.142311799170788,0.00762065763529407,0.127375310205611,0.157248288135964,2.22894775903576e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29720,0.041776447064528,0.00223729034361206,0.0373913579910484,0.0461615361380076,2.2884485920602e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,29781,0.0304926640049007,0.00163309870101683,0.0272917905509077,0.0336935374588937,2.33185043680557e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,29473,0.103348368698419,0.00554019484173437,0.0924895868086197,0.114207150588218,3.24996520321238e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,24933,0.0426239115548007,0.00228434171740367,0.0381466017886895,0.0471012213209118,3.57396013849282e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CMIP,C-Maf-inducing protein,24788,0.107608405790086,0.00577032623200845,0.0962985663753496,0.118918245204823,4.37516979197966e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,29576,0.0527176046589351,0.00282926639167305,0.0471722425312559,0.0582629667866142,4.80271081181425e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CKB,Creatine kinase B-type,24933,-0.0766125940823351,0.004111951724499,-0.0846720194623531,-0.0685531687023171,5.93249374930972e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29429,0.125665625272393,0.00675006291646913,0.112435501956114,0.138895748588673,6.48601051068248e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASAH2,Neutral ceramidase,29213,0.0683260716063977,0.00367055018714106,0.0611317932396012,0.0755203499731941,6.81652608157166e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDHB,Succinate dehydrogenase,24800,0.0892089647956489,0.00479179490139782,0.0798170467889091,0.0986008828023886,7.82176808093837e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,28926,0.0771688632896433,0.0041488858635026,0.0690370469971782,0.0853006795821084,9.04091520871762e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM13A,Protein FAM13A,24800,0.0875178290590189,0.00470353615600875,0.0782988981932418,0.0967367599247961,9.43896911328599e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,29473,0.112021721896953,0.00602816126496052,0.10020652581763,0.123836917976275,1.20970111672518e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",24847,0.0518072300974684,0.00278673195893631,0.0463452354579532,0.0572692247369835,1.26732447371699e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,24840,0.0816136220193093,0.00439128269252928,0.0730067079419519,0.0902205360966667,1.39759950042277e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",24235,0.0825869095271152,0.00444920702429474,0.0738664637594975,0.0913073552947329,2.20475638230753e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,28792,0.078280526441311,0.00421958210329011,0.0700101455188623,0.0865509073637596,2.20513080229943e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,29344,0.0465829881334735,0.00251555207784301,0.0416525060609012,0.0515134702060458,4.02002292836308e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,29473,0.0451986872337212,0.00244564976694602,0.040405213690507,0.0499921607769354,7.85177744718675e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,29781,0.0573922031691413,0.00310677978329709,0.051302914793879,0.0634814915444036,9.00711522665128e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29158,0.142925606045006,0.00774123650849114,0.127752782488363,0.158098429601648,1.11082382594063e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",29449,0.120389790600043,0.00652089487901634,0.107608836637171,0.133170744562915,1.11489687056869e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX8,Syntaxin-8,29429,0.061843372040199,0.00335000562638353,0.0552773610124873,0.0684093830679107,1.14628880716622e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,29429,0.135504021657774,0.00735014735600364,0.121097732840007,0.149910310475541,1.8149936639338e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PKD2,Polycystin-2,24106,0.0757748485780815,0.00410843087641211,0.0677223240603138,0.0838273730958493,1.93709765708527e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEXIM1,Protein HEXIM1,29429,0.103488981652107,0.00562487124033633,0.0924642340210474,0.114513729283166,3.5728002453579e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLAMF6,SLAM family member 6,28792,0.0488516313027062,0.00265587140867425,0.0436461233417047,0.0540571392637077,3.97205989231972e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29344,0.0690228942849724,0.00375319622836258,0.0616666296773817,0.0763791588925631,4.14802153624421e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,29281,0.0585285447170939,0.00318427815330273,0.0522873595366206,0.0647697298975673,4.98378815714907e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LMNB2,Lamin-B2,24840,0.0358330655322374,0.00194919969059731,0.0320126341386667,0.0396534969258081,5.60774157257148e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,29561,0.0417357639810052,0.00227369199287315,0.0372793276749738,0.0461922002870365,7.72021823335818e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLF4,Krueppel-like factor 4,24096,0.0509370909165713,0.00277512292564953,0.0454978499822982,0.0563763318508444,9.76217003793974e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IMPACT,Protein IMPACT,24840,0.0710970779815049,0.00387570526409599,0.0635006956638768,0.078693460299133,1.14286579123672e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29635,0.036873034654132,0.00201149263525589,0.0329305090890305,0.0408155602192335,1.20847975855894e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,24376,0.0996770475479974,0.00543489313807199,0.0890246569973763,0.110329438098619,1.25762038857067e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,29429,0.0974455424227309,0.00532408900343346,0.0870103279760013,0.10788075686946,2.03835596861247e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,24235,0.0406620981089234,0.00222159699028109,0.0363077680079724,0.0450164282098743,2.4806088278467e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP7,Matrilysin,28865,0.0634734221623543,0.00346987377843739,0.0566724695566171,0.0702743747680916,2.49143922423334e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALCAM,CD166 antigen,29815,0.0248260582386232,0.00135761076952324,0.0221651411303577,0.0274869753468888,2.7008113599819e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,29781,0.0853678610813718,0.00466921845956801,0.0762161929006185,0.0945195292621251,2.8790084056906e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29781,0.032963157689503,0.00180348015594825,0.0294283365838445,0.0364979787951616,3.18601237584136e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,29404,0.0585116285000129,0.00320431079185502,0.052231179347977,0.0647920776520487,4.40646137288123e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24800,0.13043334671935,0.00714074954438423,0.116437477612356,0.144429215826343,4.72360469930658e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,24224,0.0568079279364824,0.00310993141678708,0.0507124623595797,0.0629033935133851,4.80115676486695e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,29815,0.05361583201333,0.00293809785035642,0.0478571602266314,0.0593745038000286,5.3860765013815e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,29127,0.0380904108555842,0.00208760506797242,0.0339987049223582,0.0421821167888101,5.75935383497877e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,24224,0.11447454493583,0.00627525813041443,0.102175039000217,0.126774050871442,7.46149780261356e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HPSE,Heparanase,24683,0.118918886650402,0.00652283081692311,0.106134138249233,0.131703635051572,8.91517566898252e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,24933,0.0769474849933652,0.00422154114521266,0.0686732643487484,0.0852217056379821,9.44809682949746e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRKL,Crk-like protein,29486,0.133813073389712,0.00735089820751273,0.119405312902987,0.148220833876437,1.22414469071431e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,28926,0.0884566118038333,0.00486858384664052,0.0789141874644179,0.0979990361432487,2.33336722892876e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,28792,0.0460635739041419,0.00253564437694397,0.0410937109253317,0.0510334368829521,2.44890934794714e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ULBP2,UL16-binding protein 2,29213,0.0481516200157937,0.00265107470776103,0.0429555135885821,0.0533477264430053,2.56682480280398e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BACH1,Transcription regulator protein BACH1,29429,0.0926767010147349,0.00510270242264692,0.082675404266347,0.102677997763123,2.58547944796197e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,29273,0.0346508492776442,0.00190820849511524,0.0309107606272183,0.03839093792807,2.76422677588443e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATXN3,Ataxin-3,24840,0.0780555654894162,0.00429753934551628,0.0696323883722043,0.0864787426066281,3.03082421928753e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,29756,-0.153216762211922,0.00844391304289551,-0.169766831775997,-0.136666692647847,3.47923943586441e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSAP,Prosaposin,24756,0.0358527207621179,0.00197690947884032,0.0319779781835909,0.0397274633406449,4.95061881621053e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBCC,Tubulin-specific chaperone C,29213,0.101585646858962,0.00560477909120534,0.0906002798401991,0.112571013877724,5.10723376304674e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,29438,0.0442750316756949,0.00244348266170443,0.0394858056587542,0.0490642576926356,5.56692522443539e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",29576,0.0346776680373692,0.00191399966572985,0.0309262286925387,0.0384291073821997,5.71899405248151e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,29322,0.0555364178515218,0.00306580299291946,0.0495274439853997,0.061545391717644,6.0945694380383e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YWHAQ,14-3-3 protein theta,24376,0.093276261374696,0.00514890532681329,0.083184406934142,0.10336811581525,7.20711947693316e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DKK4,Dickkopf-related protein 4,29164,0.0575068433831455,0.00318523220384248,0.0512637882636142,0.0637498985026767,1.81616055321018e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACYP1,Acylphosphatase-1,24292,0.0825949167455436,0.00457301559406625,0.0736318061811738,0.0915580273099135,1.91507183556988e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADM,Pro-adrenomedullin,29720,0.0332947896869729,0.00184459821595359,0.0296793771837039,0.0369102021902419,1.9293754985929e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29561,0.0905112291599416,0.00501604294907256,0.0806797849797594,0.100342673340124,2.14068208438598e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGMB,RGM domain family member B,29689,0.033707739692709,0.00186861435241557,0.0300452555619745,0.0373702238234435,2.35113880947839e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24788,0.10433740946523,0.00578478200066133,0.0929992367439339,0.115675582186526,2.92077202289279e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28733,0.0728731318266999,0.0040452531057412,0.0649444357394471,0.0808018279139526,3.74671454380159e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPA1,Carboxypeptidase A1,29815,0.0759194409486077,0.00421573830220154,0.0676565938762927,0.0841822880209228,4.02856012892925e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29473,0.0791771656924346,0.00440110013699197,0.0705510094239303,0.0878033219609389,5.63904378833428e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSNL1,Visinin-like protein 1,24840,0.0478054358154475,0.00265809083554882,0.0425955777777718,0.0530152938531232,7.32146926992557e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SWAP70,Switch-associated protein 70,24800,0.044888988431569,0.00249639916107513,0.0399960460758617,0.0497819307872762,7.78898833651942e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,24933,0.0284723702175996,0.00158457538049167,0.0253666024718359,0.0315781379633632,9.76944063939308e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOA2,Apolipoprotein A-II,24946,-0.0604725419052398,0.00336675602349605,-0.067071383711292,-0.0538737000991875,1.10177900626297e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS3,Galectin-3,29539,0.0370802266858295,0.0020659552086,0.0330309544769735,0.0411294988946855,1.1919329626615e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MITD1,MIT domain-containing protein 1,29213,0.12019529058713,0.00669723770149371,0.107068704692202,0.133321876482058,1.23021677692346e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,29429,0.104069027629206,0.00580270083800045,0.0926957339867255,0.115442321271687,1.52446953762153e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTN,Pleiotrophin,28911,0.0623511987395967,0.00347647944488637,0.0555372990276194,0.0691650984515739,1.532833307054e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RILP,Rab-interacting lysosomal protein,29627,0.0739281966963354,0.00412382501665201,0.0658454996636975,0.0820108937289734,1.73169492716635e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXNB3,Plexin-B3,29378,0.0589167296913983,0.00328639104056333,0.0524754032518941,0.0653580561309024,1.73230110361566e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBCA,Tubulin-specific chaperone A,24376,0.107021886894414,0.00596991874649325,0.0953208461512873,0.118722927637541,2.09468142408222e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHRDL1,Chordin-like protein 1,29531,0.0391554670580254,0.00218715344899115,0.0348686462980028,0.0434422878180481,2.68988407082681e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24376,0.106372341011227,0.00594445899389356,0.0947212013831959,0.118023480639259,3.72670655306662e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,24946,0.058850913407523,0.00328977665238531,0.0524029511688478,0.0652988756461982,4.00014966068214e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,29429,0.0761997481082636,0.00426497858060397,0.0678403900902798,0.0845591061262474,5.11943010657436e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,24376,0.0861314896951081,0.0048208948822818,0.0766825357258358,0.0955804436643805,6.12683620972839e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,24788,0.141841615264347,0.00794072360635362,0.126277796995894,0.1574054335328,6.43333252651584e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NBN,Nibrin,28926,0.0650158068817201,0.00364161466965192,0.0578782421292023,0.0721533716342378,6.52172718746369e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24235,0.0596085150347914,0.00333897273877116,0.0530641284667999,0.0661529016027828,7.88608483263612e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,29213,0.0980858252468307,0.00550226461444873,0.0873013866025112,0.10887026389115,1.045062724494e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24863,0.113597868406328,0.00637229317303354,0.101108173787183,0.126087563025474,1.20565330558467e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYBB1,Beta-crystallin B1,24917,0.0809312375661429,0.00454029728940173,0.0720322548789155,0.0898302202533703,1.24069703157374e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24185,0.0445162951927588,0.00249852298143153,0.039619190149153,0.0494134002363646,1.47419475064528e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA2,Annexin A2,23902,0.0879234944251451,0.00493500948550365,0.0782508758335579,0.0975961130167323,1.51265341995007e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24204,0.098839813826573,0.00554870759837864,0.0879643469337509,0.109715280719395,1.57848650378294e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28926,0.0675340424132249,0.00379490551621303,0.0600960276014473,0.0749720572250024,1.8060084660161e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TWF2,Twinfilin-2,24933,0.103704232665231,0.00582602738375793,0.0922852189930657,0.115123246337397,1.92507416582172e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,24391,0.0806558226831387,0.00453173814045865,0.0717736159278398,0.0895380294384377,2.04507720656385e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29505,0.0281329195176568,0.00158248838892485,0.0250312422753641,0.0312345967599495,2.45414356707371e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28782,0.0970013579363049,0.00545706161708989,0.0863055171668088,0.107697198705801,2.6086257345454e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",29561,0.0754164089723497,0.00424313814631977,0.067099858205563,0.0837329597391365,2.62535594795388e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL21,C-C motif chemokine 21,29576,0.0500880223908891,0.00281818260815257,0.04456438447891,0.0556116603028681,2.65075148732183e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,24224,0.0677357367884026,0.00381076832730884,0.0602666308668773,0.0752048427099279,3.0969824906521e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA11,Annexin A11,29368,0.0822114381938571,0.00462878330531389,0.0731390229154419,0.0912838534722723,3.30926993007082e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,24863,0.0651414270748489,0.0036675631728053,0.0579530032561506,0.0723298508935473,3.81407232074278e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ROBO1,Roundabout homolog 1,29492,0.0296857998762682,0.00167255785073418,0.0264075864888292,0.0329640132637072,4.08666215976924e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,24788,0.106821550574766,0.00601853275784599,0.0950252263693881,0.118617874780144,4.78559559420236e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBM17,Splicing factor 45,24863,0.0944338083647681,0.00532374227029915,0.0839992735149818,0.104868343214554,5.74153397493399e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C19orf12,Protein C19orf12,28769,0.079277152298924,0.00447365240499096,0.0705087935851417,0.0880455110127062,6.81206361427706e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29689,0.0697018007341157,0.00393374009987657,0.0619916701383576,0.0774119313298738,6.86469821158811e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29344,0.0425491849978577,0.0024019199278525,0.0378414219392668,0.0472569480564486,7.47712465458149e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLKB1,Plasma kallikrein,24449,0.030988726653297,0.00174959686623949,0.0275595167954677,0.0344179365111264,9.26627630206883e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DBNL,Drebrin-like protein,29576,0.113435527065102,0.00641073034455595,0.100870495589772,0.126000558540432,1.0561182464546e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DXO,Decapping and exoribonuclease protein,24840,0.056076590090974,0.00317246240403846,0.0498585637790586,0.0622946164028894,1.71089879258065e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29213,0.0960512865645162,0.00543714800235596,0.0853944764798985,0.106708096649134,1.77133442970327e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRC1,Macrophage mannose receptor 1,24946,0.0348679148506954,0.00197298513342178,0.0310008639891888,0.0387349657122021,1.80759178384762e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,29449,0.0637458810153365,0.00360921995369899,0.0566718099060865,0.0708199521245865,1.88062410837817e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300LF,CMRF35-like molecule 1,29720,0.073986135605516,0.00419031762710274,0.0657731130563947,0.0821991581546374,2.05572042835571e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD164,Sialomucin core protein 24,29438,0.032833508182819,0.00185958901319401,0.0291887137169588,0.0364783026486793,2.07633258151826e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASAH1,Acid ceramidase,24728,0.0571855214230769,0.00323937189067957,0.0508363525173449,0.0635346903288088,2.55977634676974e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,28792,0.0700842613438283,0.00397318806440466,0.0622968127375952,0.0778717099500614,2.84954579211558e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,24863,0.0439109691264026,0.0024885463563793,0.0390334182678992,0.0487885199849061,2.93096929374772e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,24800,0.0938151978595476,0.00531779921468499,0.083392311398765,0.10423808432033,3.12325721488235e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP53,Cellular tumor antigen p53,28792,0.0534541527147214,0.00303214579683877,0.0475111469529174,0.0593971584765254,3.4035670342975e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MIF,Macrophage migration inhibitory factor,29381,0.0831714744939477,0.00472047683953947,0.0739193398884503,0.0924236090994451,3.97704718147431e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,24841,0.0245283714761785,0.00139154769934446,0.0218009379854633,0.0272558049668936,4.05611404222154e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTF1,Cardiotrophin-1,28911,0.103338168534773,0.00586679100843843,0.0918392581582339,0.114837078911312,4.41427009664383e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",29438,0.0942664789478675,0.00535352677015573,0.0837735664783622,0.104759391417373,4.81293689274816e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,29815,0.0876334531787608,0.00497806011895443,0.0778764553456101,0.0973904510119115,5.14099045197434e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF19,Fibroblast growth factor 19,29576,0.0940821714531058,0.0053446908968712,0.0836065772952383,0.104557765610973,5.26697181227732e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NIT1,Deaminated glutathione amidase,24235,0.0579472633659535,0.00329042175670078,0.05149803672282,0.0643964900090871,5.47330413047596e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,24840,0.0389879383939219,0.00221475419817996,0.0346470201654892,0.0433288566223546,6.05486728428586e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,24917,0.030961317645286,0.00175900719196703,0.0275136635490306,0.0344089717415413,6.26709393236476e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AIF1,Allograft inflammatory factor 1,28792,0.0640681523519526,0.00364309212912852,0.0569276917788607,0.0712086129250445,7.20937594443479e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,24788,0.0675178611636037,0.00384098166893592,0.0599895370924893,0.0750461852347181,9.45403915866282e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,24106,0.0761468514220983,0.00433320006819359,0.0676537792884389,0.0846399235557578,1.06685815524118e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,29429,0.126290406523934,0.00719252121025566,0.112193064951833,0.140387748096035,1.14676696447379e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24917,0.109347261115762,0.00622866831800279,0.0971390712124765,0.121555451019047,1.39914243853054e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24863,0.0975749745829156,0.00556896371892059,0.0866598056938312,0.108490143472,2.54350177300745e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F2R,Proteinase-activated receptor 1,29531,0.0696524807384148,0.00397774211498174,0.0618561061930505,0.077448855283779,2.63826080384429e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RILPL2,RILP-like protein 2,24917,0.119132650475687,0.00680508162573178,0.105794690489253,0.132470610462121,3.28084677768218e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,24863,0.0949522615674734,0.00542768134108002,0.0843140061389565,0.10559051699599,4.07278744535227e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24235,0.111302960567224,0.0063668618275589,0.0988239113852081,0.123782009749239,5.17877845849755e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,24899,0.0581566948580206,0.0033337042497126,0.0516226345285839,0.0646907551874574,9.50191646985109e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWC2,Brorin,29109,0.0482969474146247,0.00277031601927556,0.0428671280168446,0.0537267668124048,1.01175146288837e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NADK,NAD kinase,29473,0.0654603711872723,0.00375576252765979,0.0580990766330591,0.0728216657414855,1.08154680468944e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,29689,0.0564367028458173,0.00324382194511569,0.0500788118333905,0.0627945938582441,1.84160761377012e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADA,Adenosine deaminase,29781,0.0420194128877766,0.00241530139721407,0.037285422149237,0.0467534036263162,1.87058603058259e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,28769,0.0890510739715092,0.00512749623139613,0.0790011813579728,0.0991009665850456,3.21434322807142e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,24840,0.0327270979414702,0.00188381286980395,0.0290348247166545,0.036419371166286,3.31398859157619e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLO1,Lactoylglutathione lyase,28911,0.0698231512749098,0.00402443340815954,0.0619352617949171,0.0777110407549025,4.33307296239695e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,24376,0.0813521002697214,0.00468738202362756,0.0721648315034114,0.0905393690360314,4.53677694224214e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JAM3,Junctional adhesion molecule C,24376,0.0612837738428818,0.00353212186676204,0.0543608149840282,0.0682067327017354,4.95592695911977e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,29689,0.0361990338316997,0.00208752187594921,0.0321074909548393,0.0402905767085602,4.96923918340344e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,29561,0.0394473968991603,0.00227531178616013,0.0349877857982864,0.0439070080000342,5.29836560492882e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD160,CD160 antigen,29781,0.0563957834356172,0.00325659760892435,0.0500128521221255,0.062778714749109,7.40105246260329e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,29561,0.0443656289837695,0.00256341876336209,0.0393413282075797,0.0493899297599592,8.86674814166919e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,28792,0.0683844292535155,0.00395348759256586,0.0606355935720864,0.0761332649349446,1.07374475518323e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,28949,0.0497950559253956,0.00287951944929445,0.0441511978047784,0.0554389140460127,1.15330869041167e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,29370,0.0444427082897917,0.00257113421452741,0.039403285229318,0.0494821313502654,1.29928516261222e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APP,Amyloid-beta precursor protein,29390,0.0797995831629776,0.00462059640312806,0.0707432142128466,0.0888559521131086,1.6754481011147e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,24917,0.0571408053850419,0.00330727346856629,0.050658549386652,0.0636230613834318,1.70351184361716e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF23,Fibroblast growth factor 23,29688,0.0681240316639025,0.00394527040383497,0.060391301672386,0.0758567616554191,1.75492642799695e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,29462,0.11349537324938,0.00657653163540588,0.100605371243985,0.126385375254776,2.08191990751179e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29429,0.114886677915429,0.00665886541061119,0.101835301710631,0.127938054120227,2.24851587576205e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDC4,Syndecan-4,29473,0.0554783369413916,0.00321806647484766,0.0491709266506902,0.061785747232093,2.83245057132636e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,29576,0.124535288928945,0.00722457677223609,0.110375118455363,0.138695459402528,2.9196000763852e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24863,0.0790177611790093,0.00458237371938332,0.070036308689018,0.0879992136690006,3.0262277053009e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NID1,Nidogen-1,29513,0.0453514426615393,0.00263346661773392,0.0401898480907809,0.0505130372322978,3.88058861375471e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29561,0.0322243644625808,0.00187190179183353,0.028555436950587,0.0358932919745745,4.32593867305622e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FXN,"Frataxin, mitochondrial",29720,0.0875784022899828,0.00509137329504693,0.0775993106316908,0.0975574939482748,5.42195935928448e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29429,0.0983620832060392,0.00572097463933235,0.0871489729129478,0.109575193499131,6.27113079141419e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAPG,Macrophage-capping protein,29169,0.0696556398998383,0.00405202907748538,0.061713662907967,0.0775976168917097,6.63615718720762e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,28792,0.056189284082419,0.00326971553366987,0.049780641636426,0.0625979265284119,7.36687271376393e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,24961,0.0362842389882132,0.00211272345630733,0.0321433010138509,0.0404251769625756,9.90594018417248e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,29344,0.138593367029013,0.00807357557835155,0.122769158895444,0.154417575162582,9.95367170161276e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTA,Lymphotoxin-alpha,29429,0.0477600686840571,0.00278258996494023,0.0423061923527742,0.0532139450153399,1.03480250261146e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29429,0.0727225430341377,0.00423898155410485,0.0644141391880922,0.0810309468801832,1.19058393786981e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,24933,0.0316054292106982,0.00184153079786632,0.0279960288468802,0.0352148295745162,1.20741955642506e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATOX1,Copper transport protein ATOX1,29561,0.0848399277226771,0.00495248530398114,0.075133056526874,0.0945467989184801,1.81307177822328e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,24224,0.108272996300086,0.00631755148498869,0.0958905953895077,0.120655397210663,1.86676476469005e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAP3,Cytosol aminopeptidase,28926,0.0577922402542744,0.00337543195316899,0.0511763936260632,0.0644080868824856,2.15946112792188e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,24863,0.0658831969818768,0.00384813276064538,0.0583408567710118,0.0734255371927417,2.46164297886225e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPB6,Heat shock protein beta-6,29720,0.0456698185658831,0.00267000911028676,0.0404366007097211,0.0509030364220452,2.81218699074783e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29438,0.0328697427165647,0.00192409996803755,0.0290985067792111,0.0366409786539183,4.08392804589268e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,28792,0.0661341465007744,0.00387136471065931,0.0585462716678822,0.0737220213336666,4.16982766961094e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD48,CD48 antigen,29531,0.0355434922571253,0.00208110274085313,0.0314645308850532,0.0396224536291975,4.36205873434346e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,29391,0.0486913945806042,0.00285114899307646,0.0431031425541744,0.0542796466070341,4.47822751058436e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,24863,-0.0534296242278689,0.00312859987754028,-0.0595616799878478,-0.0472975684678899,5.10530026196873e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,29429,0.060744801553056,0.00355867011488205,0.0537698081278872,0.0677197949782248,5.14979906369056e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATXN2L,Ataxin-2-like protein,24863,0.0572483016748015,0.00335234471958696,0.0506777060244111,0.0638188973251919,5.16741714267561e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29429,0.11952638650298,0.00700427252789444,0.105798012348307,0.133254760657653,5.58088312472213e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THBD,Thrombomodulin,29473,0.0339889630548358,0.0019918598916145,0.0300849176672714,0.0378930084424002,5.65581651117483e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,28792,0.0469343519528989,0.00275222955124541,0.0415399820324579,0.0523287218733399,6.89834168881033e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRADD,Death domain-containing protein CRADD,29158,0.0895531682042324,0.00525716254398882,0.0792491296180143,0.0998572067904505,9.3825569617315e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,29589,0.0352014507249359,0.00206725187222812,0.0311496370553688,0.039253264394503,1.03414619052503e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24800,0.128616265734242,0.00756296527736793,0.1137928537906,0.143439677677883,1.72025340118632e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24800,0.0766368266305251,0.00450667850528765,0.0678037367601613,0.0854699165008889,1.74641651002208e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN4,CCN family member 4,29720,0.0473019830581227,0.00278444678418875,0.0418444673611128,0.0527594987551327,2.03415215548988e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,24788,0.049836623042849,0.0029322629416487,0.0440893876772175,0.0555838584084804,2.04060848414489e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMOT,Angiomotin,24376,0.0477143845397592,0.00280964447176833,0.0422074813750933,0.0532212877044251,2.60270263691332e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,29468,0.0460118046336571,0.00271137453958269,0.040697510536075,0.0513260987312392,2.7729521853134e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPARC,SPARC,29561,0.0827130029969165,0.00487915177759288,0.0731498655128345,0.0922761404809986,3.72151593922424e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRN,Progranulin,29308,0.0290480331981099,0.00171389095036904,0.0256888069353865,0.0324072594608332,3.98758237974895e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARSA,Arylsulfatase A,29438,0.052701966803279,0.00311068124619477,0.0466050315607372,0.0587989020458208,4.42243148301237e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24863,0.0934074123904726,0.00551422569846419,0.0825995300214828,0.104215294759462,5.27773462236008e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YJU2,Splicing factor YJU2,24788,0.0383233361701554,0.00226280532379596,0.0338882377355153,0.0427584346047955,5.57814466500528e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD36,Platelet glycoprotein 4,24224,0.0534537353440221,0.00315629842890077,0.0472673904233766,0.0596400802646677,5.74648775163305e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,24190,0.0947517235668195,0.0056001398538974,0.0837754494531806,0.105727997680458,7.53223300973494e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,24376,0.148122303180714,0.00875592550885079,0.130960689183367,0.165283917178062,7.83369320098414e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,24800,0.0757366320381272,0.00447807340226757,0.0669596081696828,0.0845136559065717,8.26389888041447e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPART,Spartin,24376,0.0912601733228997,0.00539568778712595,0.0806846252601328,0.101835721385667,8.27526490225242e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,24376,0.140217108272852,0.00829068879602075,0.123967358232652,0.156466858313053,8.4064959045565e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24376,0.074840162532566,0.00442673336877116,0.0661637651297746,0.0835165599353575,9.32645736487554e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL14,C-C motif chemokine 14,29430,0.0464418589150447,0.00274938649378267,0.0410530613872307,0.0518306564428588,1.03459221407981e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEXN,Nexilin,24946,0.0810836665710739,0.00479840787686314,0.0716787871324221,0.0904885460097256,1.05302687205072e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOXJ3,Forkhead box protein J3,24224,0.0522114566258157,0.00309016993624526,0.046154723550775,0.0582681897008565,1.11656104431187e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OGA,Protein O-GlcNAcase,24800,0.0832348913759139,0.00492855016528962,0.0735749330519462,0.0928948496998815,1.24533693476012e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,29473,0.0773110354085617,0.00458136960021062,0.0683315509921489,0.0862905198249745,1.36610480800985e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIFBP,KIF-binding protein,29344,0.0965282502453316,0.0057210373224851,0.0853150170932608,0.107741483397402,1.43090391737837e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,24946,0.0851292665665654,0.00505683995975816,0.0752178602454394,0.0950406728876914,3.05028184778294e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CETN2,Centrin-2,28769,0.0788912842449114,0.00468815509067457,0.0697025002671892,0.0880800682226335,3.06733486624118e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,29344,0.0851147470156056,0.00506307745730074,0.0751911151992962,0.0950383788319151,4.01494724126154e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,28857,0.0612676535777405,0.00364453774462426,0.054124359598277,0.0684109475572041,4.06488809168582e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFASC,Neurofascin,29781,0.0330395657112823,0.00196736892125626,0.02918352262562,0.0368956087969446,5.2884901944168e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,24235,0.0360730009199636,0.00214807843366766,0.031862767189975,0.0402832346499522,6.22139565715268e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29781,0.0333438269502006,0.0019871816793882,0.0294489508585998,0.0372387030418015,6.71682209241403e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RRAS,Ras-related protein R-Ras,24190,0.153265422680165,0.00913143936926043,0.135367801516415,0.171163043843916,7.21219295774806e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24788,0.0411712873197182,0.00245585350853584,0.0363578144429879,0.0459847601964484,9.83454607788401e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXNB2,Plexin-B2,29696,0.0277507261153615,0.0016564598165866,0.0245040648748518,0.0309973873558713,1.04532516249499e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,29344,0.0655486724170986,0.00391819380402555,0.0578690125612085,0.0732283322729887,1.5637090742687e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA7A,Semaphorin-7A,29731,0.0321094155188497,0.00191969293998608,0.028346817356477,0.0358720136812224,1.62899557005277e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,24224,0.113461143258053,0.00678001313319909,0.100172317516983,0.126749968999123,1.64646241294771e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,24847,0.0754752156819727,0.00451360867551342,0.0666285426779663,0.084321888685979,2.00054771325868e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN5,CCN family member 5,29438,0.0451988697976985,0.00270429630964247,0.0398984490307992,0.0504992905645977,2.0217234882618e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGMN,Legumain,29576,0.0415378325786047,0.0024884863664312,0.0366603993003996,0.0464152658568098,2.89081361068862e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,28911,0.108382147332109,0.00649300091373829,0.0956558655411817,0.121108429123036,2.92762096069967e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29344,-0.0229157236984836,0.00137307587108792,-0.0256069524058159,-0.0202244949911513,3.0375069229828e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBC1D23,TBC1 domain family member 23,29344,0.103870723801158,0.00623292198447249,0.0916541967115924,0.116087250890724,4.55831578473998e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24376,0.0701998256826411,0.00421069565412902,0.0619468622005482,0.078452789164734,4.64323080061835e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24800,0.137059321450231,0.00822188591559801,0.120944425055659,0.153174217844803,4.71413711793433e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PF4,Platelet factor 4,24817,0.112804401963958,0.00676834623191837,0.0995384433493976,0.126070360578518,5.00028578481797e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CIAPIN1,Anamorsin,29561,0.0723584479684681,0.00434792707522332,0.0638365109010304,0.0808803850359058,6.61668744630741e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,29111,0.0340289595516465,0.00204697360379986,0.0300168912881987,0.0380410278150942,9.00323202472458e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,29473,0.0779325571872835,0.00469482536753879,0.0687306994669075,0.0871344149076596,1.33560265605894e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP10,Caspase-10,28769,0.0823642365233351,0.00496478876031186,0.0726332505531239,0.0920952224935464,1.59993116764116e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,29512,0.0309847221147826,0.00186819511215932,0.0273230596949503,0.0346463845346149,1.6893583251034e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29531,0.0587587757112584,0.0035442528522749,0.0518120401207995,0.0657055113017172,1.8881122997459e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA9,Serpin A9,29222,0.0833655406334958,0.0050305951222163,0.0735055741939518,0.0932255070730397,2.12985066258618e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATG4A,Cysteine protease ATG4A,28792,0.0677686770767778,0.00409037349475449,0.059751545027059,0.0757858091264966,2.29154299306098e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MESD,LRP chaperone MESD,29438,0.139517392330592,0.00842597131906481,0.123002488545224,0.156032296115959,2.65586802354075e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCG2,Secretogranin-2,29554,0.0374869415114563,0.00226490240383748,0.0330477327999348,0.0419261502229778,2.96205223826842e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA3,Annexin A3,29635,0.0799993220444328,0.00483419017158323,0.0705243093081297,0.0894743347807359,3.08565575896434e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLG4,Disks large homolog 4,24840,0.0817514118111962,0.00494296057739755,0.072063209079497,0.0914396145428954,4.08556490749286e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAL,Galanin peptides,29576,-0.0740436478449505,0.00448048906671827,-0.0828254064157183,-0.0652618892741827,4.49903330884848e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24917,0.0845599535345083,0.00511848337269772,0.0745277261240207,0.0945921809449958,5.5171574590516e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VNN1,Pantetheinase,24946,0.0837185812454162,0.00506837503503613,0.0737845661767454,0.093652596314087,5.75958683044699e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,24518,0.0643135856099971,0.00389505648493328,0.0566792748995279,0.0719478963204663,6.46325315309396e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH2B3,SH2B adapter protein 3,28792,0.112257433514473,0.00680711914397156,0.0989154799922884,0.125599387036657,8.07764152804109e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTRK3,NT-3 growth factor receptor,29689,-0.0248006083161142,0.00150401543037902,-0.0277484785596571,-0.0218527380725713,8.13155986740738e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMEM106A,Transmembrane protein 106A,24788,0.0813337768921427,0.00493108754047033,0.0716688453128209,0.0909987084714646,8.53993455356179e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,29189,0.112295575428944,0.00681332318188587,0.098941461992448,0.125649688865441,9.34465827345749e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29438,0.0411879518531763,0.00249984397691778,0.0362882576584175,0.0460876460479352,1.01806919966811e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEP1A,Meprin A subunit alpha,24800,0.0827398480457809,0.00502345527167447,0.0728938757132989,0.0925858203782629,1.25155648315928e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCRN1,Secernin-1,29429,0.0637453754808633,0.00387554377080698,0.0561493096900816,0.0713414412716449,1.61301155830386e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDC,Nuclear migration protein nudC,29781,0.0722704856572778,0.00439465974714804,0.0636569525528677,0.080884018761688,1.68293424773757e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,24800,0.0670041220132027,0.00407387601079554,0.0590193250320435,0.074988918994362,1.83564022663136e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL2,Fc receptor-like protein 2,29640,0.0562918549521636,0.00342426010321149,0.0495803051498691,0.0630034047544581,1.86002686507808e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,29429,0.104446921735859,0.00635381741109932,0.0919934396101041,0.116900403861613,1.88903770432896e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,28769,0.0705508242397923,0.00429824987360603,0.0621262544875245,0.0789753939920601,2.86362645336712e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPBP,Platelet basic protein,24811,0.096648307955048,0.00588941077042285,0.0851050628450192,0.108191553065077,3.34149408168908e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB6,Serpin B6,29618,0.0672825902210492,0.00410620945238241,0.0592344196943797,0.0753307607477187,4.46083249601799e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,29315,0.0477656833459411,0.00291522965311712,0.0420518332258315,0.0534795334660506,4.53989027002966e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RFC4,Replication factor C subunit 4,24788,0.0242918984710516,0.00148282911400051,0.0213855534076106,0.0271982435344926,5.30864629925955e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,24917,0.032460632642639,0.00198249158810448,0.0285749491299543,0.0363463161553238,6.07040673700717e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",24862,0.025859494993596,0.00157940992662414,0.0227638515374127,0.0289551384497794,6.15673799017288e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,24863,0.0972751930666382,0.0059418929063015,0.0856290829702872,0.108921303162989,6.33995149447625e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,29399,0.0225877497189295,0.00138171449742402,0.0198795893039784,0.0252959101338806,8.31109960397622e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GHRL,Appetite-regulating hormone,29473,0.0915796374718559,0.005613108316186,0.0805779451721313,0.10258132977158,1.40261640840005e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29213,0.106608136425879,0.00653961604969126,0.0937904889684846,0.119425783883274,1.75308975559745e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMA4,Laminin subunit alpha-4,29576,0.037836227429313,0.00232153572592186,0.0332860174065062,0.0423864374521199,1.85573672280415e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,24917,0.0931523714248065,0.00571372700228792,0.0819534665003221,0.104351276349291,1.90223457415202e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,29429,0.117956629564404,0.00723972293922017,0.103766772603532,0.132146486525275,2.01690716187752e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MATN2,Matrilin-2,29492,0.033661649560554,0.00206641949405773,0.0296114673522008,0.0377118317689071,2.11923795305626e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICA1,Islet cell autoantigen 1,28926,0.0899668924137989,0.00552331154805831,0.0791412017796046,0.100792583047993,2.1884386432379e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29269,0.0295767466505093,0.00181612021830784,0.026017151022626,0.0331363422783927,2.27753524526231e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23845,0.037614300226911,0.00230857078428001,0.0330895014897222,0.0421390989640998,2.30571204658407e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RSPO3,R-spondin-3,29720,0.0320913560692055,0.0019716838868671,0.028226855650946,0.035955856487465,2.63494311223133e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLTA,Clathrin light chain A,28911,0.0532657255051664,0.00327316679240928,0.0468503185920442,0.0596811324182886,2.79668564896402e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24376,0.0478598557044441,0.00293999199357615,0.0420974713970348,0.0536222400118533,2.86505778536776e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,24235,0.0618782896210008,0.00380132590749286,0.0544276908423148,0.0693288883996868,2.91569461758017e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24788,0.0546897612173372,0.00336042844316728,0.0481033214687293,0.0612762009659451,3.03334715089253e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29492,0.0383881293492812,0.00236096053200544,0.0337606467065506,0.0430156119920119,3.46146291751314e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29473,0.0939466811991993,0.00578440688529717,0.0826092437040169,0.105284118694382,4.64518445884653e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C4BPB,C4b-binding protein beta chain,29561,0.0452296985484584,0.0027854365159126,0.0397702429772697,0.050689154119647,4.90262057829045e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLL1,Delta-like protein 1,29561,0.0337260097855838,0.00207765007620582,0.0296538156362204,0.0377982039349472,5.32823685193772e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLSTN3,Calsyntenin-3,24840,0.0344892063322047,0.00212797073573525,0.0303183836901636,0.0386600289742458,8.93783215820629e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",24324,0.0968455103356722,0.00597937933858016,0.0851259268320552,0.108565093839289,1.08213023743111e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24917,0.110450475159464,0.00682165932121628,0.0970800228898799,0.123820927429048,1.16143310708435e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OPHN1,Oligophrenin-1,24840,0.121028628795464,0.00748869295373455,0.106350790606145,0.135706466984784,1.87362232601087e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TST,Thiosulfate sulfurtransferase,28701,0.0848201077835943,0.005255673674299,0.0745189873819682,0.0951212281852203,2.46287610397096e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,24376,0.0929893709285477,0.00576155111366178,0.0816967307457706,0.104282011111325,2.69591764499553e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CERT,Ceramide transfer protein,28769,0.0687846919160389,0.00426547677176493,0.0604243574433796,0.0771450263886981,3.02324320405412e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL26,C-C motif chemokine 26,29429,0.0997126429528601,0.0061881094370361,0.0875839484562693,0.111841337449451,3.63581054483561e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NGRN,Neugrin,24840,0.0249068236987518,0.00154533735691576,0.0218779624791969,0.0279356849183067,3.80050366645205e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24840,0.109576362698333,0.00680214906394621,0.0962441505329983,0.122908574863667,4.34207398415016e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,24840,0.0597722786888389,0.00371221351582145,0.0524963401978289,0.0670482171798489,4.90039034400711e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL1,Growth-regulated alpha protein,29415,0.106321880651683,0.0066095956664105,0.0933670731455179,0.119276688157847,5.65897832139881e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28792,0.0730345523911642,0.00454143544159335,0.0641333389256412,0.0819357658566871,6.12393855295193e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINE2,Glia-derived nexin,24917,0.0720492264171363,0.00448133209230732,0.0632658155162139,0.0808326373180587,7.16361914171015e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GM2A,Ganglioside GM2 activator,24417,0.0429256009385409,0.00267515058274815,0.0376823057963545,0.0481688960807272,1.20206086898684e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,24235,0.0686503722208815,0.0042790631464095,0.0602634084539188,0.0770373359878441,1.26193872344546e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLMH,Bleomycin hydrolase,29815,0.0353696624922069,0.00220811704477655,0.0310417530844449,0.039697571899969,1.66345291629503e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24440,0.0553559228378722,0.00345495906814123,0.0485842030643154,0.062127642611429,1.75744751256271e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RP2,Protein XRP2,29344,0.0465950395542778,0.00290987013505059,0.0408916940895786,0.0522983850189769,1.82509078722007e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UMOD,Uromodulin,29745,-0.0599668728132264,0.00374638732257212,-0.0673097919654678,-0.0526239536609851,1.9985081369711e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,29473,0.142068015741565,0.00888374135491422,0.124655882685933,0.159480148797197,2.53737318306651e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,28581,0.0426969527848669,0.00267025601020457,0.0374632510048659,0.0479306545648678,2.66832390957169e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADD1,Alpha-adducin,24376,0.0781038654707504,0.00488389669544566,0.0685314279476769,0.0876763029938239,2.83878950912922e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,24224,0.0644563864970831,0.00403165569116285,0.0565543413424039,0.0723584316517623,3.0642867537029e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24840,0.0887516223886581,0.00555215265730176,0.0778694031803467,0.0996338415969696,3.13526193645176e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28792,0.0941546136928278,0.0058934893188716,0.0826033746278395,0.105705852757816,3.3091295715145e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL19,C-C motif chemokine 19,29689,0.136271841189895,0.00853535570158608,0.119542544014787,0.153001138365004,3.84208935292281e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FEN1,Flap endonuclease 1,28792,0.0698470277786646,0.00437781917484749,0.0612665021959635,0.0784275533613656,4.64055094501952e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,28930,0.0869394226181616,0.00546825676482829,0.0762216393590981,0.097657205877225,1.12121469813891e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24800,0.0847451587690517,0.00532888765410603,0.0743005389670039,0.0951897785710995,1.15270417541939e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,28792,0.0842731635956979,0.00530207247476662,0.0738811015451553,0.0946652256462404,1.20801820568599e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29429,0.0901084819802907,0.00567362082337852,0.0789881851664688,0.101228778794113,1.45169635347456e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,28911,0.0540341046711454,0.00340385883897573,0.047362541346753,0.0607056679955378,1.65386239783618e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24863,0.118431547722654,0.00746087348302995,0.103808235695915,0.133054859749392,1.82754865614816e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,29815,0.0174504678075189,0.00110138617569958,0.0152917509031477,0.01960918471189,2.62334271953379e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM3B,Protein FAM3B,29344,0.0392597443261224,0.00247845180576556,0.0344019787868219,0.0441175098654229,2.80303733539244e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBCB,Tubulin-folding cofactor B,29213,0.110526515933929,0.00698130029932378,0.0968431673472546,0.124209864520604,3.21951480732117e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,24106,0.0736096882035334,0.00464827728137127,0.0644990647320457,0.0827203116750211,3.38051105804949e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24235,0.0844314415816449,0.00533277840219918,0.0739791959133345,0.0948836872499553,3.5520000598324e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24917,0.0441239417103805,0.00278820797596105,0.0386590540774968,0.0495888293432641,3.91733876779344e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,24800,0.0528579622454704,0.00334439711232887,0.0463029439053058,0.0594129805856349,5.40300843777757e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,24032,0.060703099809577,0.00384185776813873,0.0531730585840251,0.0682331410351289,5.9135093363181e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,24863,0.0853854584595235,0.00540647343904422,0.0747887705189968,0.0959821464000502,6.48664846754155e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29568,0.12241577822917,0.00775724363458801,0.107211580705378,0.137619975752963,7.1328414225815e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPL,Periplakin,24224,0.0360057193788326,0.00228164035123472,0.0315337042904125,0.0404777344672526,8.03035111154621e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEPTIN8,Septin-8,24796,0.0353960753076599,0.00224371502574391,0.0309983938572018,0.0397937567581179,8.55508780018039e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,28769,0.0419759683418738,0.0026621259749373,0.0367582014309967,0.0471937352527509,8.87570566855811e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,24788,0.0564391651047506,0.00357911174154311,0.0494241060913261,0.0634542241181751,9.49157620279261e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24440,0.116392417205233,0.00738104586040539,0.101925567318838,0.130859267091627,9.5679164200802e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,28792,0.0656716067597268,0.00416690680616917,0.0575044694196352,0.0738387440998184,9.98927572348009e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,24440,0.0617979256403629,0.00392124216566053,0.0541122909956683,0.0694835602850575,1.10709386798916e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,29438,-0.057417765041367,0.00364691257584901,-0.0645657136900311,-0.050269816392703,1.27016804382732e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACYBP,Calcyclin-binding protein,24324,0.113112963846608,0.00718304787282605,0.0990341900158685,0.127191737677347,1.35199923281716e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPR,Nucleoprotein TPR,24106,0.0524143312866281,0.00332954037230302,0.0458884321569142,0.058940230416342,1.47031129669115e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,29349,0.097429173863411,0.00619660401675937,0.0852838299905627,0.109574517736259,1.77372647686564e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THTPA,Thiamine-triphosphatase,24750,0.0967022445332184,0.00614899205336454,0.0846502201086239,0.108754268957813,1.84858057349044e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,29344,0.0426617636989326,0.00271381251131766,0.03734269117675,0.0479808362211152,1.85226913324633e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,24863,0.0729716771337002,0.0046463360991309,0.0638648583794037,0.0820784958879968,2.57173501079896e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMED8,Protein TMED8,24800,0.112637042166564,0.00717670584600482,0.0985706987083945,0.126703385624733,3.02954253760383e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29296,0.0823850071572231,0.00525411253319572,0.0720869465921595,0.0926830677222867,3.47158866733195e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTRB1,Chymotrypsinogen B,29438,0.0606052251065164,0.0038684988344419,0.0530229673910103,0.0681874828220225,4.29234807843388e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,29720,0.0637575671150789,0.00407794105404075,0.055764802649159,0.0717503315809988,6.98974708369648e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,24863,0.0530247462887225,0.00339831114221778,0.0463640564499757,0.0596854361274694,1.25692604498582e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,28979,0.0369366314735213,0.0023682234514574,0.0322949135086648,0.0415783494383778,1.27783059223383e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29647,0.0304688468460539,0.00195494798172044,0.0266371488018819,0.034300544890226,1.504714751175e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,24106,0.0467945466182223,0.00300210986477312,0.040910411283267,0.0526786819531776,1.64219860711007e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRAP,BRCA1-associated protein,24560,0.119192423030051,0.00765007555588194,0.104198274940523,0.13418657111958,1.80043934782512e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29589,-0.0412262877120006,0.0026471701859956,-0.046414741276552,-0.0360378341474492,1.80830936733286e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,28769,0.0555401709040019,0.0035661310096512,0.0485505541250855,0.0625297876829182,1.81624777425905e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPT1,Angiopoietin-1,29317,0.0910073707329555,0.00584562620950617,0.0795499433623235,0.102464798103588,1.97118340032757e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24440,0.0722833476645212,0.00464384697816151,0.0631814075873246,0.0813852877417177,2.28318011313377e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,28769,0.061277891742662,0.00394859270672729,0.0535386500374766,0.0690171334478475,4.2838394322461e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ING1,Inhibitor of growth protein 1,28714,0.0495997616438128,0.00319647463800236,0.0433346713533282,0.0558648519342975,4.41566641867958e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,24863,0.127892520018596,0.0082520633556355,0.11171847584155,0.144066564195641,6.37669992561672e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,24759,0.0759555140748861,0.00490093289006319,0.0663496856103623,0.0855613425394099,6.39937848160551e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,24946,-0.0285038523481809,0.00184489854502524,-0.0321198534964304,-0.0248878511999314,1.33545946270462e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE1,Ribonuclease pancreatic,24946,0.0262762563612431,0.00170113209334978,0.0229420374582775,0.0296104752642087,1.41481990330313e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,24106,0.0716973017454548,0.00464511593826588,0.0625928745064537,0.080801728984456,1.71780619549169e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,24800,0.0895839497010458,0.00580807160180892,0.0782001293615004,0.100967770040591,1.99883773806632e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,29473,0.0673955322518605,0.00437321431783762,0.0588240321888988,0.0759670323148222,2.23199796449131e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24863,0.106680328672031,0.00693106763260675,0.0930954361121222,0.120265221231941,3.28087211208678e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLG,Plasminogen,24416,0.023740831902091,0.00154253120695869,0.020717470736452,0.0267641930677301,3.35505789957358e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29720,0.0359313343934201,0.00233877887331225,0.0313473278017281,0.0405153409851121,4.61844498473178e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,28342,0.0336572632374697,0.0021920685039287,0.0293608089697694,0.0379537175051699,5.43678101523763e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,28792,0.0483261418849583,0.00314967942036658,0.0421527702210398,0.0544995135488768,6.37535796280296e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,29115,0.0462032894489914,0.00301265140445085,0.0402984926962678,0.0521080862017151,7.03296426646226e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,24788,0.100897489061636,0.00658585180913257,0.0879892195157362,0.113805758607536,9.7625834742126e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,24224,0.0434933664520679,0.00283951734532951,0.0379279124552221,0.0490588204489138,1.03788461206385e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,24676,0.0646689132088549,0.0042228142397643,0.0563921972989169,0.0729456291187929,1.07512185075306e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24917,0.0568850262849506,0.00371744648725359,0.0495988311699336,0.0641712213999676,1.28372435999546e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PALM,Paralemmin-1,24652,0.0318972303926029,0.00208663012201473,0.027807435353454,0.0359870254317518,1.63966253230745e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNST,Consortin,29473,0.114983271938787,0.00752670968421043,0.100230920957734,0.129735622919839,1.73851771199802e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,29344,0.0215426268964645,0.00141278987840882,0.0187735587347832,0.0243116950581458,2.68340494310119e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDHD2,Phospholipase DDHD2,24863,0.0703966926677636,0.0046195521137167,0.0613423705248789,0.0794510148106484,3.36350320899348e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29689,0.0481904759288375,0.00316393230741708,0.0419891686063,0.054391783251375,3.4600518585393e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,29473,0.0609245658646037,0.004000996814845,0.0530826121075075,0.0687665196217,3.68042196392674e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TADA3,Transcriptional adapter 3,24788,0.0420279265607185,0.00276180853594231,0.0366147818302715,0.0474410712911654,4.65353838765202e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD226,CD226 antigen,24224,0.0447135970434461,0.00293924336467786,0.0389526800486775,0.0504745140382147,5.07638180606162e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,29473,-0.0418763159910203,0.00275611142424094,-0.0472782943825326,-0.0364743375995081,6.10240683943623e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GET3,ATPase GET3,24917,0.0583374960678769,0.00383873633186669,0.0508135728574182,0.0658614192783356,6.32651437824755e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLRX,Glutaredoxin-1,29286,0.0592693153263602,0.00390263993656421,0.0516201410506943,0.0669184896020261,6.80459021798804e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL8,Interleukin-8,29213,0.0715458364427063,0.00471533550725363,0.0623037788484892,0.0807878940369234,8.41513129925299e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX7,Syntaxin-7,24224,0.0525982144017501,0.00346565605200604,0.0458055285398182,0.0593909002636819,8.69943531231304e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29158,0.10128982170752,0.00667801444663725,0.0882009133921115,0.114378730022929,9.1325061464208e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RETN,Resistin,29357,0.0444791418012351,0.00293300534629718,0.0387304513224926,0.0502278322799776,9.47163597928772e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPL14,60S ribosomal protein L14,24235,0.0425145791264488,0.00280603523122364,0.0370147500732505,0.0480144081796471,1.28484155989337e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",24840,0.11187800642441,0.00739877331134697,0.0973764107341701,0.12637960211465,1.99128244078429e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPB1,Heat shock protein beta-1,29034,0.0722723170163698,0.00478119083754524,0.0629011829747811,0.0816434510579584,1.99588660203921e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24224,0.0470486350401996,0.00311429940335496,0.0409446082096239,0.0531526618707753,2.48579113756488e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A11,Protein S100-A11,29203,0.047777752950549,0.00316598196628063,0.0415724282966389,0.053983077604459,2.89980948772807e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,29438,0.0448150894999935,0.00297647527761342,0.0389811979558711,0.0506489810441158,4.85539594847111e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,28911,0.0392697271958379,0.00262196078405798,0.0341306840590842,0.0444087703325915,1.60104565235822e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFB,Complement factor B,24533,0.0342407855767136,0.00228607169719441,0.0297600850502126,0.0387214861032147,1.71052597285202e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACRBP,Acrosin-binding protein,24788,0.0405189746422179,0.00270629219885775,0.0352146419324567,0.0458233073519791,1.85701769252137e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24235,0.047361161436321,0.00316470763381445,0.0411583344740447,0.0535639883985974,2.07641346928294e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,24840,0.0486421566658138,0.00325492007545046,0.0422625133179309,0.0550218000136967,2.81222610971595e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,24788,0.0578967784101887,0.00387537435263219,0.0503010446790296,0.0654925121413477,3.01154420271852e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29213,0.036926721795788,0.00247326083919738,0.0320791305509611,0.0417743130406148,3.20469665310301e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29344,0.0976220488044493,0.00654440581883599,0.0847950133995307,0.110449084209368,3.91063195142258e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,29344,0.0225688800963397,0.00151371259646129,0.0196020034072756,0.0255357567854038,4.35565535261198e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,29218,0.041895806498239,0.00281081771143182,0.0363866037838326,0.0474050092126453,4.65967822536725e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THPO,Thrombopoietin,28911,0.0399948454039504,0.00268432368622875,0.034733570978942,0.0452561198289587,5.1010040116164e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,24863,0.0645376404380463,0.00433564849190106,0.0560397693939203,0.0730355114821724,6.73461778236465e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPO,Myeloperoxidase,29438,0.047522850583736,0.00319384306910053,0.0412629181682989,0.053782782999173,6.80121367263357e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,24235,0.0451259787899657,0.0030362298023707,0.0391749683773191,0.0510769892026123,9.56632768690187e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GMFG,Glia maturation factor gamma,24917,0.0742213381409725,0.00499726731414447,0.0644266942052493,0.0840159820766956,1.09593539359178e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,28911,0.0559011639723285,0.00376552000719634,0.0485207447582237,0.0632815831864333,1.13382655077814e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP8,Caspase-8,29627,0.0635225907849409,0.00427911716909637,0.055135521133512,0.0719096604363698,1.13486284065458e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,24917,0.0732865033826078,0.00493568889210743,0.0636125531540772,0.0829604536111384,1.164471483445e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,29720,0.0339468874782326,0.00228809584949653,0.0294622196132195,0.0384315553432458,1.28501787627299e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GTPBP2,GTP-binding protein 2,24190,0.083884407693925,0.00565269032583907,0.0728051346552804,0.0949636807325696,1.34077479455769e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F13B,Coagulation factor XIII B chain,24828,0.0267169117510934,0.00180053648944742,0.0231878602317764,0.0302459632704103,1.35182027982903e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,24235,0.0950115626055455,0.0064135465077156,0.0824410114504229,0.107582113760668,1.95259212589426e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,29429,0.0880170442053319,0.00595954826233823,0.0763363296111489,0.0996977587995148,3.47996677930903e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRSF1,G-rich sequence factor 1,23857,0.0832467482921081,0.00563662084832301,0.072198971429395,0.0942945251548212,3.83373029751941e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CIT,Citron Rho-interacting kinase,24190,0.0468037590347505,0.00317097646170772,0.0405886451698033,0.0530188728996976,4.33743351803525e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,24376,0.0258526149214808,0.00175156391015778,0.0224195496575715,0.02928568018539,4.34121634498667e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,29344,0.0548929120381663,0.00372312327611633,0.0475955904169783,0.0621902336593544,5.05540742306974e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29589,0.0431291174140921,0.00292677767222992,0.0373926331765214,0.0488656016516627,5.64561212244728e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TTF2,Transcription termination factor 2,24190,0.0505492034732871,0.00343394887874574,0.0438186636709455,0.0572797432756288,7.7576204212091e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL2,C-C motif chemokine 2,29164,0.0535553763766871,0.00364848891192105,0.0464043381093218,0.0607064146440523,1.3150245727888e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGA11,Integrin alpha-11,29429,-0.0349430717646914,0.00238160192896296,-0.0396110115454588,-0.030275131983924,1.44522120612501e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,24376,-0.0261846306554654,0.00178416629366728,-0.0296815965910533,-0.0226876647198776,1.4784180352254e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PMVK,Phosphomevalonate kinase,28752,0.111881477255757,0.00762738375660777,0.0969318050928061,0.126831149418708,1.53964244413659e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BOLA1,BolA-like protein 1,24096,0.0560460152003556,0.00382327266965576,0.0485524007678303,0.0635396296328809,1.90395980975601e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,24840,0.101852443582102,0.00694970825085476,0.0882310154104271,0.115473871753778,1.97611922105606e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,25972,-0.0318276146655761,0.00217278611064971,-0.0360862754424495,-0.0275689538887027,2.15581812524344e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,24190,0.0443600363121666,0.00302914871288345,0.0384229048349151,0.0502971677894182,2.35785333321867e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,28911,0.113085718463495,0.00772677253323645,0.0979412442983513,0.128230192628638,2.48170597404508e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,28792,0.0445974309517801,0.00304788273453924,0.0386235807920832,0.050571281111477,2.60856011724039e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP7,Caspase-7,24840,0.0857208827463555,0.00585983602619266,0.0742356041350179,0.0972061613576931,2.93383102479557e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUGT1,Protein SGT1 homolog,28792,0.0819139843449497,0.00560871520505899,0.0709209025430341,0.0929070661468653,3.89489029191005e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LARP1,La-related protein 1,24788,0.0640454956855879,0.00438554635590564,0.0554498248280129,0.072641166543163,4.21237710793077e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29576,0.121088592142079,0.0082967848748406,0.104826893787391,0.137350290496766,4.46679314615346e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24224,0.0497945172322923,0.00341092030096478,0.0431091134424014,0.0564799210221833,4.59256056940346e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24863,0.0481457950808939,0.00329840272808196,0.0416809257338532,0.0546106644279345,4.66187450238312e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGF,Pro-epidermal growth factor,29374,0.104630084039937,0.00717442394318885,0.0905682131112868,0.118691954968587,5.2468274887725e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX9,Sorting nexin-9,29473,0.0692721076745543,0.00475089772971288,0.0599603481243171,0.0785838672247915,5.46700136869638e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENAH,Protein enabled homolog,28926,0.0483046736257269,0.00331521975105775,0.0418068429136538,0.0548025043378001,6.39312566333274e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24961,0.0262975733856198,0.00180472409642487,0.0227603141566271,0.0298348326146126,6.70897050282512e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,24376,0.0888147572485453,0.00609491975744852,0.0768687145239462,0.100760799973144,6.74155897937004e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,28792,0.09276423147465,0.00637756220387436,0.0802642095550563,0.105264253394244,9.23072427151349e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,29429,0.0710213295225376,0.0048858293610753,0.06144510397483,0.0805975550702452,1.04629077169635e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FADD,FAS-associated death domain protein,29473,0.0771246466376545,0.00530744717347344,0.0667220501776466,0.0875272430976625,1.12082317157503e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,24863,0.0390596902881099,0.00268711577514255,0.0337929433688305,0.0443264372073893,1.12617619539677e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,24961,0.018761449415204,0.0012911720030774,0.0162307522891723,0.0212921465412357,1.21488956458614e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,24788,0.0294119221847466,0.00202550119575408,0.0254419398410686,0.0333819045284246,1.40325443031663e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,29187,0.0482088229145073,0.00332175477979773,0.0416981835461037,0.0547194622829108,1.4673823077422e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,29561,0.0691945545906993,0.00477092542975421,0.0598435407483811,0.0785455684330176,1.67988378283058e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,24800,0.115244000664134,0.00794340544722416,0.0996749259875751,0.130813075340694,1.68519545763298e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOXO3,Forkhead box protein O3,28792,0.0972033875802175,0.00670707938914978,0.0840575119774839,0.110349263182951,1.98149068625236e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTN6,Dynactin subunit 6,28769,0.0718973932274016,0.00496116036457286,0.0621735189128388,0.0816212675419644,1.99945453391608e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL7,Interleukin-7,29429,0.0646862892487108,0.00447459612394821,0.0559160808457723,0.0734564976516492,3.31985884493958e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24224,0.0703270073847877,0.00486335306006876,0.060794835387053,0.0798591793825225,3.38145626248149e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PZP,Pregnancy zone protein,24961,0.0537462848823405,0.00371796341469534,0.0464590765895376,0.0610334931751434,3.57359852917704e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPPK1,Epiplakin,24235,0.0742845679061986,0.00513957922879934,0.0642109926177518,0.0843581431946453,3.74835480663758e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,24224,0.0334183126298908,0.00231215021293709,0.0288864982125341,0.0379501270472475,3.75372951584618e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,29390,0.0832729303939036,0.00576818287842445,0.0719672919521917,0.0945785688356155,4.41490974964512e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,24106,0.0622545766584361,0.00431149549196277,0.0538040454941891,0.0707051078226831,4.61101454327313e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24863,0.0675058641044966,0.00468053118695414,0.0583320229780665,0.0766797052309267,5.76722188531654e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP5,Platelet glycoprotein V,24376,0.0364403537806677,0.00252682961867846,0.0314877677280579,0.0413929398332774,5.92888209852541e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,28769,0.0671305742925194,0.00467541976312419,0.057966751556796,0.0762943970282428,1.37229953420072e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,24946,0.0401666139908713,0.00279708821965815,0.0346843210803413,0.0456489069014013,1.41206741678203e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,29537,0.0512026019840228,0.00356842203332817,0.0442084947986996,0.058196709169346,1.55469205725853e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,24440,0.0737914114580196,0.00514130345482294,0.0637144566865667,0.0838683662294726,1.58561134464746e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,28792,0.0467574451493404,0.00326683530705117,0.0403544479475201,0.0531604423511607,2.62718237315462e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,24376,0.0388553716697014,0.00271497348839963,0.0335340236324381,0.0441767197069647,2.8571999198813e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JAM2,Junctional adhesion molecule B,29689,0.0265619757713794,0.0018570086974931,0.0229222387242929,0.0302017128184658,2.9601538810112e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,28926,0.0651259825169503,0.00456432290822899,0.0561799096168215,0.0740720554170791,4.93121642338455e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,29668,0.0420025005507636,0.0029455781037793,0.0362291674673562,0.047775833634171,5.55338730851781e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,29781,0.0726954240252616,0.00509944685493877,0.0627005081895816,0.0826903398609416,5.86746294519378e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PVR,Poliovirus receptor,29689,0.0366838082047526,0.00257358389215333,0.0316395837761321,0.0417280326333732,6.00669779266168e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COMT,Catechol O-methyltransferase,28586,0.0835800661929477,0.00586915398819182,0.0720765243760917,0.0950836080098036,7.36685225792064e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29781,0.0272329134321097,0.00191403344142077,0.023481407886925,0.0309844189772944,8.67724734984814e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,29321,0.0281798445407374,0.00198102877775453,0.0242970281363385,0.0320626609451363,9.12593205648099e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,24096,0.0986703499527584,0.0069465331050408,0.0850551450668785,0.112285554838638,1.31789038449807e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,24190,0.0675793034932562,0.00476359735007264,0.0582426526871139,0.0769159542993986,1.68885107000775e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,24724,0.0438707394681467,0.00309531405360349,0.0378039239230838,0.0499375550132095,2.02081318780604e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28792,0.0662351730490832,0.00469565456608855,0.0570316900995496,0.0754386559986167,4.95477922445108e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,24190,0.0712569450375374,0.00505748891978396,0.0613442667547608,0.081169623320314,6.64598218440084e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,24190,0.0602010764399588,0.00427683134386716,0.0518184870059792,0.0685836658739385,8.01009945541248e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",24933,0.0410292791965627,0.0029150802897931,0.0353157218285682,0.0467428365645571,8.05457125293957e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,24800,0.0861442816377828,0.00612316992354173,0.074142868587641,0.0981456946879246,8.81265754080852e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F12,Coagulation factor XII,24961,0.040683654082804,0.00289716496825412,0.0350052107450259,0.0463620974205821,1.26550520380125e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,29720,0.0382050176238108,0.00272286639636928,0.032868199486927,0.0435418357606946,1.3948074346504e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD40LG,CD40 ligand,29781,0.0757809530450714,0.00540095522596733,0.0651950808021754,0.0863668252879674,1.39677054897149e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,29561,0.0814088627417256,0.00581068098875266,0.0700199280037704,0.0927977974796808,1.87384994063918e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPC5,Glypican-5,29213,0.0547630688103934,0.00390962888693277,0.0471001961920052,0.0624259414287816,1.9612344097582e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,24224,0.088423399555465,0.0063175894123901,0.0760409243071804,0.10080587480375,2.44227017329391e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTD,Deoxycytidylate deaminase,24376,0.0927977110103943,0.00663324297529456,0.079796554778817,0.105798867241972,2.67076244424201e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,28792,0.0492667752014746,0.00352575033044344,0.0423563045538055,0.0561772458491438,3.16023498492529e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNRD2,Protein ZNRD2,24800,0.0670750057645316,0.00480136246813199,0.0576643353269929,0.0764856762020703,3.49622887552179e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA2,Carbonic anhydrase 2,29363,0.0666915298871062,0.00477621367881169,0.0573301510766352,0.0760529086975771,3.61750159191106e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCN1,Ficolin-1,24914,0.0545946120955233,0.00390999469579103,0.0469310224917729,0.0622582016992737,3.85602289088457e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL32,Interleukin-32,29429,-0.0422216524525028,0.00302715177239292,-0.0481548699263929,-0.0362884349786127,4.49344825992252e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CR1,Complement receptor type 1,24898,0.0349642059004753,0.00250831265127085,0.0300479131039844,0.0398804986969661,5.34879572628589e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYO9B,Unconventional myosin-IXb,28926,0.063941848667023,0.00459334357205413,0.0549388952657969,0.0729448020682491,6.58825163676764e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP6,Gastrotropin,28867,0.0545403326197105,0.00391904106265902,0.0468590121368988,0.0622216531025222,6.94925752248593e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP2,Caspase-2,29429,0.0656074924244084,0.00471513932186077,0.0563658193535613,0.0748491654952555,7.1535956761092e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24224,0.0544009651357189,0.00391063108501997,0.0467361282090798,0.0620658020623581,8.00616296531e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24800,0.09978878364505,0.00717814676222106,0.0857196159910967,0.113857951299003,9.02662012970638e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29393,0.0235738462552741,0.00169808871425084,0.0202455923753424,0.0269021001352057,1.11026899091674e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28926,0.0574509699064816,0.00415360994746944,0.0493098944094415,0.0655920454035217,2.26006458170119e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24917,0.0852945858035472,0.00616749081853047,0.0732063037992275,0.0973828678078669,2.44044056592119e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,24235,0.05446543520832,0.00393869886164458,0.0467455854394966,0.0621852849771434,2.5147486254806e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24376,0.0859426633193328,0.00621599278239839,0.0737593174658319,0.0981260091728336,2.58745999474782e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD7,T-cell antigen CD7,24172,0.0421192878419189,0.0030500757320607,0.0361411394070799,0.0480974362767579,3.27166948679326e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBS,Cystathionine beta-synthase,24235,0.0492393545383659,0.00357264895637616,0.0422369625838686,0.0562417464928632,4.73573367565442e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS4,Galectin-4,29449,0.0522523118543779,0.00379406187267954,0.044815950583926,0.0596886731248298,5.09971650740358e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPP,Lipoma-preferred partner,24106,0.0639373921307176,0.00464437471188795,0.0548344176954172,0.073040366566018,5.88572327724554e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL6,Interleukin-6,29344,0.070528860430405,0.00513445730630595,0.0604653241100453,0.0805923967507646,8.34268021035192e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,24376,0.0397198575337846,0.00289158756427562,0.0340523459078044,0.0453873691597648,8.87968678761914e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAG6,Large proline-rich protein BAG6,28911,0.0347917232004982,0.00253407521422873,0.0298249357806098,0.0397585106203865,9.20336279015778e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,28792,0.0721577901321609,0.00525695536223497,0.0618541576221804,0.0824614226421415,9.65457085025636e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GZMH,Granzyme H,28911,0.0730759774334207,0.00532611197045195,0.0626367979713349,0.0835151568955065,1.04448198924762e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,24376,0.107318375677541,0.00783180105991386,0.0919680456001096,0.122668705754972,1.403531241186e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,24440,0.0676269388745624,0.00493530388843832,0.0579537432532233,0.0773001344959015,1.40620616409456e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,29720,0.0512940942499307,0.00374728701786242,0.0439494116949203,0.058638776804941,1.60506856641999e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSNAX,Translin-associated protein X,24106,0.0375853008746674,0.00274892747288837,0.0321974030278062,0.0429731987215286,2.12798727216584e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,29158,0.0303496790143592,0.00222059888849193,0.025997305192915,0.0347020528358034,2.15035296419998e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24376,0.099444812262743,0.00727562170363552,0.0851845937236174,0.113705030801869,2.25337269148387e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",29213,0.055296290923983,0.00405197561644559,0.0473544187157496,0.0632381631322163,2.84619085342605e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP1,Interstitial collagenase,28419,0.0868505537862334,0.00636469304204826,0.0743757554238188,0.099325352148648,2.91212014455599e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH7,Protocadherin-7,24800,0.0332034962476427,0.00243359531948766,0.0284336494214469,0.0379733430738385,3.12371492605011e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,29420,0.0211191232979473,0.00155153536465398,0.0180781139832255,0.0241601326126692,4.5736554754781e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRR3,Small proline-rich protein 3,24840,0.0645526073517944,0.00474423715809654,0.0552539025219252,0.0738513121816636,5.18218916143053e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28792,0.0802176939088989,0.00590608797456991,0.0686417614787419,0.091793626339056,6.87644973422378e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29213,0.0672140853764066,0.00495006401096567,0.0575119599149138,0.0769162108378993,7.20714137518243e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,24840,0.0211492499610619,0.0015576811165552,0.0180961949726137,0.0242023049495101,7.69392912923216e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL24,C-C motif chemokine 24,29531,0.0781609580189308,0.00575928272914969,0.0668727638697974,0.0894491521680642,7.91365676472877e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSM,Oncostatin-M,29288,0.0670063825715045,0.00493925897010786,0.057325434990093,0.0766873301529159,8.51436233296337e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29429,0.114346048506428,0.00843069537010326,0.097821885581026,0.130870211431831,8.85746018193409e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,29356,0.0319755033667816,0.00235846666085557,0.0273529087115047,0.0365980980220586,9.52521559128153e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A12,Protein S100-A12,29018,0.0708037441137065,0.00522306101424381,0.0605665445257886,0.0810409437016244,9.7884497206867e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,24863,0.119618243325733,0.0088282267754292,0.102314918845892,0.136921567805575,1.12167400814987e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,24106,0.0628694532909543,0.00464114687301301,0.0537728054198488,0.0719661011620598,1.18730972324745e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,28792,0.0455556568879985,0.00336690474764393,0.0389565235826164,0.0521547901933806,1.38643638228886e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,24863,0.0882308859424175,0.00652000383010349,0.0754516784354147,0.10101009344942,1.41489700266304e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,29344,0.0216139757623047,0.00159795238594744,0.0184819890858477,0.0247459624387617,1.46296899533388e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLAMF8,SLAM family member 8,28792,0.0504505131134499,0.00373267233419089,0.0431344753384357,0.057766550888464,1.68654147673109e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24863,0.0448129521188946,0.00331624346086245,0.0383131149356042,0.051312789302185,1.8326776804072e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,29689,0.0464118517998152,0.00343717769937219,0.0396749835090458,0.0531487200905847,1.99324299266895e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29109,0.031285448442871,0.00231771312848154,0.0267427307110472,0.0358281661746949,2.12938348705941e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23618,0.101960496609189,0.00755288516612076,0.0871568416835922,0.116764151534786,2.24135840967908e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INHBB,Inhibin beta B chain,24376,0.0489245865054515,0.0036266198019159,0.0418164116936964,0.0560327613172067,2.50711239268335e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,24840,0.0345563675693779,0.00256392520154624,0.0295310741743473,0.0395816609644085,2.94741229301208e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MICALL2,MICAL-like protein 2,24190,0.0644796751230672,0.00478516461814492,0.0551007524715032,0.0738585977746313,3.09645656957875e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BMP6,Bone morphogenetic protein 6,28879,0.0386765011514615,0.00287320477147218,0.033045019799376,0.044307982503547,3.52765112599054e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29473,0.0459323414801597,0.0034124940036769,0.0392438532329529,0.0526208297273664,3.55736822684313e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,24106,0.0642651349133544,0.00477289870891151,0.0549102534438878,0.073620016382821,3.56147379422007e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,28657,0.0539558017330709,0.00401002060465284,0.0460961613479513,0.0618154421181905,3.82523316095945e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,28792,0.0313575366577753,0.00233091483420585,0.0267889435827318,0.0359261297328188,3.94295258602364e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,29438,0.028145911343857,0.00209396596244667,0.0240417380574615,0.0322500846302525,4.57016813362342e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NID2,Nidogen-2,29438,0.0685197254952794,0.00510153694101493,0.0585207130908901,0.0785187378996687,5.24410708390938e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,24106,0.0649090981162082,0.0048348668062487,0.0554327591759608,0.0743854370564557,6.04123588037338e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,24788,0.0456799814284672,0.00340295593888645,0.0390101877882497,0.0523497750686846,6.11433835515347e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DOK1,Docking protein 1,24840,0.127941335109524,0.00953335481866091,0.109255959664948,0.146626710554099,6.38026270952128e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29603,0.0959385980493355,0.00716075455786962,0.0819035191159111,0.10997367698276,8.18901712766733e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCRIB,Protein scribble homolog,24235,0.0843866856450228,0.00630991375036965,0.0720192546942983,0.0967541165957473,1.2014823182993e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE3,Eosinophil cationic protein,29338,0.100793069604334,0.00756230176326353,0.0859709581483371,0.11561518106033,2.07626203911306e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,29689,0.0264755953835248,0.00198668078460829,0.0225817010456925,0.030369489721357,2.12019258011281e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",29781,0.0628708357475472,0.00471872581906649,0.0536221331421769,0.0721195383529175,2.20065165684973e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EHD3,EH domain-containing protein 3,24235,0.109134904663888,0.00818997687544718,0.0930825499880114,0.125187259339764,2.28516635439669e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,28911,0.0481964051265857,0.00362339500344447,0.0410945509198345,0.0552982593333369,2.98217373739505e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS27,Serine protease 27,29390,0.0372443299469318,0.00280335394842856,0.0317497562080118,0.0427389036858517,3.66342540408857e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,24224,0.026783695602306,0.00202146710414336,0.022821620078185,0.030745771126427,6.24615109434844e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29576,0.0248113779019017,0.00187418800797647,0.0211379694062679,0.0284847863975356,6.83473742900897e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POSTN,Periostin,24933,-0.0349874950936511,0.00264272946281327,-0.0401672448407652,-0.0298077453465371,7.1100862168279e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPM1F,Protein phosphatase 1F,24917,0.0486480405243312,0.00367539655557307,0.041444263275408,0.0558518177732545,7.40090085430089e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24800,0.0435827541017896,0.00329445478302959,0.0371256227270516,0.0500398854765276,8.13091396121086e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAS6,Growth arrest-specific protein 6,29634,-0.0233826335181979,0.0017703419461217,-0.0268525037325964,-0.0199127633037994,1.02227263706831e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29429,0.110345362237483,0.00836077491275759,0.0939582434084785,0.126732481066488,1.16851096539868e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",29390,0.100301610589344,0.00761809207988177,0.085370150112776,0.115233071065913,1.77614712461273e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,29689,0.0213387339048456,0.00162178841967164,0.0181600286022892,0.024517439207402,1.98659235050346e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD69,Early activation antigen CD69,29339,0.0800897741136706,0.00610369789898271,0.0681265262316645,0.0920530219956767,3.19823896990278e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADA2,Adenosine deaminase 2,29323,0.0390418104173703,0.00297860134586898,0.0332037517794671,0.0448798690552735,3.84759793899234e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,24224,0.0370852509057958,0.00283013234257497,0.0315381915143488,0.0426323102972427,4.25991127582345e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29457,0.0529882785921128,0.00404512246029737,0.04505983856993,0.0609167186142957,4.2751105022334e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,24106,0.0333695815340449,0.00254914803965496,0.0283732513763211,0.0383659116917686,5.07239248644436e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,24800,0.050182567514807,0.003833937467757,0.0426680500780033,0.0576970849516108,5.12493750852637e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24106,0.0333696591439381,0.00255142365548713,0.0283688687791833,0.0383704495086928,5.90607665657209e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28769,0.101765600479605,0.00778371137169921,0.086509526191075,0.117021674768136,5.97500259786731e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DBN1,Drebrin,24224,0.0468767827182164,0.00358546026729322,0.0398492805943216,0.0539042848421111,6.27117666162149e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1B,Interleukin-1 beta,28740,0.0512208912283017,0.00392067698435861,0.0435363643389589,0.0589054181176446,6.79987134567095e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,29164,0.036416276788249,0.0027898907190389,0.0309480909789328,0.0418844625975652,7.85780242652362e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,24863,0.0543557167860633,0.00416681686901892,0.0461887557227862,0.0625226778493403,9.11135787094602e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,24840,0.0530704276649553,0.0040690445877777,0.045095100272911,0.0610457550569996,9.40615758116052e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BGN,Biglycan,28745,-0.108749341862068,0.00834078210377721,-0.125097274785472,-0.0924014089386651,9.5501252824754e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,29213,0.0430232427940328,0.00330047837389264,0.0365543051812033,0.0494921804068624,9.86647503601182e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP6,Platelet glycoprotein VI,29395,0.0797133455198016,0.00612052465274032,0.0677171172004306,0.0917095738391726,1.14463514003696e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLIT2,Slit homolog 2 protein,28769,0.0471897362964249,0.00362332966074004,0.0400880101613745,0.0542914624314754,1.15198305974614e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24224,0.0727733913795262,0.00559252957897897,0.0618120334047274,0.083734749354325,1.39780767244198e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,24440,0.0615638115123328,0.00473129056145777,0.0522904820118756,0.07083714101279,1.40419434004574e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29429,0.0339770062183673,0.00261278096324365,0.0288559555304098,0.0390980569063249,1.48040562429443e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28911,0.044045642170446,0.00339157335472929,0.0373981583951766,0.0506931259457154,1.86335838364438e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXN,Thioredoxin,24642,0.0397463961294728,0.00306124704941056,0.0337463519126281,0.0457464403463175,2.02360658271031e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,24106,0.0611346729777793,0.00471446224777993,0.0518943269721306,0.0703750189834279,2.51420713520736e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,24917,0.0291669723679524,0.00225405407585298,0.0247490263792805,0.0335849183566242,3.56363244920422e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP3,Caspase-3,29815,0.0789986951698292,0.00611506061229368,0.0670131763697336,0.0909842139699248,4.46782698086011e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MGLL,Monoglyceride lipase,29531,0.0778674924388307,0.00602990354194712,0.0660488814966143,0.089686103381047,4.78630634505496e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,24933,0.0746844631043726,0.00579368511678024,0.0633288402754833,0.0860400859332619,6.71587579931387e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN3,CCN family member 3,29790,0.0303086168099479,0.00235521224771991,0.0256924008044169,0.0349248328154789,8.51318415112615e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD84,SLAM family member 5,29429,0.0279265584663337,0.00217311508384946,0.0236672529019887,0.0321858640306786,1.07352514295726e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,29781,0.0227627546501898,0.00177133017916172,0.0192909474990328,0.0262345618013468,1.07440699954756e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,24788,0.0554498913200553,0.00431711736541422,0.0469883412838434,0.0639114413562672,1.22272065367896e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24376,0.0615157908580145,0.00479240963100914,0.0521226679812365,0.0709089137347924,1.3630669597974e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,28926,0.0314229975571999,0.00244978833308308,0.026621412424357,0.0362245826900427,1.46912452344922e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,24759,0.0367634859818942,0.00286567244444018,0.0311467679907914,0.042380203972997,1.48782841021056e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24224,0.0391091105417209,0.0030487694531369,0.0331335224135726,0.0450846986698693,1.51787494009755e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,24224,0.0275857819253782,0.00215372700972266,0.0233644769863218,0.0318070868644346,1.94707051145219e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24933,0.0556651263911482,0.0043524516961077,0.0471343210667771,0.0641959317155193,2.46379214780422e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24235,0.0911981656092885,0.00713108328509087,0.0772212423705104,0.105175088848067,2.50047191264235e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24863,0.0523870225469685,0.00410580153289098,0.0443396515425021,0.0604343935514348,3.62128489107556e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG4,Regenerating islet-derived protein 4,29492,0.0441288790750011,0.00345958024063592,0.0373481018033547,0.0509096563466475,3.64053012125958e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24235,0.0687609871289079,0.00538917951476376,0.058198195279971,0.0793237789778449,3.65512365294304e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24173,0.0247154643876796,0.0019388971708619,0.0209152259327903,0.0285157028425689,4.25705160130815e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGA6,Integrin alpha-6,29429,0.0461606761886533,0.00362289910597215,0.0390597939409479,0.0532615584363587,4.36524293255082e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TEK,Angiopoietin-1 receptor,29561,0.0193588441663511,0.00152036667678948,0.0163789254798437,0.0223387628528585,4.85076936444664e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,24840,0.0264807340769291,0.00208027426635214,0.0224033965148789,0.0305580716389793,5.29623732480722e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,24376,0.0328091019889147,0.00258108827113276,0.0277501689774945,0.0378680350003349,6.70033167060864e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29429,0.0881755859043911,0.00694682497387225,0.0745598089556015,0.101791362853181,8.08449736492547e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XRCC4,DNA repair protein XRCC4,28769,0.0327011859672659,0.00257868677871882,0.027646959880977,0.0377554120535548,9.41485846343872e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,29336,0.030757874602768,0.00242636691891275,0.026002195441699,0.035513553763837,9.96479766192499e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BGLAP,Osteocalcin,24933,0.0783293251267316,0.00617850252602587,0.0662194601757209,0.0904391900777423,1.02047196603276e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,24011,0.0451660136724642,0.00356342723477317,0.0381816962923088,0.0521503310526196,1.06847902419397e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRGN,Neurogranin,24946,0.0805995314183861,0.00637540824780601,0.0681037312526863,0.0930953315840859,1.59840865413634e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,24566,0.0494256542469571,0.00391026414866625,0.0417615365155712,0.0570897719783429,1.65160469549724e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24440,0.0336005945699616,0.00266476517027511,0.0283776548362224,0.0388235343037008,2.438426997137e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL25,C-C motif chemokine 25,29781,0.043099758305453,0.00341990618859829,0.0363967421758003,0.0498027744351056,2.52941164601315e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,29576,0.0765391011497931,0.00608650406700746,0.0646095531784585,0.0884686491211277,3.57755955527594e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OPLAH,5-oxoprolinase,24235,0.0601840513051993,0.00478774462242457,0.0508000718452471,0.0695680307651514,3.981157166835e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK13,Kallikrein-13,28840,0.0385374710598338,0.00306958802942738,0.0325210785221561,0.0445538635975114,4.66112586396365e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,24800,0.0861167288036389,0.00686623940316821,0.0726588995734292,0.0995745580338486,5.6523888751628e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XG,Glycoprotein Xg,29688,0.0280390544445476,0.00224039448271234,0.0236478812584314,0.0324302276306638,7.5922385227046e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,29429,0.0415167554823963,0.00332149381866559,0.0350066275978118,0.0480268833669809,9.27080960520942e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,24235,-0.0530677806366232,0.00424727616674565,-0.0613924419234447,-0.0447431193498017,1.03040170970683e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DMD,Dystrophin,24235,0.0450528288123987,0.00360656542818386,0.0379839605731584,0.0521216970516391,1.06510299456464e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28792,0.0690212198820524,0.00552690297295006,0.0581884900550703,0.0798539497090345,1.07133413602304e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFD,Complement factor D,24961,0.0170514197231283,0.00136553156664574,0.0143749778525026,0.0197278615937539,1.12366064800181e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,24840,0.0334669319693113,0.00268188195231096,0.0282104433427818,0.0387234205958407,1.24504524836894e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,29452,-0.0841270394285747,0.00674569378132392,-0.0973485992399696,-0.0709054796171798,1.31862853121904e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB10,Ras-related protein Rab-10,24917,0.0465020822456502,0.00373246599535676,0.0391864488947509,0.0538177155965494,1.59827640617598e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17D,Interleukin-17D,28926,0.0296120595334283,0.00237831687349614,0.0249505584613759,0.0342735606054808,1.70656788337252e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,24321,0.047312592800582,0.00380016759492339,0.0398642643145321,0.0547609212866318,1.79129299891934e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAT,Catalase,24582,0.0465064136156331,0.00374152233287789,0.0391730298431924,0.0538397973880737,2.30052024466055e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,24706,0.0420014627405451,0.00338053166290386,0.0353756206812536,0.0486273047998367,2.45405191246479e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LY75,Lymphocyte antigen 75,29429,0.0335720443866646,0.0027027921669212,0.0282745717394991,0.0388695170338302,2.45825499522847e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28792,0.0500924698520636,0.0040341974932168,0.0421854427653587,0.0579994969387686,2.60446537448246e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,29421,0.08410576444801,0.00678053771297067,0.0708159105305875,0.0973956183654325,3.04609773963472e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28714,0.0405517079231857,0.0032703826352627,0.0341417579580708,0.0469616578883006,3.2297251103566e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PI3,Elafin,29009,0.0474259993630997,0.00383013593442045,0.0399189329316356,0.0549330657945638,3.99713755414919e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,28769,0.0497492049861892,0.00402442193297794,0.0418613379975524,0.0576370719748259,5.16142433982799e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OGN,Mimecan,29438,0.0362062695686125,0.00293422500616591,0.0304551885565273,0.0419573505806977,6.78824791754786e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGA,Fibrinogen alpha chain,24402,0.0266025850886092,0.00215591621359716,0.0223769893099588,0.0308281808672597,7.06765363898715e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29473,0.0291255994688985,0.00236192326974762,0.0244962298601932,0.0337549690776038,7.49050360005816e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",24917,0.0435461663891531,0.00353506464730407,0.0366174396804372,0.0504748930978691,9.11092691841236e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28792,0.0512437785186511,0.00416112710983937,0.0430879693833659,0.0593995876539362,9.21640916852919e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNLY,Granulysin,29438,0.0447571855616455,0.00363557303070538,0.037631462421463,0.0518829087018281,9.63693967426505e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29668,0.0295748048221006,0.00240553025674008,0.0248599655188901,0.0342896441253112,1.17763663043747e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTGR1,Prostaglandin reductase 1,24917,0.0699498610061125,0.00569298157101241,0.0587916171269281,0.0811081048852968,1.33955036607708e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,24235,0.0629550399973433,0.0051236915000127,0.0529126046573184,0.0729974753373682,1.34803927232862e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DHPS,Deoxyhypusine synthase,24788,0.034991908233559,0.00284921983760116,0.0294074373518607,0.0405763791152573,1.44042087832448e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24917,0.0257460067310468,0.00210081626282107,0.0216284068559175,0.0298636066061761,1.97919533255101e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PARD3,Partitioning defective 3 homolog,24440,0.0634853890164453,0.00518490767641155,0.0533229699706787,0.073647808062212,2.27417434215825e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBC1D5,TBC1 domain family member 5,29429,0.0664050061285728,0.00543004391698888,0.0557621200512746,0.077047892205871,2.63057976082625e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA13,Carbonic anhydrase 13,29109,0.0888126447990055,0.00726266235323175,0.0745778265866712,0.10304746301134,2.65301932509907e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA4,Annexin A4,29336,0.0612705395470392,0.00501525837457507,0.051440633132872,0.0711004459612063,3.06206147008979e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAYN,Layilin,29158,0.0297382260698957,0.00243534992906175,0.0249649402089347,0.0345115119308567,3.28930952677526e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,24933,0.0317260184390295,0.00259924707506962,0.026631494171893,0.0368205427061659,3.62179817568546e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,29344,0.0507236261955637,0.00416306822122017,0.0425640124819721,0.0588832399091552,4.56215216059145e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,24440,0.0289213719286812,0.00237342579365116,0.0242694573731249,0.0335732864842375,4.66384501896146e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX6,Syntaxin-6,28792,0.0569967129577852,0.00468626953338444,0.0478116246723517,0.0661818012432187,5.96552917380023e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29213,0.0252070463047502,0.00207273711750128,0.0211444815544477,0.0292696110550527,6.04073136248972e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24235,0.0358108001041001,0.00294720682104216,0.0300342747348574,0.0415873254733427,7.13264694421204e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24224,0.0304846065208861,0.00250899531238086,0.0255669757086196,0.0354022373331526,7.18858965992873e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24235,0.0418981238590681,0.00345962086093873,0.0351172669716282,0.0486789807465081,1.16116226901704e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSE,Cathepsin E,24376,0.0442578063764973,0.00365475592421173,0.0370944847650423,0.0514211279879523,1.17328690405232e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,24235,0.0651977983735261,0.00538423702787984,0.0546446937988816,0.0757509029481706,1.18386659308377e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",29373,0.057110331543019,0.00471814375003836,0.0478627697929439,0.0663578932930942,1.20391132318218e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1R,Complement C1r subcomponent,24961,0.0163734768894394,0.00135443732653975,0.0137187797294215,0.0190281740494573,1.50300506162732e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,29373,0.0342560663877532,0.00283575734714671,0.0286979819873456,0.0398141507881607,1.6172471264697e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24863,0.055859460523019,0.00462719216052584,0.0467901638883883,0.0649287571576496,1.84236708847493e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPA2,Carboxypeptidase A2,29572,0.0547609630001744,0.00454068456129253,0.0458612212600411,0.0636607047403078,2.05653702677213e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK6,Kallikrein-6,29514,0.0256048497329093,0.00213093300912474,0.0214282210350248,0.0297814784307938,3.5091002246832e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29344,0.0453166675303956,0.00377282774204667,0.0379219251559841,0.0527114099048071,3.70671205196879e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARFIP1,Arfaptin-1,24863,0.057785213556895,0.00481029770401835,0.048357030057019,0.067213397056771,3.76017323490107e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29449,0.0246789351308179,0.00205745936873952,0.0206463147680884,0.0287115554935474,4.51568809631452e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFHR5,Complement factor H-related protein 5,24618,0.0350230673079429,0.00292132829059381,0.0292972638583791,0.0407488707575068,5.03126422930112e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHCY,Adenosylhomocysteinase,29473,0.0563779270425082,0.00470567360851799,0.0471548067698129,0.0656010473152034,5.34302727551414e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENO2,Gamma-enolase,29689,0.0545664556924779,0.00455516632370304,0.0456383296980199,0.0634945816869358,5.45371827369265e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,24235,0.0437718338889416,0.00365745003967926,0.0366032318111703,0.050940435966713,6.48503352708607e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDGF,Hepatoma-derived growth factor,29683,0.0777104067216012,0.0065095203438072,0.0649517468477391,0.0904690665954633,8.92102813698781e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UNC79,Protein unc-79 homolog,24011,0.0468484381541896,0.00392402003244376,0.0391573588905998,0.0545395174177794,9.1895304720001e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,28714,0.0550308993723767,0.00461654607139583,0.0459824690724408,0.0640793296723125,1.10740094968322e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFC1,Cryptic protein,28792,0.0390341662240408,0.00327889094459768,0.0326075399726293,0.0454607924754522,1.33462747853078e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BIN2,Bridging integrator 2,29438,0.0745312544976457,0.00626415367127931,0.0622535133019383,0.0868089956933531,1.43886970251133e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LY6D,Lymphocyte antigen 6D,29278,0.0317827340569599,0.00267592712211853,0.0265379168976076,0.0370275512163122,1.84469907025686e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24800,0.0421042973348994,0.00354636561934866,0.035153420720976,0.0490551739488227,2.01342570075673e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMTN,Smoothelin,24771,0.07838490295942,0.00660400841540981,0.0654410464652167,0.0913287594536232,2.0926835833985e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,29448,0.0636141185155085,0.00536123732408381,0.0531060933603042,0.0741221436707127,2.11844011756413e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24376,0.0340198959742753,0.0028669738250977,0.0284006272770838,0.0396391646714668,2.17980979124732e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CORO1A,Coronin-1A,28842,0.0737002384981584,0.00621458390700713,0.0615196540404244,0.0858808229558924,2.29208229412664e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IMPA1,Inositol monophosphatase 1,29213,0.050315596018879,0.00424515475001882,0.0419950927088421,0.0586360993289158,2.47842432101095e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGB1A1,Uteroglobin,29518,0.0456244086310227,0.00385014800246686,0.0380781185461877,0.0531706987158578,2.5466997359418e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INSR,Insulin receptor,24224,0.0140707719000512,0.00118722221346838,0.0117438163616532,0.0163977274384492,2.58622202852896e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,24863,0.0731540677341606,0.00617890519323629,0.0610434135554175,0.0852647219129038,2.98445011238875e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYTL1,Cytokine-like protein 1,24933,0.0199435110259943,0.00168515780630108,0.0166406017256442,0.0232464203263444,3.14702772744625e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24106,0.0231602447818987,0.00195790398426015,0.0193227529727488,0.0269977365910486,3.38991553101223e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELOB,Elongin-B,24106,0.0327739942274911,0.00277135884556264,0.0273421308901884,0.0382058575647939,3.51816782998289e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29815,0.0225511755426283,0.00191017571236345,0.018807231146396,0.0262951199388607,4.29509059789148e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,29344,0.0449991100697421,0.00381433956482842,0.0375230045226784,0.0524752156168058,4.75964784723336e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,29328,0.0214244199703874,0.00181839108973824,0.0178603734345004,0.0249884665062743,5.70196133811538e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,24863,0.0559709954118087,0.00475546954915431,0.0466502750954663,0.0652917157281511,6.78798955448659e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF2,Fibroblast growth factor 2,29429,0.0552098353182098,0.00469271935799129,0.0460121053765469,0.0644075652598727,6.97110223471769e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,24440,0.0617639785309225,0.00524856149543057,0.0514767979998786,0.0720511590619664,6.97521752071062e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,24235,0.0420942344801007,0.00357711512296194,0.0350830888390952,0.0491053801211061,6.99867075540476e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28792,0.0803996172559579,0.00684023608922218,0.0669927545210824,0.0938064799908334,7.97197370825987e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS22,Brain-specific serine protease 4,24224,0.0287031051086422,0.00244625334604873,0.0239084485503867,0.0334977616668977,1.04614093839885e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLB,Beta-klotho,28769,-0.0605017687117538,0.00516017717195762,-0.0706157159687907,-0.0503878214547169,1.12391148939158e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,24106,0.0314927614619302,0.00268622489219929,0.0262277606732196,0.0367577622506408,1.17347979260824e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29127,0.0334053900124817,0.002850155622311,0.0278190849927522,0.0389916950322113,1.17832893893544e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TLR3,Toll-like receptor 3,29781,0.0498145068788978,0.00425238662368961,0.0414798290964662,0.0581491846613294,1.26084773629757e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,24788,0.0560134477515438,0.00478219517517339,0.046640345208204,0.0653865502948837,1.32615981992524e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29438,0.019820428770211,0.00169278240671089,0.0165025752530576,0.0231382822873643,1.35054568901724e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB9,Serpin B9,29213,0.0270462634289024,0.00231020815600653,0.0225182554431296,0.0315742714146752,1.37628661631942e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,29368,0.0714222255022797,0.00610618216375726,0.0594541084613155,0.0833903425432439,1.55677385807688e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,29669,0.0544160850479736,0.00465233332401943,0.0452975117328955,0.0635346583630517,1.55775056502472e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24788,0.0879690946563051,0.00753647764394162,0.0731975984741796,0.102740590838431,2.13044774382427e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX16,Syntaxin-16,28792,0.0471221205310956,0.00404640870065579,0.0391911594778103,0.055053081584381,2.84603132517347e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP10,Stromelysin-2,29434,-0.0477815377199018,0.00411009389218056,-0.0558373217485756,-0.0397257536912279,3.58156457074567e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VGF,Neurosecretory protein VGF,24863,0.0246466677798066,0.00212156117241277,0.0204884078818776,0.0288049276777356,4.05451191742767e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,24096,0.0385005595948291,0.00331877423748905,0.0319957620893506,0.0450053571003077,4.93503400160302e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,24863,0.0310458875893572,0.00268045930179905,0.025792187357831,0.0362995878208833,6.08473667603172e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK11,Kallikrein-11,29291,0.0248775465854963,0.00214896125479068,0.0206655825261066,0.0290895106448861,6.32820441017455e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24190,0.043559317579314,0.00376954795404714,0.0361710035893816,0.0509476315692464,8.33570073829848e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C5,Complement C5,24961,0.0122220532126129,0.00105838454305766,0.0101476195082199,0.0142964869170059,9.06512484046543e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,24440,0.0608701603750458,0.00528075146994872,0.0505198874939463,0.0712204332561453,1.16054032800217e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNG,Interferon gamma,28926,0.0910539812535556,0.00792448377280106,0.0755219930588655,0.106585969448246,1.72099538430569e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,24224,0.0512460464982978,0.00446742311142953,0.042489897199896,0.0600021957966997,2.20957315780774e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24440,0.0697711256614575,0.00609160832175304,0.0578315733508215,0.0817106779720935,2.69432819963933e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEPR,Leptin receptor,29473,-0.0247765872610794,0.00216451445543386,-0.0290190355937298,-0.020534138928429,2.83024284761368e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH3,Cadherin-3,29689,0.0288488759478411,0.0025207367674363,0.0239082318836659,0.0337895200120162,2.89613227934335e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIP,Gastric inhibitory polypeptide,24235,0.0408547261763068,0.00357112953486185,0.0338553122879776,0.0478541400646361,3.14545720536295e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,29211,0.0464085260796803,0.00406738523924242,0.0384364510107651,0.0543806011485954,4.32127198069611e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",29473,0.0581692093793678,0.00510080295153731,0.0481716355943547,0.0681667831643809,4.62153973598787e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFF2,Trefoil factor 2,29531,0.0457533712936464,0.00401494501763615,0.0378840790590795,0.0536226635282132,5.07250611097289e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24788,0.0301992048568425,0.00265377550871211,0.0249978048597668,0.0354006048539183,6.26293100579847e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,29589,0.0218788835724556,0.00192345252690161,0.0181089166197284,0.0256488505251828,6.44328254098483e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F2,Prothrombin,24961,0.0117612439523402,0.00103393681326091,0.00973472779834884,0.0137877601063316,6.58553084003004e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29213,0.0828631764919591,0.00728720388993876,0.0685802568676791,0.097146096116239,6.73696942678217e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,29118,0.0203654157863007,0.00179444394233029,0.0168483056593333,0.0238825259132681,8.65097206793126e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,28792,0.0237305224954478,0.0020917129439521,0.0196307651253017,0.0278302798655939,9.08243504644463e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRELP,Prolargin,29449,0.0183613425353941,0.00162024515616212,0.0151856620293164,0.0215370230414719,1.04448909182153e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24800,0.0170093476125279,0.00150130846231813,0.0140667830263843,0.0199519121986714,1.10677380275453e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,24440,0.0277037633081564,0.0024479773429521,0.0229057277159703,0.0325017989003425,1.28127224166627e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24840,0.0376974120996632,0.00333757567805444,0.0311557637706765,0.0442390604286499,1.64250254122836e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24235,0.0550055975343358,0.00487485931294939,0.045450873280955,0.0645603217877166,1.87479045786488e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP1,Caspase-1,28769,0.0533808012174663,0.00473235733129843,0.0441053808481214,0.0626562215868113,1.90071096371886e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAX,Apoptosis regulator BAX,28717,0.0708328613612012,0.00629312509877914,0.0584983361675941,0.0831673865548084,2.5041423021987e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA1,Carbonic anhydrase 1,28862,0.0468090733474312,0.00416093534814092,0.038653640065075,0.0549645066297874,2.67601665880057e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAPK2,Death-associated protein kinase 2,24224,0.042206598502762,0.00375234443464608,0.0348520034108557,0.0495611935946683,2.7985656849188e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24106,0.0318436545740334,0.00283166201977922,0.0262935970152662,0.0373937121328007,2.88061530853121e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAST,Gastrin,24840,0.102302402179775,0.00910533440679452,0.0844559467424573,0.120148857617092,3.21322768206142e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,24788,0.0467107501051201,0.00416260719003716,0.0385520400126472,0.0548694601975929,3.75983416816694e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTC,Probetacellulin,28792,0.0581440349788194,0.00518292923197874,0.0479854936841411,0.0683025762734978,3.80854539023627e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOLR1,Folate receptor alpha,29378,0.0225719999956551,0.00201232254237062,0.0186278478126087,0.0265161521787015,3.86196157019731e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,29576,0.0164148783030436,0.00146531265003394,0.0135428655089771,0.0192868910971101,4.54643207424712e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,29473,0.0674113220820124,0.00602961401937641,0.0555932786040346,0.0792293655599901,5.84087339328477e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,24190,0.0484913630177082,0.00434136050521264,0.0399822964274914,0.057000429607925,6.75876747800991e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,29344,0.0243491721531777,0.00218103233411699,0.0200743487783084,0.028623995528047,6.99122873800096e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,28792,0.0359064282516225,0.00321704241573003,0.0296010251167916,0.0422118313864533,7.22782420562721e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29678,0.0232325306595187,0.0020878275207779,0.019140388718794,0.0273246726002434,1.04950860066908e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,24800,0.0220585188724766,0.00198375045006823,0.0181703679903429,0.0259466697546103,1.1774226976081e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29492,0.0206447653911875,0.00185951844509387,0.0170001092388035,0.0242894215435715,1.39447946016069e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29720,0.0200250887896472,0.00180407768581126,0.0164890965254571,0.0235610810538372,1.42936092963069e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DENR,Density-regulated protein,24224,0.0445325298557731,0.00401690555155124,0.0366593949747327,0.0524056647368135,1.71277395355025e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD5L,CD5 antigen-like,24828,0.0366140143251935,0.00330277974237123,0.0301405660301459,0.0430874626202411,1.71496756737873e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFF1,Trefoil factor 1,29314,0.0608627206174629,0.00550191861154175,0.0500789601388411,0.0716464810960847,2.18065163944544e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,29520,0.0918320596088394,0.00831066588565385,0.0755431544729579,0.108120964744721,2.49422838182961e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASS1,Argininosuccinate synthase,24106,0.0612817305575507,0.00554502717699777,0.0504134772906351,0.0721499838244664,2.51743044064901e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNM1,Dynamin-1,24800,0.0882911582606833,0.00800042762956873,0.0726103201067286,0.103971996414638,2.98757511050152e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,24106,0.046436150757643,0.00420888861967515,0.0381867290630797,0.0546855724522063,3.09942643054992e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RALY,RNA-binding protein Raly,24788,0.0371241250809256,0.00336722616296025,0.0305243618015235,0.0437238883603277,3.36219602487275e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AFP,Alpha-fetoprotein,29127,0.0521827523022201,0.00473916763903904,0.0428939837297036,0.0614715208747366,3.8459494687858e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,29781,0.0450793229009871,0.00410271987034534,0.0370379919551102,0.0531206538468639,4.95985663744548e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LCP1,Plastin-2,24933,0.0363708110469484,0.00331136886415119,0.029880528073212,0.0428610940206847,5.31257994110984e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD55,Complement decay-accelerating factor,28485,0.0201242836863524,0.00183255925797363,0.0165324675407241,0.0237160998319807,5.3378285765024e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,29561,0.0185575643778702,0.00169237747502245,0.0152405045268262,0.0218746242289142,6.3466191100912e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HYAL1,Hyaluronidase-1,29260,0.0175553719034187,0.00160231344353099,0.014414837554098,0.0206959062527394,7.02528429888557e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,29438,-0.0334453856866901,0.00305584952363713,-0.0394348507530189,-0.0274559206203614,7.97114382948658e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMS,Spermine synthase,24096,0.0490803590502996,0.00448701195533358,0.0402858156178458,0.0578749024827534,8.78748386502504e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSLN,Mesothelin,29288,0.0426316680718761,0.00390192077000838,0.0349839033626596,0.0502794327810925,9.8150773303405e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24840,0.0659494728914005,0.0060389954129785,0.0541130418819626,0.0777859039008383,1.0623741650074e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APLP1,Amyloid-like protein 1,29473,-0.0391129125865872,0.00358529759430326,-0.0461400958714216,-0.0320857293017528,1.17605320397193e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINC1,Antithrombin-III,24909,0.0112613710414452,0.001032280805835,0.00923810066200856,0.0132846414208818,1.20304972675781e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,28792,0.0552389707999343,0.00507286260196326,0.0452961601000863,0.0651817814997823,1.47027130116815e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,24840,0.035293649893533,0.00324978870445699,0.0289240640327973,0.0416632357542687,2.0536862790628e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PMM2,Phosphomannomutase 2,24106,0.0455879782379622,0.00420514498335157,0.0373458940705931,0.0538300624053313,2.5446249315387e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,29561,-0.0180288170498593,0.00166761182892017,-0.0212973362345428,-0.0147602978651758,3.42710561420314e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24788,0.040975759950988,0.00379656806109001,0.0335344865512516,0.0484170333507245,4.27519001920941e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,24235,0.0446459267197315,0.00414035670186723,0.0365308275840717,0.0527610258553913,4.76523481837836e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,28926,0.0501431947858238,0.00466344996485998,0.0410028328546982,0.0592835567169493,6.49355840918707e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28792,0.0379118563895184,0.00352619912775857,0.0310005060991116,0.0448232066799252,6.56074704771869e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29473,-0.0780890778380544,0.00727773508974327,-0.0923534386139512,-0.0638247170621575,8.26194647684094e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WNT9A,Protein Wnt-9a,28926,0.0215541734701455,0.00201174451126494,0.0176111542280662,0.0254971927122248,9.80413120629794e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17RB,Interleukin-17 receptor B,29029,-0.0400007664301032,0.00373468200080439,-0.0473207431516798,-0.0326807897085266,1.01816094995325e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIF22,Kinesin-like protein KIF22,24106,0.0920043745230054,0.00859640560281694,0.0751554195414842,0.108853329504527,1.13546568249108e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,24796,0.0287371872653805,0.00268762279622823,0.0234694465847731,0.0340049279459878,1.26258853501627e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29531,0.0567808260677535,0.00531154949996641,0.0463701890478193,0.0671914630876877,1.26745237692752e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28911,0.0426526967517856,0.003991303905714,0.0348297410965862,0.0504756524069851,1.32144618374898e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,28714,0.0314986256182401,0.00295410116228799,0.0257085873401557,0.0372886638963246,1.7057288547336e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,29561,0.0207295023487427,0.00194419449714809,0.0169188811343324,0.0245401235631529,1.7078175766942e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX5,Sorting nexin-5,24235,0.0222061506198767,0.00208542704337587,0.01811871361486,0.0262935876248934,2.03272544640703e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRK1,Protein BRICK1,28769,0.0331992251298371,0.003118977773268,0.0270860286942318,0.0393124215654424,2.07683866031944e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP8,Neutrophil collagenase,29635,0.0536540762207683,0.00504135903574414,0.0437730125107098,0.0635351399308269,2.10311696627101e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,24917,0.0440413283782598,0.00415256442834998,0.0359023020986939,0.0521803546578258,3.18530146684463e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX2,Sorting nexin-2,24788,0.0603032099754052,0.00569187433789631,0.0491471362731284,0.0714592836776819,3.59105245214015e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28769,0.0472806181336175,0.00446375076024886,0.0385316666435297,0.0560295696237052,3.62224275026723e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29373,0.0481397429247304,0.00454696985443304,0.0392276820100416,0.0570518038394191,3.80800170053487e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",29438,0.0277589874036792,0.00262304559196158,0.0226178180434345,0.0329001567639239,3.99301386573401e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CR2,Complement receptor type 2,29589,0.0342451411499276,0.00324450754007462,0.0278859063713813,0.0406043759284738,5.36894810178514e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDA,Cytidine deaminase,24885,0.0343953565636683,0.00326024914259839,0.0280052682441755,0.0407854448831612,5.7690976108411e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NECTIN4,Nectin-4,29561,0.0234471339911895,0.00222720537656909,0.019081811453114,0.0278124565292649,7.16290784864475e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,24788,0.0321228814897047,0.00305187455537703,0.0261412073611657,0.0381045556182437,7.46421858948383e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28714,0.0351144169442549,0.00334097375110038,0.0285661083920982,0.0416627254964117,8.63338832863966e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28792,0.0346890416698604,0.00330453527083494,0.0282121525390239,0.0411659308006969,9.88277887977472e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29429,0.0669301847300378,0.00638143048371372,0.0544225809819589,0.0794377884781167,1.08567230887182e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,29576,0.0188439491437567,0.00179749035370138,0.015320868050502,0.0223670302370114,1.14137114981535e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEPH,Hephaestin,24917,0.0193164354757339,0.0018449279362601,0.0157003767206641,0.0229324942308037,1.34069791482498e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH1,Cadherin-1,28472,0.0292108295915683,0.00279784315636605,0.0237270570050909,0.0346946021780458,1.80103926187841e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24933,0.0263862816548555,0.00253099918908426,0.0214255232442504,0.0313470400654607,2.14490345570018e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29158,0.0530152208165304,0.00509700685390511,0.0430250873828764,0.0630053542501844,2.70989956289766e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24863,0.0518979809322842,0.0049888887968739,0.0421197588904113,0.061676202974157,2.71597407910014e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,24106,0.0370261070538822,0.00356269105676847,0.030043232582616,0.0440089815251484,3.02562824700933e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,29441,0.0313777998089589,0.00302061635547376,0.0254573917522304,0.0372982078656875,3.11308945624487e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,24800,0.0311446975764172,0.00299899591760114,0.025266665577919,0.0370227295749155,3.26741296128564e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,29540,-0.0212233586487322,0.00204845072868855,-0.0252383220769617,-0.0172083952205026,4.13264309788672e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL3,Fc receptor-like protein 3,28926,0.0390646687621232,0.00377332549944075,0.0316689507832193,0.0464603867410271,4.4935558901524e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,29473,0.0204466670244875,0.00197599144736492,0.0165737237876523,0.0243196102613228,4.73953462396811e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TREML1,Trem-like transcript 1 protein,24946,0.0381184717308778,0.00369044775726612,0.0308851941266362,0.0453517493351194,5.85321611029777e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GZMB,Granzyme B,29429,0.0467750102811918,0.00454079680734484,0.0378750485387959,0.0556749720235877,7.68094104244578e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,29473,0.030455111242922,0.00296930493260442,0.0246352735750174,0.0362749489108267,1.21543740497639e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,24224,0.0619322783626279,0.00604221799321475,0.050089531095927,0.0737750256293288,1.32977408022466e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,28769,0.0455665979451521,0.00445042354674073,0.0368437677935403,0.054289428096764,1.46562645746881e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29344,0.0277199824736939,0.00271191094828797,0.0224046370150495,0.0330353279323383,1.74502167751703e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,24106,0.0259815666392414,0.00254139130212286,0.0210004396870806,0.0309626935914022,1.74862675399918e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,28548,0.0716799037015366,0.0070307819205946,0.0578995711371711,0.085460236265902,2.29468316812044e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24440,0.0260258671269369,0.00255249518834277,0.0210229765577851,0.0310287576960888,2.30608043022505e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,28792,0.0375558257111629,0.00368574542046899,0.0303317646870437,0.0447798867352821,2.43016024021388e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLVRB,Flavin reductase,29438,0.0462124513969388,0.00453790963248759,0.0373181485172632,0.0551067542766145,2.57454522222501e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RCOR1,REST corepressor 1,28911,0.0316933284551948,0.00311598351379334,0.0255860007681598,0.0378006561422298,2.92888730035758e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,29344,0.024350514430521,0.00239705220690531,0.0196522921049866,0.0290487367560554,3.32997728680786e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPAG1,Sperm-associated antigen 1,24863,0.0410649534762104,0.00404837605183061,0.0331301364146224,0.0489997705377984,3.94428434477953e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL6,Fc receptor-like protein 6,29429,0.0479794640891585,0.00473125035506364,0.0387062133932338,0.0572527147850833,3.98267875119941e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,24106,0.0838368483723152,0.00828322893467849,0.0676017196603453,0.100071977084285,4.96622264762582e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24235,0.0198674263186915,0.00196551409596676,0.0160150186905966,0.0237198339467863,5.68040796680718e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,29428,0.0522189181728068,0.00519399856125887,0.0420386809927394,0.0623991553528742,9.66510892640655e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEFL,Neurofilament light polypeptide,28669,0.0314054477315148,0.00312570077802697,0.025279074206582,0.0375318212564477,1.03158693708344e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSC2,Desmocollin-2,29130,0.0240832780934416,0.00239746701851183,0.0193842427371585,0.0287823134497248,1.05316330215079e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMB1,Laminin subunit beta-1,24235,0.0212982821979566,0.00212550910276564,0.0171322843565359,0.0254642800393772,1.37953627541832e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,28769,0.050996614732116,0.00510443190929602,0.0409919281898958,0.0610013012743362,1.82903930447667e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LUZP2,Leucine zipper protein 2,24788,0.0313147220284439,0.00313529594745451,0.0251695419714331,0.0374599020854548,1.90894719774822e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29429,0.030098659256369,0.00301869860860974,0.0241820099834939,0.0360153085292441,2.22967322623375e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,29395,0.0586567150854565,0.00588662797628006,0.0471189242519475,0.0701945059189654,2.37633428506245e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,29561,0.0189851718684318,0.00190537110744791,0.0152506444978339,0.0227196992390297,2.38406213314233e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24696,0.0211204901642743,0.00212271321807119,0.0169599722568548,0.0252810080716938,2.79652711659601e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,28792,0.0358133431012704,0.0036007896857887,0.0287557953171245,0.0428708908854163,2.86338637871469e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,29429,0.0453748379732332,0.00456372411337724,0.0364299387110138,0.0543197372354526,2.95895068003674e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,24800,0.037359555525556,0.00375926318493525,0.0299913996830829,0.0447277113680291,3.14434663893606e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTN2,Dynactin subunit 2,29344,0.0652946166089261,0.00657168573741291,0.0524141125635968,0.0781751206542554,3.16656060344601e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,24863,0.0272208478932544,0.00275522766739397,0.0218206016651622,0.0326210941213466,5.62047249319916e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,24946,0.0435996870611963,0.00441647232940694,0.0349434012955587,0.052255972826834,6.0622396333076e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",24106,0.0388664927472554,0.00394847157034579,0.0311274884693776,0.0466054970251331,8.08024679640138e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,24096,0.0526512121196223,0.00535450399118317,0.0421563842969033,0.0631460399423413,8.95293723751532e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,24788,0.0233859074076268,0.00238483722674072,0.0187116264432149,0.0280601883720386,1.16569619117624e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28792,0.0298356542441245,0.0030548802821167,0.0238480888911757,0.0358232195970732,1.69827821944458e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,24106,0.0478784355470133,0.00491511653247807,0.0382448071433563,0.0575120639506703,2.21553236950972e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNL1,Interferon lambda-1,28769,0.0307767159771036,0.00316116459800484,0.0245808333650142,0.0369725985891931,2.29535551746081e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH17,Protocadherin-17,29473,0.0244470562583008,0.00251434249267426,0.0195189449726592,0.0293751675439423,2.59810157521099e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBP7,Retinoid-binding protein 7,24800,0.0409937382692925,0.00421655888827547,0.0327292828482726,0.0492581936903124,2.66095919276589e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A13,Protein S100-A13,24224,0.0239016562236619,0.00246112213570313,0.0190778568376838,0.0287254556096401,2.95206879666644e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,24190,0.0405670343752178,0.00417921779740158,0.0323757674923107,0.0487583012581249,3.09550794936616e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSTN,Growth/differentiation factor 8,28911,0.035601656152286,0.0036688773905277,0.0284106564668517,0.0427926558377203,3.1442103175379e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,28792,0.0355642553609005,0.00366501530767206,0.0283808253578633,0.0427476853639378,3.14458991720412e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POMC,Pro-opiomelanocortin,24235,0.0477829666335046,0.00493874587100089,0.0381030247263428,0.0574629085406663,4.21754126907582e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINI1,Neuroserpin,24324,0.0207158135566135,0.0021435201896463,0.0165145139849068,0.0249171131283203,4.68038201910924e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29438,0.0800565863944788,0.00828510656593965,0.0638177775252371,0.0962953952637206,4.68267763827026e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,24800,0.0202604648597417,0.00209721981521452,0.0161499140219213,0.0243710156975622,4.84620340712164e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,24235,0.0287564226492069,0.0029839226799094,0.0229079341965845,0.0346049111018294,6.10206581870557e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFIC,Nuclear factor 1 C-type,24863,0.02987162106915,0.00311470774209235,0.023766793894649,0.035976448243651,9.55975135136066e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBP2,Guanylate-binding protein 2,28926,0.040042982307385,0.00417952168889628,0.0318511197971483,0.0482348448176217,1.03764236717671e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,29815,0.0274385025915398,0.00286566018147937,0.0218218086358402,0.0330551965472393,1.09521499606775e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29213,-0.0765055954637351,0.00799964541908561,-0.0921849004851429,-0.0608262904423273,1.22319359419738e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,29781,0.0226205337396644,0.00236543008715697,0.0179842907688368,0.0272567767104921,1.22922386512412e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28926,0.0283192263084512,0.00296934312702596,0.0224993137794803,0.0341391388374221,1.57842291289811e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,24252,0.018786924336742,0.00196963371954207,0.0149264422464395,0.0226474064270445,1.58419757024555e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24224,0.0397806305629294,0.00417190646001675,0.0316036939012965,0.0479575672245622,1.62946270310355e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24235,0.0247919505621624,0.00260146938462045,0.0196930705683063,0.0298908305560185,1.71576521145899e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBP4,Guanylate-binding protein 4,28769,0.0325559570101458,0.00342470013333931,0.0258435447488008,0.0392683692714909,2.12562457629003e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPR15L,Protein GPR15L,24800,0.0407102413355844,0.00428297679120757,0.0323156068248175,0.0491048758463512,2.17298563735495e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDN1,Endothelin-1,24235,0.0193960567534953,0.0020406644719745,0.0153963543884253,0.0233957591185654,2.1845962619249e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PER3,Period circadian protein homolog 3,24224,0.0795627965428879,0.00839880514921619,0.0631011384504242,0.0960244546353517,2.95674343525668e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLIN3,Perilipin-3,29473,0.0280745354916848,0.00296884668892124,0.0222555959813992,0.0338934750019705,3.41648646038572e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,24104,0.0273261057490857,0.00288960129340167,0.0216624872140184,0.032989724284153,3.4586936033671e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ROBO2,Roundabout homolog 2,29689,0.0152356874850082,0.00161256480550361,0.0120750604662211,0.0183963145037953,3.69466327805395e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,29815,0.019960970563334,0.0021152596534983,0.0158150616424773,0.0241068794841907,4.11909593565323e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGAV,Integrin alpha-V,29720,-0.0109074066322618,0.00115762136820726,-0.013176344513948,-0.00863846875057557,4.72408011920837e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24235,0.0411543159076717,0.00438732881023892,0.0325551514396034,0.04975348037574,7.13951965706351e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,29429,0.0240371166517833,0.00256317995026489,0.0190132839492641,0.0290609493543025,7.20038324327365e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL19,Interleukin-19,28649,0.0460392401740206,0.00491319681829914,0.0364093744101543,0.055669105937887,7.73040856500324e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NXPH1,Neurexophilin-1,28769,0.0249597559624519,0.00266427982816645,0.0197377674992457,0.0301817444256582,7.89289281054416e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEDD9,Enhancer of filamentation 1,24224,0.0218672659099827,0.00233471498671873,0.0172912245360139,0.0264433072839514,8.15878113740628e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,29513,0.0232203277358175,0.00248007231825684,0.0183593859920341,0.0280812694796009,8.30177128865116e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28911,0.0575839170877915,0.00615420541498226,0.0455216744744263,0.0696461597011567,8.79101323995053e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST7,Cystatin-F,29493,0.0605963586872283,0.00647891948194668,0.0478976765026129,0.0732950408718438,9.11603736528326e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH1,Protocadherin-1,29708,0.0138350235777367,0.00147936735283988,0.0109354635661705,0.0167345835893029,9.18611715589924e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DRAXIN,Draxin,29213,0.0279790391273641,0.00299202432142002,0.0221146714573809,0.0338434067973474,9.26416715508464e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29428,0.0209147518396845,0.00223753735333559,0.0165291786271467,0.0253003250522222,9.61435268883015e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP9,Caspase-9,24224,0.0410094722659298,0.00440761873135289,0.0323705395524781,0.0496484049793815,1.46066472900166e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYOM3,Myomesin-3,24376,-0.0608444779021353,0.00654215772501294,-0.0736671070431607,-0.04802184876111,1.51367766146168e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,29473,0.0206018100441036,0.00221688117501346,0.0162567229410772,0.02494689714713,1.5978800735471e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24440,0.0470162956516708,0.00507108875051112,0.037076961700669,0.0569556296026726,1.98388100532773e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AZU1,Azurocidin,28529,0.0492745503388713,0.00532738072380198,0.0388328841202195,0.0597162165575232,2.41267311220901e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,29213,0.0327261666170469,0.00353999129769939,0.0257877836735561,0.0396645495605377,2.5145404576888e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",28769,0.0178122621242907,0.00192752700994202,0.0140343091848043,0.021590215063777,2.60558731326659e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24800,0.0277024096211225,0.00299988946401367,0.0218226262716557,0.0335821929705893,2.79734800572576e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,24235,0.0520762741014116,0.00564234611113942,0.0410172757235783,0.0631352724792448,2.93388538203247e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29367,0.0382580575515805,0.00414592648204281,0.0301320416467766,0.0463840734563844,2.9405054442094e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,29429,-0.0337399809653414,0.00366504059394785,-0.0409234605294792,-0.0265565014012036,3.60635003974853e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,29449,-0.0219365870118706,0.002386320910205,-0.0266137759958724,-0.0172593980278688,4.07821091069874e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOL1,Apolipoprotein L1,24946,0.0385301748446065,0.00420068500484648,0.0302968322351074,0.0467635174541056,4.9758978039631e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INSL5,Insulin-like peptide INSL5,24800,0.0627314941208809,0.00684344875484908,0.0493183345613767,0.0761446536803851,5.24765875202717e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24840,0.0403812949711683,0.00440543007662488,0.0317466520209836,0.0490159379213531,5.26620158258268e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24800,0.0254659352969382,0.00278040090261418,0.0200163495278144,0.030915521066062,5.62734911238471e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,24800,0.01644095636734,0.00179535252170849,0.0129220654247914,0.0199598473098887,5.70998894472335e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29689,-0.0291688120707882,0.00319065945085296,-0.03542250459446,-0.0229151195471164,6.5144636021273e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LMNB1,Lamin-B1,24751,0.0376428725370944,0.00411991538686597,0.0295678383788371,0.0457179066953517,6.91218975611452e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTB,Lymphotoxin-beta,24788,0.022324493744774,0.00244589100396729,0.0175305473769981,0.0271184401125499,7.5405701148321e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LIF,Leukemia inhibitory factor,28769,0.0326632373656306,0.00358485786411173,0.0256369159519716,0.0396895587792896,8.64252798843779e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,24800,0.0312690951609109,0.00343283509150583,0.0245407383815594,0.0379974519402623,8.9401396554438e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA3G,Semaphorin-3G,24376,0.0282122774221924,0.00310079188578762,0.0221347253260487,0.0342898295183361,9.84918084617359e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,24946,0.0165146725130124,0.00181568805093864,0.0129559239331727,0.0200734210928522,1.00949609016063e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYGD,Gamma-crystallin D,24840,0.061567751138877,0.00677110747689566,0.0482963804841615,0.0748391217935925,1.03634892702321e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,24190,0.0343961439804281,0.00378485776055127,0.0269778227697477,0.0418144651911086,1.08585675005516e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COPB2,Coatomer subunit beta',24106,0.0273723758620202,0.00301220953143182,0.0214684451804139,0.0332763065436266,1.09299802648475e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,28792,0.0299948048328911,0.00330945129304382,0.0235082802985252,0.036481329367257,1.34283560817836e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,29025,0.018449065043872,0.00203658932527963,0.0144573499663239,0.02244078012142,1.3994897036327e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24106,0.0355946354879791,0.00393282624687058,0.0278862960441127,0.0433029749318454,1.52600778470834e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,24840,0.0234898286499955,0.00259686812039381,0.0183999671340236,0.0285796901659673,1.59688806093671e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,24106,0.0352717533482317,0.00390014827449257,0.0276274627302263,0.0429160439662371,1.62598338612397e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOM,Apolipoprotein M,29540,-0.0174519155262006,0.00193198392167671,-0.0212386040126869,-0.0136652270397142,1.76684913028019e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,29438,-0.0169751678256717,0.00187935579818489,-0.020658705190114,-0.0132916304612293,1.77880749898472e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFHR2,Complement factor H-related protein 2,24784,0.0359924304918296,0.00398517000632765,0.0281814972794274,0.0438033637042318,1.81213263244957e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLPS,Colipase,29395,0.0446618235456752,0.00494670695852466,0.0349662779069668,0.0543573691843835,1.84235995306805e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRLB,Fc receptor-like B,28792,0.0385449086356154,0.00427234196085914,0.0301711183923315,0.0469186988788993,1.9594860813021e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,28792,0.0363110279683371,0.00403069199610056,0.0284108716559801,0.0442111842806942,2.21210760147052e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,24224,0.0355902923229636,0.00395058281460511,0.0278471500063375,0.0433334346395896,2.23178530214279e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,28926,0.0182002291881908,0.00202319493837998,0.014234767108966,0.0221656912674156,2.48531083719757e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,24106,0.0282131742869963,0.00314263235194028,0.0220536148771934,0.0343727336967993,2.96586013314527e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA1,Annexin A1,24276,0.0267721988798809,0.00299673011353181,0.0208986078573585,0.0326457899024032,4.40185713748739e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRDT,Bromodomain testis-specific protein,24106,0.0230050450631296,0.00257965739953123,0.0179489165600483,0.0280611735662108,5.08352449084967e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP9,Matrix metalloproteinase-9,29406,0.0375890702556253,0.00422052028330487,0.0293168505003477,0.0458612900109028,5.57518142225923e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CENPF,Centromere protein F,24440,0.0338190948076694,0.00380154423763952,0.026368068101896,0.0412701215134429,6.17377996736585e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,24224,0.0347784047212697,0.00393042729294847,0.0270747672270907,0.0424820422154487,9.46350262183726e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,24800,0.0161405910072164,0.00182478287254268,0.0125640165770328,0.0197171654374001,9.73126037296979e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AREG,Amphiregulin,29344,0.0281731630746441,0.00318610116057319,0.0219284047999206,0.0344179213493675,9.87110907947955e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL5,Fc receptor-like protein 5,29438,0.0354022397980061,0.00401208209421988,0.0275385588933352,0.0432659207026771,1.16518971826082e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAS2,Growth arrest-specific protein 2,24440,0.0325589955109679,0.00370375444829214,0.0252996367923153,0.0398183542296205,1.58074476122018e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDK2,Protein sidekick-2,24376,0.0238150149094227,0.00271569131677397,0.0184922599285458,0.0291377698902997,1.91114621241972e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPON1,Spondin-1,29492,0.0200166807879165,0.00228937052720503,0.0155295145545947,0.0245038470212384,2.38162655425895e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPEP2,Dipeptidase 2,29344,0.0178679456509519,0.00204424861884818,0.0138612183580094,0.0218746729438943,2.44012047778091e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,29815,0.0158851689526806,0.00181810824288093,0.012321676796634,0.0194486611087272,2.51237748139575e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,24224,0.0229129915710394,0.00262269378332425,0.0177725117557239,0.0280534713863549,2.55868627069887e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOLR2,Folate receptor beta,29689,0.0177575527789532,0.00204050734420133,0.0137581583843185,0.0217569471735878,3.41072556129587e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEPACAM2,HEPACAM family member 2,24840,-0.0253881118492307,0.00294111439051294,-0.031152696054636,-0.0196235276438253,6.37649195330422e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,24840,0.0200795778167596,0.0023271386256677,0.0155183861104509,0.0246407695230683,6.58547518648931e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,24376,-0.0195154415409663,0.00226480299674126,-0.0239544554145792,-0.0150764276673535,7.2936158534663e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD248,Endosialin,24933,-0.0240513056766274,0.00281082920914213,-0.0295605309265459,-0.0185420804267088,1.22771658962283e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,29473,0.0399046693953397,0.00466547344603954,0.0307603414411022,0.0490489973495772,1.25443811944756e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEZ6L,Seizure 6-like protein,29561,0.0163410116665284,0.00191682017327364,0.0125840441269121,0.0200979792061448,1.59891094066009e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,28926,0.021084399802047,0.00247508781737975,0.0162332276799827,0.0259355719241113,1.69146063611962e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24224,0.0209642457328073,0.00246142549841729,0.0161398517559094,0.0257886397097052,1.72948864813337e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,28926,0.0287489028842676,0.00337681775877745,0.0221303400770638,0.0353674656914714,1.76645305558969e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,29213,0.0308877646348999,0.00363136261681725,0.0237702939059381,0.0380052353638617,1.88778177550259e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RSPO1,R-spondin-1,29213,0.0207941967843248,0.00244527319368791,0.0160014613246965,0.0255869322439532,1.92051512332636e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DGCR6,Protein DGCR6,24096,0.0261442184050892,0.0030750482049742,0.0201171239233398,0.0321713128868386,1.9692359022264e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HRG,Histidine-rich glycoprotein,24828,0.0186381860027403,0.00219399642897229,0.0143379530019546,0.022938419003526,2.08723154372361e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLGN,Calmegin,24190,0.0267763574956067,0.00315401204163746,0.0205944938939973,0.0329582210972161,2.19058737464014e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,24863,0.0209464520580253,0.00246846819919864,0.016108254387596,0.0257846497284547,2.26388319832602e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24224,0.0200302871905883,0.00236214810986042,0.0154004768952618,0.0246600974859147,2.3850073759145e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,28769,0.0243360444711357,0.00287192573569413,0.0187070700291752,0.0299650189130962,2.48753121291408e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24917,0.0199755552624925,0.00235798343045438,0.0153539077388019,0.0245972027861831,2.55541796111486e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,24863,0.0178056619645048,0.00210740195420313,0.0136751541342667,0.021936169794743,3.09395701746078e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,29473,0.0265042604508925,0.00313907555181508,0.0203516723693349,0.03265684853245,3.2237208952408e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24788,0.0218908771381173,0.00259780513885012,0.016799179065971,0.0269825752102635,3.74663825235725e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBC1D17,TBC1 domain family member 17,28769,0.0262011341577111,0.00311199373390894,0.0201016264392496,0.0323006418761726,3.95755837999004e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENSA,Alpha-endosulfine,24788,0.0311451676956676,0.00369893931711433,0.0238952466341236,0.0383950887572117,3.96507159267355e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29429,-0.0229398269140021,0.00272594304664792,-0.028282675285432,-0.0175969785425722,4.09162941646422e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINI2,Serpin I2,24800,0.0333955782714497,0.00397771033305889,0.0255992660186543,0.0411918905242452,4.87656411682805e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGFLAM,Pikachurin,24800,0.0180800138777001,0.00215850183224519,0.0138493502864995,0.0223106774689007,5.75285100368208e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24235,-0.0205379436325695,0.00245533057096173,-0.0253503915516545,-0.0157254957134845,6.35114060393914e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JUN,Transcription factor AP-1,28926,0.0292494239572124,0.00349846027726703,0.0223924418137691,0.0361064061006558,6.51355594458804e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29689,0.0160789077324608,0.00192369951221391,0.0123084566885215,0.0198493587764001,6.63578180683844e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,29576,0.016639214535331,0.00199173773777235,0.0127354085692972,0.0205430205013648,6.87709710326462e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CABP2,Calcium-binding protein 2,24190,0.0382536213430648,0.00458373268816165,0.029269505274268,0.0472377374118617,7.46494436254701e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB44,Ras-related protein Rab-44,24788,0.0246163236364057,0.00295091577817113,0.0188325287111903,0.0304001185616211,7.68499761306314e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PVALB,Parvalbumin alpha,29594,0.0652550088014498,0.00782594713686811,0.0499161524131883,0.0805938651897113,7.86029638776916e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",24096,0.042454698260258,0.00511061400235342,0.0324378948156454,0.0524715017048707,1.03122460668516e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLMP,CXADR-like membrane protein,29720,0.0122618201983238,0.00147745073400906,0.00936601675966602,0.0151576236369815,1.09103056822844e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,24910,0.0143962002710967,0.00173856024299928,0.0109886221948181,0.0178037783473753,1.28721111747699e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,24224,0.0223560642459686,0.00270173968437192,0.0170606544645996,0.0276514740273375,1.35353587371036e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24011,0.0386209065082742,0.00467693933599136,0.0294541054097311,0.0477877076068172,1.56042500708497e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAM,Signal transducing adapter molecule 1,24788,0.0212864477193782,0.00258151771834384,0.0162266729914242,0.0263462224473321,1.72242033938403e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,24235,0.0138139781011894,0.00167977305845789,0.0105216229066119,0.0171063332957668,2.07097131991424e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,24235,0.0218800145738078,0.0026610281716636,0.0166643993573472,0.0270956297902685,2.09393530567269e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F11,Coagulation factor XI,24601,0.0178221318330472,0.00216972356971693,0.0135694736364021,0.0220747900296924,2.2434178562092e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSH,Pro-cathepsin H,28847,0.0419681173867604,0.00511744351796609,0.0319379280915469,0.051998306681974,2.48218214448293e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANPEP,Aminopeptidase N,29526,0.0160449914199499,0.00195676191190589,0.0122097380726144,0.0198802447672855,2.50524704292607e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,28792,0.0300298109965027,0.00366940840316148,0.0228377705263062,0.0372218514666992,2.86203357033423e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSHB,Thyrotropin subunit beta,29473,0.0438750404610719,0.00536801934309964,0.0333537225485966,0.0543963583735472,3.11689239843807e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,29720,0.0218513418090805,0.00267816998327298,0.0166021286418654,0.0271005549762955,3.50850931749927e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,24235,0.0545577626343912,0.0066908587150518,0.0414436795528897,0.0676718457158928,3.68761295664978e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA12,Serpin A12,28623,0.0635092539846885,0.0078017396379708,0.0482178442942658,0.0788006636751113,4.09843955099307e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,24235,0.0183880886338295,0.00226003732940817,0.0139584154681895,0.0228177617994695,4.27335893790035e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29344,-0.0239616407751038,0.00294589496826826,-0.0297355949129096,-0.0181876866372981,4.31925880054524e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSPN,Persephin,29429,0.0532605493630845,0.00654846062817174,0.0404255665318679,0.0660955321943012,4.3407312066611e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,24788,0.0337834468945291,0.00415466299755698,0.0256403074193174,0.0419265863697408,4.43860137051808e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,28792,0.0231256110564683,0.00285063010544013,0.0175383760498056,0.0287128460631309,5.15643510094934e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,24840,0.0228114921379786,0.00281233678030734,0.0172993120485762,0.028323672227381,5.24100792808858e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,28985,0.016922173196565,0.00208966034487487,0.0128264389206103,0.0210179074725197,5.80206180822618e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX6,Peroxiredoxin-6,29720,-0.0337726397519498,0.00417141625972839,-0.0419486156210174,-0.0255966638828822,5.88494338015452e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TREH,Trehalase,24933,0.0423264139623332,0.00523349650790454,0.0320687608068403,0.0525840671178261,6.35998733414892e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,28911,0.0322791923175875,0.0040162429842487,0.02440735606846,0.0401510285667149,9.54240275043678e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,24376,0.0158452951650507,0.00197481276022251,0.0119746621550146,0.0197159281750868,1.0720179990755e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOBR,Apolipoprotein B receptor,24235,-0.0238847076974348,0.00297874095437904,-0.0297230399680177,-0.0180463754268519,1.11949020922484e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALB1,Calbindin,29344,0.024369120181827,0.00304710760938887,0.0183967892674248,0.0303414510962292,1.31654908861012e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24224,0.0202029715440766,0.0025304851212798,0.0152432207063682,0.025162722381785,1.48118217508844e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRUNE2,Protein prune homolog 2,24440,0.0163461969832231,0.00204988752350924,0.012328417437145,0.0203639765293013,1.60056493092557e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LY96,Lymphocyte antigen 96,29213,0.0196749204449798,0.00248167907238374,0.0148108294631077,0.0245390114268519,2.30473843479932e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,24788,0.022676116147735,0.00286172708716472,0.0170671310568922,0.0282851012385779,2.39749828000023e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,24172,0.0324192142888809,0.00409491389634432,0.0243931830520461,0.0404452455257158,2.5382274379212e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,28769,0.027189687732761,0.00344109754026848,0.0204451365538347,0.0339342389116872,2.85454793171968e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AFAP1,Actin filament-associated protein 1,24376,0.0465707303807905,0.0058949904703065,0.0350165490589898,0.0581249117025913,2.90505584491979e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA14,Carbonic anhydrase 14,29720,-0.0195985596266537,0.00248167918703675,-0.0244626508332457,-0.0147344684200616,2.94792396575033e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,24796,0.0205887646152018,0.00261145467205751,0.0154703134579691,0.0257072157724345,3.29998206810322e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMBS,Porphobilinogen deaminase,29720,0.0236153938294542,0.00300491845589145,0.017725753655907,0.0295050340030015,4.00516151405466e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SYT1,Synaptotagmin-1,24840,0.0217468514291851,0.00276783713618035,0.0163218906422717,0.0271718122160986,4.09366363705902e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATXN2,Ataxin-2,24096,0.0611512554167279,0.00779123652499352,0.0458804318277406,0.0764220790057152,4.37709113704451e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NINJ1,Ninjurin-1,28792,0.0301990116505472,0.00386330124255216,0.022626941215145,0.0377710820859494,5.59844579347708e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",29344,0.0564171236155238,0.00722198224424098,0.0422620384168115,0.0705722088142361,5.82244219369847e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24800,0.0449123920388859,0.00576101587790848,0.0336208009181853,0.0562039831595865,6.64471762165413e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24933,-0.0143788597861299,0.00184954390942071,-0.0180039658485945,-0.0107537537236653,7.88042976258442e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GC,Vitamin D-binding protein,24961,0.0140161959118729,0.00180952649750793,0.0104695239767574,0.0175628678469884,9.85972885683872e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29429,0.0458739744599317,0.0059239866668227,0.0342629605929592,0.0574849883269041,9.96052205923795e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA10,Annexin A10,28769,0.0443270790364618,0.00572871837833462,0.033098791014926,0.0555553670579977,1.04542922166527e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29344,0.0306783464917229,0.00396517553561718,0.0229066024419132,0.0384500905415326,1.05093980036256e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,29283,0.0121238954023561,0.00156920846005817,0.00904824682064204,0.0151995439840701,1.14409942288225e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,29344,0.01133132916977,0.00146880946684018,0.00845246261476321,0.0142101957247767,1.25168549675382e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,28926,0.0215295355563742,0.00279406268934639,0.0160531726852553,0.0270058984274932,1.34540479537235e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,29274,0.0321234947127582,0.00419880441937102,0.0238938380507909,0.0403531513747254,2.06135850129538e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TYMP,Thymidine phosphorylase,29296,0.0355045777918033,0.00464184169087692,0.0264065680776845,0.0446025875059221,2.09057267549268e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,29344,0.036844977456452,0.00481814834409632,0.0274014067020233,0.0462885482108808,2.11804254694502e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,29383,0.025643929755742,0.0033599138049241,0.0190584986980907,0.0322293608133932,2.37551911011735e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29627,0.0377631318260944,0.00496395486338369,0.0280337802938624,0.0474924833583265,2.87800441780169e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,28769,0.0446865510014438,0.00587524539715012,0.0331710700230296,0.0562020319798581,2.9155174797483e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST5,Cystatin-D,28885,0.029473088930671,0.0038752961789765,0.0218775084198771,0.037068669441465,2.92703775127939e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TF,Serotransferrin,24961,0.01148222017203,0.00151097409215074,0.00852071095141453,0.0144437293926454,3.08390102093292e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDI2,Protein DDI1 homolog 2,24376,0.0405823709583194,0.00537250895994111,0.0300522533968348,0.051112488519804,4.37890995730917e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,24106,0.0524866506263677,0.00696426954950375,0.0388366823093403,0.066136618943395,4.99507290946806e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,24840,0.126225073367301,0.0167637573274177,0.0933681090055619,0.159082037729039,5.26108502158416e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,29784,0.030110351470414,0.00401196122826541,0.0222469074630138,0.0379737954778141,6.30744246940905e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,29561,0.0514289766536185,0.00685819495849262,0.037986914534973,0.064871038772264,6.61565658166402e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PMS1,PMS1 protein homolog 1,24190,0.0267134257490208,0.00356508511565758,0.0197258589223319,0.0337009925757096,6.95878872538265e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,28792,0.020829869739197,0.00278119113843273,0.0153787351078689,0.0262810043705252,7.10914537259482e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN1,Contactin-1,29815,-0.0142172340363566,0.00190004515255912,-0.0179413225353725,-0.0104931455373408,7.48884032034475e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24840,0.0193592878979082,0.00259038602853782,0.0142821312819741,0.0244364445138423,8.06586486186546e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELL,L-selectin,24961,0.0121212009073559,0.00162256479607592,0.00894097390704711,0.0153014279076647,8.25764673248316e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29429,0.0317596928357177,0.00425252823827703,0.0234247374886948,0.0400946481827407,8.3409863996256e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24863,0.0255041913893667,0.00341814494292486,0.018804627301234,0.0322037554774994,8.84046920019876e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG1B,Lithostathine-1-beta,29815,0.0293089842419426,0.00392917668777751,0.0216077979338987,0.0370101705499865,8.93386279535238e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,28792,0.0305672470264035,0.00411402669571416,0.0225037547028038,0.0386307393500033,1.1160760579054e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,29748,0.0271020916583464,0.00364928981402201,0.0199494836228633,0.0342546996938296,1.14347597132804e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,29781,0.0189653436438631,0.0025607272271184,0.013946318278711,0.0239843690090151,1.33379896762703e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",24106,0.0325816217258883,0.00440056132870938,0.0239565215216179,0.0412067219301586,1.36506744969748e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BOC,Brother of CDO,28911,-0.0120701970054271,0.00163662939999035,-0.0152779906294081,-0.00886240338144599,1.68714856459357e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK8,Kallikrein-8,28439,0.0185196523264499,0.00251474910263748,0.0135907440852804,0.0234485605676194,1.82757026686423e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,28769,0.019671763147403,0.00268080426665264,0.0144173867847638,0.0249261395100422,2.22530086411503e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29561,0.0177946769749447,0.00243126967253961,0.013029388416767,0.0225599655331223,2.56020069298847e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NMI,N-myc-interactor,24701,0.0368408958052136,0.00505041927697493,0.0269420740223427,0.0467397175880844,3.08529041975597e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,29815,-0.0127048255808998,0.00174341772562094,-0.0161219243231168,-0.00928772683868271,3.24051419434657e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA4C,Semaphorin-4C,29344,0.0143167219991093,0.00196460797625392,0.0104660903656516,0.018167353632567,3.24161165130959e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,24224,0.010404787697299,0.00142911550263776,0.00760372131212896,0.013205854082469,3.42533672748323e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FBLN2,Fibulin-2,24933,0.0159315250625744,0.00219582678463847,0.011627704564683,0.0202353455604658,4.12287274467314e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,28911,0.0270006463085893,0.0037244880069327,0.0197006498150012,0.0343006428021774,4.28828041701014e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,29084,0.0588603491114673,0.00813227787500121,0.0429210844764649,0.0747996137464697,4.6708358695688e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM3D,Protein FAM3D,24800,0.0428670964445894,0.00592687804543213,0.0312504154755425,0.0544837774136364,4.87367459638358e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24224,0.0157961019454209,0.00218679491373705,0.0115099839144963,0.0200822199763455,5.22015273804376e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMOX1,Heme oxygenase 1,29160,-0.024156266151712,0.00335316542724558,-0.0307284703891134,-0.0175840619143107,5.98809157869288e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PFDN2,Prefoldin subunit 2,28769,0.0279568528223743,0.00388142047688863,0.0203492686876726,0.0355644369570761,6.04650917876551e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,24933,0.0273906235179522,0.00380567107839943,0.0199315082042894,0.0348497388316151,6.31468760081004e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAFB2,Scaffold attachment factor B2,24863,0.0137110324482777,0.00192214800543489,0.00994362235762531,0.0174784425389301,1.00761104133177e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24235,0.0164662294872014,0.00230941452613241,0.0119397770159819,0.020992681958421,1.03152007866875e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,29815,0.0306438843295301,0.00431774937338994,0.0221810955576858,0.0391066731013744,1.30164417289781e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGT,Angiotensinogen,24946,0.0114391293757884,0.00161737223254822,0.00826907979999386,0.0146091789515829,1.55999297425523e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK7,Kallikrein-7,23796,0.0194063938683835,0.0027449517584462,0.0140262884218289,0.024786499314938,1.59389857155594e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,29473,0.00867903109708978,0.0012304507426087,0.00626734764157672,0.0110907145526028,1.78272436453157e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGAM,Integrin alpha-M,29438,-0.0155308272567516,0.00220802781536665,-0.0198585617748702,-0.011203092738633,2.05372110772068e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POF1B,Protein POF1B,24224,0.0225818001645523,0.00321658552168626,0.0162772925420472,0.0288863077870573,2.27032645101235e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,24840,0.0151478796863012,0.00215772393480463,0.0109187407740841,0.0193770185985183,2.2708238284914e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29503,0.0240561821229867,0.00343445611890759,0.0173246481299278,0.0307877161160455,2.53427495068996e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD209,CD209 antigen,29522,-0.0189787484064765,0.00271129359868421,-0.0242928838598976,-0.0136646129530555,2.61642487673915e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24190,0.0267688065090893,0.00382500147525315,0.0192718036175931,0.0342658094005854,2.65703514510608e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARG1,Arginase-1,29211,0.0252524512869652,0.00361292829034312,0.0181711118378926,0.0323337907360377,2.81851696468803e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTF4,Neurotrophin-4,28792,0.0192521383782177,0.00275537567511879,0.0138516020549849,0.0246526747014505,2.86691891700442e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FSHB,Follitropin subunit beta,24235,0.0315950419899339,0.00452632465491009,0.0227234456663101,0.0404666383135577,3.02177624128702e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",24440,0.0224184397480426,0.00321197449787947,0.0161229697321988,0.0287139097638863,3.03493920937795e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,28717,0.0345559048226111,0.00495848834138934,0.024837267673488,0.0442745419717342,3.25999801908411e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,29428,-0.0234428571431619,0.00337208146746653,-0.0300521368193963,-0.0168335774669275,3.67542510315833e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INSL3,Insulin-like 3,24840,0.0365226157703545,0.00528689791685189,0.0261602958533248,0.0468849356873842,5.02914826835242e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OMD,Osteomodulin,29576,-0.0207710395325098,0.00300788700678539,-0.0266664980658092,-0.0148755809992104,5.10288979785914e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA3,Carbonic anhydrase 3,29756,0.0288763659286636,0.0041828726257002,0.0206779355822912,0.037074796275036,5.17628942834628e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICOSLG,ICOS ligand,29344,0.00918892407048311,0.00133325402374646,0.00657574618394005,0.0118021019570262,5.60848397567161e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARTN,Artemin,28926,0.0215173856256529,0.00312452241687292,0.015393321688582,0.0276414495627239,5.83033910349436e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPM1A,Protein phosphatase 1A,28792,0.0149085467473637,0.00217356371171761,0.0106483618723971,0.0191687316223302,7.07295505486586e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,24961,0.00806731243348753,0.00117792346047021,0.00575858245096592,0.0103760424160091,7.6223504280537e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,24224,0.0187302924781248,0.00273528672809693,0.0133691304910548,0.0240914544651947,7.6867118466279e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB37,Ras-related protein Rab-37,28926,0.0392138346755885,0.00573806401682356,0.0279672292026143,0.0504604401485627,8.42266188668881e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24224,0.0213117398845438,0.00312486422631749,0.0151870060009616,0.0274364737681261,9.31487892549735e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24788,0.0235791159175738,0.0034605821142399,0.0167963749736636,0.030361856861484,9.73484135307478e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29627,0.0163654659353899,0.00240283781335531,0.0116559038212135,0.0210750280495664,9.88491885267145e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29815,0.0129227868041294,0.00189846038194819,0.00920180445551099,0.0166437691527479,1.01554536288948e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA7,Carbonic anhydrase 7,24440,-0.0164192821681308,0.00241227983046565,-0.0211473506358435,-0.0116912137004181,1.02286741750654e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFAP,Glial fibrillary acidic protein,28748,0.0219553365613217,0.00322774487683103,0.0156289566027329,0.0282817165199106,1.05149188793909e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRTN3,Myeloblastin,28666,0.02250839897476,0.00330999452048629,0.0160208097146069,0.0289959882349131,1.06574914385102e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RCC1,Regulator of chromosome condensation,24788,0.0245248689417863,0.00360901318068942,0.017451203107635,0.0315985347759375,1.10422431587223e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SATB1,DNA-binding protein SATB1,24863,0.0141228663953222,0.00207971467915707,0.0100466256241743,0.0181991071664701,1.14049433088503e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",24190,0.0185635328666275,0.00273789382868748,0.0131972609624,0.0239298047708549,1.22753070327038e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,29429,-0.023335291080478,0.00344503779795659,-0.030087565164473,-0.0165830169964831,1.27985129377076e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29781,0.0165239494583658,0.00243972021557715,0.0117420978358346,0.0213058010808971,1.28583993649558e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,29815,0.011721612030054,0.00173969795096204,0.00831180404616838,0.0151314200139396,1.63808314579734e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,24224,0.0150170603601953,0.00222976727188102,0.0106467165073085,0.0193874042130821,1.67819082693354e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEP1B,Meprin A subunit beta,29473,0.0548984718895747,0.00815457907445617,0.0389154969036406,0.0708814468755088,1.70151198515642e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGA2,Integrin alpha-2,24376,0.0161573835324396,0.00240498155397018,0.011443619686658,0.0208711473782211,1.87910498098901e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,29473,0.0159579604454647,0.00237730027644813,0.0112984519036264,0.0206174689873031,1.94600239907774e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,28769,0.0165029472980084,0.00246215371628845,0.011677126014083,0.0213287685819337,2.08458015970728e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,24883,-0.0228988450764946,0.00342314397995128,-0.0296082072771991,-0.0161894828757901,2.28812068850489e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPOCK1,Testican-1,29213,0.0120109271492036,0.00179612303766869,0.00849052599537297,0.0155313283030342,2.31674686716716e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLU,Clusterin,24961,0.0148413156301311,0.00222109462455299,0.0104879701660073,0.019194661094255,2.40695053968212e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MUC16,Mucin-16,29344,0.0880285979057624,0.0131910430295406,0.0621741535678628,0.113883042243662,2.54458661800227e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17RA,Interleukin-17 receptor A,29438,0.020463094942778,0.00307597838091057,0.0144341773161933,0.0264920125693627,2.93108167215644e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP9,Fatty acid-binding protein 9,29429,0.025947005791947,0.0039045688782532,0.0182940507905707,0.0335999607933233,3.0789452591965e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSMB,Beta-microseminoprotein,29308,0.0322277381174935,0.00485556356503064,0.0227108335300335,0.0417446427049536,3.25095479430278e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,24788,0.0243053484849008,0.00367496873338619,0.0171024097674639,0.0315082872023377,3.82317689282858e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,28911,0.0154617046579836,0.00233988478898217,0.0108755304715786,0.0200478788443887,3.96605623385335e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,24376,0.0132612042126265,0.0020074562290184,0.00932659000375043,0.0171958184215026,4.03052449647765e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,29537,-0.0141981440697609,0.00215645228278741,-0.0184247905440242,-0.00997149759549753,4.65543270103487e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TLR1,Toll-like receptor 1,24224,0.0121587176613773,0.00184995616095327,0.00853280358590884,0.0157846317368457,5.05052361059981e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,29429,0.0214660670069837,0.00326901547933587,0.0150587966674854,0.027873337346482,5.23609971357771e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24190,0.0476660968186153,0.00727497274799478,0.0334071502325455,0.0619250434046851,5.78880474594333e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCN2,Transcobalamin-2,29752,0.0136808794459679,0.00209201560353761,0.00958052886303419,0.0177812300289016,6.26961610257314e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,24788,0.0206251433616675,0.00315395496452538,0.0144433916311978,0.0268068950921373,6.29462755912763e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MDM1,Nuclear protein MDM1,24190,0.0143790884450381,0.00219908538696965,0.0100688810865776,0.0186892958034986,6.33076400506923e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSV,Cathepsin L2,29613,-0.0189028545779412,0.00289122080597678,-0.0245696473576557,-0.0132360617982267,6.33531378412863e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,24011,0.0281228931271471,0.00430273004003527,0.019689542248678,0.0365562440056162,6.44290506452122e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,29213,0.0106070554220897,0.00162630633210489,0.00741949501116413,0.0137946158330153,7.04264755952207e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24788,0.0237307509530597,0.00363931000596878,0.0165977033413609,0.0308637985647585,7.13402626365706e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL10,Interleukin-10,28926,0.0372361123337026,0.00571188981799867,0.0260408082904252,0.04843141637698,7.19174633314445e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29344,0.0203710870623438,0.00313547375141809,0.0142255585095643,0.0265166156151232,8.32645330232299e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMPD3,AMP deaminase 3,24840,0.0321513009712221,0.00496162951796399,0.0224265071160127,0.0418760948264315,9.34492778929638e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFHR4,Complement factor H-related protein 4,24887,0.0329325570006022,0.00512483707535455,0.0228878763329072,0.0429772376682971,1.333164765583e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNPY2,Protein canopy homolog 2,28911,0.027326565753964,0.00425527799213004,0.0189862208893891,0.0356669106185389,1.36758471815478e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,24106,0.0161063862176959,0.00251177123186287,0.0111833146032446,0.0210294578321471,1.45938368759534e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBLN4,Cerebellin-4,29720,0.0142001489151717,0.00221531524898617,0.00985813102715881,0.0185421668031846,1.47710517880257e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29815,0.0103432455483736,0.0016140295143781,0.00717974770019257,0.0135067433965547,1.4931109781809e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,24788,0.0179463806852062,0.00280251225661359,0.0124534566622436,0.0234393047081688,1.54399031462297e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,28728,0.0127771349113393,0.00200035254587992,0.00885644392141463,0.0166978259012639,1.71264549204189e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,24235,-0.011149488638624,0.00174555829270593,-0.0145707828923277,-0.00772819438492041,1.71851631237623e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,29344,0.0204492236140493,0.00320831088937967,0.0141609342708651,0.0267375129572334,1.87104338738974e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THBS4,Thrombospondin-4,29513,0.0201039978589995,0.00315468758055547,0.0139208102011108,0.0262871855168882,1.88422250548865e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28911,-0.00954675532778803,0.0014982582291626,-0.0124833414569467,-0.00661016919862934,1.89508344950323e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC3B,Tetranectin,24376,0.00951338767698259,0.00149629591010896,0.00658064769316904,0.0124461276607961,2.08076428976592e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,29657,0.0180176982973213,0.00284146855233769,0.0124484199347395,0.0235869766599032,2.31593225316989e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPPB,Natriuretic peptides B,28911,-0.0593231508626418,0.00935699401846714,-0.0776628591388374,-0.0409834425864462,2.33187545179843e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24840,0.0243100543097815,0.00384606862476687,0.0167717598052384,0.0318483488143246,2.64713342990187e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX2,Peroxiredoxin-2,24551,0.027270566388019,0.00431595597264174,0.0188112926816412,0.0357298400943968,2.68569879461833e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPC1,Glypican-1,29720,0.0129838322045048,0.00205538748346745,0.00895527273690858,0.017012391672101,2.70506857350804e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,29492,0.0105206627262678,0.00166744934166956,0.00725246201659542,0.0137888634359401,2.84032074416511e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,24440,0.0307033021995075,0.00488193321561197,0.021134713096908,0.0402718913021069,3.24576204106378e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,29668,0.0133343345894253,0.00212198316356431,0.00917524758883928,0.0174934215900114,3.34763953950088e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OLFM4,Olfactomedin-4,23493,0.0542298571886724,0.00863503311455064,0.0373051922841531,0.0711545220931916,3.44033118621051e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PROCR,Endothelial protein C receptor,24106,-0.0157803425466791,0.00251295392508865,-0.0207057322398529,-0.0108549528535054,3.45242649380324e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,24788,0.0154755820491917,0.00246478303183929,0.0106446073067867,0.0203065567915967,3.47125609385202e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,24800,0.0244561011094071,0.00389513758040455,0.0168216314518142,0.0320905707670001,3.47247802564627e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATXN10,Ataxin-10,28769,0.0318610985420449,0.00507622763159066,0.0219116923841272,0.0418105046999626,3.51147551464559e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX3,Syntaxin-3,24840,0.0168527649508606,0.00268839136790554,0.0115835178697657,0.0221220120319555,3.70023375000488e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24106,0.021179020945948,0.00338618299082216,0.0145421022839365,0.0278159396079594,4.05386201495539e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,28926,0.0253759920300201,0.00406541225252545,0.0174077840150702,0.0333442000449699,4.38219983101216e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,29449,0.0109713550928115,0.0017579451611449,0.00752578257696748,0.0144169276086555,4.40673004614771e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,24376,0.0176722700720794,0.00283317825112017,0.0121192406998839,0.023225299444275,4.51602352329548e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,28792,0.0164261501588611,0.00263652520030653,0.0112585607662603,0.0215937395514619,4.7220560506542e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RLN2,Prorelaxin H2,24321,0.0494366368219931,0.00796120843528694,0.0338326682888307,0.0650406053551555,5.39487443749912e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,24497,0.0185199370036059,0.00298276824327333,0.0126737112467901,0.0243661627604216,5.41877133927528e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA5,Annexin A5,28645,0.0131891584540564,0.00212587102239275,0.00902245125016663,0.0173558656579462,5.57564691995338e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,28926,0.0256804721280546,0.00415356467460613,0.0175394853658266,0.0338214588902826,6.38344801846266e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOSB,Protein fosB,28769,0.016684349922565,0.00270475638443522,0.0113830274090719,0.021985672436058,6.98492264243968e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,24376,0.0228902389187274,0.00371311870129854,0.0156125262641823,0.0301679515732725,7.17283791560404e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24863,0.0182379078627671,0.00295997952074187,0.0124363480021131,0.0240394677234212,7.3166631163705e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28769,0.0129852483789706,0.0021083995737188,0.00885278521448178,0.0171177115434595,7.42601974133199e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,24788,0.0180936566749876,0.0029379382379472,0.0123352977286111,0.0238520156213641,7.45080351786695e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX1,Peroxiredoxin-1,28664,-0.0386453171223797,0.00628594545421485,-0.0509657702126408,-0.0263248640321186,7.9555115196509e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,24190,0.0208025807616535,0.00339459301948275,0.0141491784434673,0.0274559830798397,9.02798387167811e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,24011,0.0329328153913963,0.0053744124623186,0.0223989669652518,0.0434666638175407,9.054336913517e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACAN,Aggrecan core protein,29187,0.0120990483330429,0.00197483390360822,0.00822837388197083,0.015969722784115,9.09152094018909e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24011,-0.0131133759344831,0.00214489911763213,-0.0173173782050421,-0.00890937366392415,9.88183648705229e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24440,0.0278096651779711,0.00455024770122506,0.01889117968357,0.0367281506723722,1.00078790261136e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,28769,0.0361081988900255,0.00594527049503525,0.0244554687197564,0.0477609290602946,1.26773605160988e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24096,0.0263416238371503,0.00434178311992078,0.0178317289221056,0.0348515187521951,1.32260589663276e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24224,0.0186501884698407,0.0030823665583131,0.0126087500155471,0.0246916269241344,1.46419478913039e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,24106,0.0193433866551233,0.00320342644117692,0.0130646708304165,0.02562210247983,1.57983907606931e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,28717,0.0225978799693238,0.00374567956190746,0.0152563480279851,0.0299394119106624,1.62859171289014e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGA4,Pepsin A-4,24946,0.0300587987429067,0.00498231237590791,0.0202934664861272,0.0398241309996862,1.6310827098743e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPAN8,Tetraspanin-8,24800,0.0423079847149773,0.00702229372034213,0.0285442890231068,0.0560716804068479,1.71695483162538e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNN,Tenascin-N,24933,0.018278612263607,0.00304137683540773,0.0123175136662079,0.0242397108610062,1.88123685582414e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNXB,Tenascin-X,29438,-0.0108140876270166,0.0018025409599277,-0.0143470679084749,-0.00728110734555828,2.00411532195562e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,24106,0.0279820889968759,0.00466901897417567,0.0188308118074916,0.0371333661862602,2.08751084105206e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM171B,Protein FAM171B,24788,0.0114079871372418,0.00190359044631674,0.00767694986246103,0.0151390244120226,2.09006230652197e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,29429,-0.0193242876905543,0.00322780814088156,-0.0256507916466822,-0.0129977837344265,2.1646852136369e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAEP,Glycodelin,29213,-0.0549284189089286,0.0091927436626744,-0.0729461964877704,-0.0369106413300867,2.32477995153202e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29531,0.0370833348115009,0.00621333778018464,0.024905192762339,0.0492614768606628,2.42406237976264e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,24106,0.0184288917250947,0.0030890778508394,0.0123742991374495,0.02448348431274,2.46801413679133e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,29344,0.0169659050997649,0.00285233268306598,0.0113753330409555,0.0225564771585742,2.74375974586043e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,28926,0.0233909429324541,0.00393888506232262,0.0156707282103017,0.0311111576546064,2.90981011479077e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,24440,0.0182747240344649,0.00308043559852706,0.0122370702613519,0.024312377807578,3.02350543555643e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RALB,Ras-related protein Ral-B,24224,0.0122745010645917,0.00207307840646135,0.00821126738792749,0.016337734741256,3.24491298768336e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,24610,0.0265742486158662,0.00449556207708552,0.0177629469447786,0.0353855502869539,3.44064625918359e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,24224,0.0266955000196532,0.00451716647114543,0.0178418537362081,0.0355491463030982,3.47131556773373e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLASP1,CLIP-associating protein 1,24011,0.0302058825938408,0.00511819009716112,0.020174230003405,0.0402375351842767,3.64667884574115e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,29438,-0.0116982242227359,0.00199403871822588,-0.0156065401104586,-0.00778990833501317,4.49582064439411e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NXPH3,Neurexophilin-3,24224,0.01244167629568,0.0021208146128282,0.00828487965453674,0.0165984729368233,4.50984496217867e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LHB,Lutropin subunit beta,28792,0.035400589739603,0.00607187590102742,0.0234997129735893,0.0473014665056168,5.59329436362164e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,28926,0.0175562642484204,0.00301127365656287,0.0116541678815572,0.0234583606152837,5.595593588948e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPEP1,Dipeptidase 1,29158,-0.0197554785436288,0.0033893083471211,-0.0263985229039861,-0.0131124341832714,5.64270702052964e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB6,Integrin beta-6,28926,0.0123419223189467,0.00212140527727652,0.00818396797548478,0.0164998766624087,6.02533225120724e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24106,0.026983700308578,0.00463971002060313,0.0178898686681959,0.0360775319489602,6.11010122477948e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRTAP,Cartilage-associated protein,24190,0.0199195595273709,0.00342570847868441,0.0132051709091494,0.0266339481455923,6.14969090661938e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOB,Apolipoprotein B-100,24946,0.00915553845273353,0.00157682004047443,0.00606497117340364,0.0122461057320634,6.46312219931858e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,24840,0.0285097861411626,0.00491574396142303,0.0188749279767735,0.0381446443055517,6.72435752237815e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GUCA2A,Guanylin,29328,0.0138478764960123,0.00239129023756166,0.00916094763039142,0.0185348053616331,7.06972849891321e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24376,0.0152641552122405,0.00264040291497954,0.0100889654988806,0.0204393449256004,7.51663563667346e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDRG1,Protein NDRG1,28769,0.027197914371716,0.00470901453517745,0.0179682458827682,0.0364275828606638,7.74168141156394e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28926,0.014679106715601,0.00254206883689761,0.00969665179528172,0.0196615616359203,7.79840653241617e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSG4,Desmoglein-4,29237,0.019991165634505,0.00346294784485535,0.0132037878585885,0.0267785434104215,7.87178808231496e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24096,0.0130073608959225,0.00225962918728362,0.00857848768884662,0.0174362341029984,8.69626745471271e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HLA_A,,24863,0.0131727390321539,0.00229142233090838,0.0086815512635735,0.0176639268007343,9.09753915543557e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL34,Interleukin-34,28717,0.0145071535023592,0.00252376588174285,0.00956057237414323,0.0194537346305752,9.11023517045052e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,28911,0.0247843662659071,0.00431692722217993,0.0163231889104344,0.0332455436213798,9.4945455928409e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENO1,Alpha-enolase,29387,0.0315440312371996,0.00550231180834791,0.0207595000928377,0.0423285623815615,9.97124442996553e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29522,0.0228904822265277,0.00399620937077602,0.0150579118598067,0.0307230525932487,1.02578776983407e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNU13,NHP2-like protein 1,24106,0.0250709289516331,0.00438525093559889,0.0164758371178593,0.033666020785407,1.09635972879052e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRTN,Neurturin,28926,0.0196854921594571,0.00345173628059158,0.0129200890494976,0.0264508952694166,1.1881536394856e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,28769,0.0156072315488799,0.00273668658456261,0.0102433258431372,0.0209711372546226,1.18893561806867e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28493,-0.0340665081943578,0.00598408718311982,-0.0457953190732726,-0.0223376973154429,1.26163656848576e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PROK1,Prokineticin-1,29429,0.0243474239872845,0.00428107419925762,0.0159565185567396,0.0327383294178294,1.30344809354753e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPO,Erythropoietin,29429,0.0299842010556009,0.00529133666260856,0.0196131811968881,0.0403552209143136,1.46968502738813e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,24933,-0.0130781403916059,0.00231006380885576,-0.0176058654569632,-0.00855041532624865,1.51814373996726e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24440,0.0174175803884701,0.00310674583899653,0.0113283585440368,0.0235068022329033,2.08839216916232e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28911,0.0124341719406936,0.00222205433925431,0.00807894543575517,0.016789398445632,2.21594466515154e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOE,Apolipoprotein E,24961,0.0283755650396021,0.0050857005992292,0.0184075918651128,0.0383435382140913,2.43740899620972e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EP300,Histone acetyltransferase p300,24224,0.0117993929674889,0.00211761702945466,0.00764886358975781,0.0159499223452201,2.54488132680512e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THBS2,Thrombospondin-2,29438,0.014542971096216,0.00261211516669431,0.00942322536949514,0.0196627168229368,2.60660902260769e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPT2,Angiopoietin-2,29720,0.0147513516645634,0.00266093139489504,0.0095359261305691,0.0199667771985576,2.98694563873884e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX1B,Syntaxin-1B,24190,0.0162200940128099,0.00292698392178474,0.0104832055261118,0.021956982499508,3.02891980969606e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PKD1,Polycystin-1,24917,0.0102931270246862,0.00185855762649418,0.0066503540767576,0.0139358999726148,3.08621190706828e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN4,Contactin-4,29438,-0.00930178395493518,0.0016805584199469,-0.0125956784580311,-0.00600788945183926,3.13993446741935e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP3,Stromelysin-1,29438,-0.0189365003499291,0.00342354254728376,-0.0256466437426052,-0.0122263569572529,3.20641892613865e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,24224,0.0410561921689851,0.00743798398869893,0.0264777435511352,0.055634640786835,3.42862578887894e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VIT,Vitrin,24917,0.0145127910192374,0.00263325705419536,0.00935160719301451,0.0196739748454603,3.59626894757508e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28911,0.0104878007115541,0.00190602872125352,0.00675198441789719,0.014223617005211,3.77755134665671e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,29473,-0.0103970639346869,0.00189376062517026,-0.0141088347600206,-0.00668529310935316,4.0486180672958e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,28769,0.055472849984213,0.0101286381043644,0.0356207192996587,0.0753249806687672,4.36630464238689e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24011,0.0220250796581192,0.00402178177896267,0.0141423873713524,0.0299077719448861,4.38299880664508e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYZL2,Lysozyme-like protein 2,24011,0.0138077203686786,0.00252650107746671,0.00885577825684383,0.0187596624805133,4.67103537167217e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAP,Prolyl endopeptidase FAP,29815,0.0104547938060392,0.00191588209230022,0.00669966490513081,0.0142099227069477,4.88350709567856e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24917,0.0281019836076033,0.00516885188904038,0.0179710339050841,0.0382329333101224,5.47573248251959e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29689,0.0269751639502381,0.00496273147308839,0.0172482102629848,0.0367021176374913,5.50583220065061e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD2,T-cell surface antigen CD2,24106,0.0146520244324969,0.00269568796931227,0.00936847601264486,0.019935572852349,5.52175722636642e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,24440,0.0173111585373378,0.00319394630506374,0.0110510237794129,0.0235712932952627,6.01662177743729e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,29429,0.0156279517015632,0.00288631527546876,0.00997077376164446,0.021285129641482,6.19412117290215e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,24917,0.0131175872889586,0.00242455946479823,0.00836545073795403,0.0178697238399631,6.35001407598908e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,29561,-0.0159417833209635,0.00294995520559934,-0.0217236955239382,-0.0101598711179887,6.56466370050674e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHNAK2,Protein AHNAK2,24235,0.0112384276509058,0.00208247533630885,0.00715677599174043,0.0153200793100711,6.85270149881554e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,24909,0.0070756393668961,0.00131468268113985,0.00449886131186199,0.00965241742193022,7.43227883318724e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,24788,0.0107846547491489,0.00200675434984412,0.00685141622345442,0.0147178932748434,7.76273210985849e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,24727,0.0186124411109202,0.00349053954270157,0.0117709836072251,0.0254538986146152,9.78528940549656e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,29618,0.0302188936123246,0.00573513333876647,0.0189780322683423,0.0414597549563068,1.38065562296911e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYOM2,Myomesin-2,24106,-0.0188299521130813,0.00357743472541928,-0.025841724174903,-0.0118181800512595,1.42521641239456e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24917,0.0120442339654407,0.00228928894116959,0.0075572276407483,0.0165312402901331,1.4436078977822e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VIM,Vimentin,28911,0.0428490025975755,0.0081456184009838,0.0268835905316473,0.0588144146635038,1.44785577849224e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPQ,Carboxypeptidase Q,24915,0.0135628663333735,0.00257973199374422,0.00850659162563484,0.0186191410411122,1.47254143424387e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29213,0.0223539654797547,0.0042550742710995,0.0140140199083997,0.0306939110511097,1.50294384808161e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBP1,Retinol-binding protein 1,24190,0.0256313093154244,0.004879057058243,0.0160683574812681,0.0351942611495807,1.5063633536577e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,29561,0.0290477298034141,0.00553137181435561,0.0182062410472771,0.0398892185595511,1.5194887777598e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,28926,0.0165680182710478,0.00316328610345161,0.0103679775082826,0.022768059033813,1.63818608517557e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,29815,0.00828609646498091,0.00158614180243824,0.00517725853220195,0.0113949343977599,1.7622001607699e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,24235,0.0175642054752996,0.00336659409349289,0.0109656810520535,0.0241627298985457,1.83139659617171e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTPN,Myotrophin,28911,0.0119315333090358,0.00229090133578377,0.00744136669089959,0.016421699927172,1.91959502833521e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,29344,0.00762460664790485,0.00146411924183279,0.00475493293391257,0.0104942803618971,1.92546709894595e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,29438,0.0105417058982083,0.00203113575795363,0.00656067981261924,0.0145227319837975,2.11626884388049e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHGB,Secretogranin-1,29585,0.0148725241246816,0.00287128628479401,0.00924480300648538,0.0205002452428779,2.23647599920578e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPA4,Carboxypeptidase A4,23897,0.0158802665391575,0.00307622581528791,0.00985086394119317,0.0219096691371218,2.45945019841149e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,24190,0.022641307699088,0.00438835449624755,0.0140401328864428,0.0312424825117332,2.49688960580545e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX5,Syntaxin-5,24224,0.0147333322506831,0.00286465719460705,0.00911860414925325,0.0203480603521129,2.72288797533324e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FZD8,Frizzled-8,24096,0.0159215535063501,0.00309588557008769,0.00985361778897824,0.021989489223722,2.72776972586998e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24788,0.0241027614449517,0.00468701971558492,0.0149162028024052,0.0332893200874981,2.73242317859821e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELAVL4,ELAV-like protein 4,24096,0.0305425284553788,0.005955285306485,0.0188701692546682,0.0422148876560894,2.94099376652612e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24106,0.0184032844472941,0.00360438165036889,0.0113386964125711,0.0254678724820171,3.31888367918832e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24440,0.0186688941995052,0.00367056551433326,0.0114745857914121,0.0258632026075984,3.6818713847989e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,24788,0.0132777362692722,0.00261111840869969,0.00815994418822085,0.0183955283503236,3.70154699750491e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLSTN2,Calsyntenin-2,29781,-0.0140373177669192,0.00276165894789155,-0.0194501693047866,-0.00862446622905177,3.73905616825209e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28911,0.0125378907626766,0.00246709473519431,0.0077023850816957,0.0173733964436574,3.75714536007152e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERC2,ERC protein 2,24190,0.0268124084175272,0.00529729552411012,0.0164297091902714,0.037195107644783,4.18959062276001e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOD3,Extracellular superoxide dismutase,24946,-0.0212222780829924,0.00419739058758204,-0.0294491636346532,-0.0129953925313316,4.31025767760822e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLL4,Delta-like protein 4,24235,0.0303934169278247,0.00601681270506664,0.0186004640258941,0.0421863698297553,4.41733623481322e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG1A,Lithostathine-1-alpha,29348,0.0173379468045091,0.00343449794124768,0.0106063308396637,0.0240695627693546,4.48716487497917e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17A,Interleukin-17A,28874,0.0150454770419797,0.00298242881683807,0.00919991656097709,0.0208910375229823,4.56971156327002e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOC1,Apolipoprotein C-I,24909,-0.01317644693271,0.00262007535331176,-0.0183117946252011,-0.00804109924021898,4.96380752862114e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSG3,Desmoglein-3,29584,0.0119761754884032,0.002386585515928,0.0072984678771843,0.016653883099622,5.24815692702407e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF16,Fibroblast growth factor 16,24224,0.0168389948603243,0.00335717563060978,0.0102589306243291,0.0234190590963194,5.31804799592421e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24224,0.030552182595174,0.00609797417724897,0.018600153207766,0.042504211982582,5.47509019785444e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL33,Interleukin-33,28926,0.0135898822737621,0.00272102856786655,0.00825666628074368,0.0189230982667806,5.93649456372151e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,24440,0.0203837883880181,0.00408656702058044,0.0123741170276804,0.0283934597483557,6.14264577720298e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,24190,0.0182403016920941,0.00367378363455148,0.0110396857683731,0.025440917615815,6.91718480808682e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST1,Cystatin-SN,21651,0.0366599772475978,0.00738649144304074,0.022182454019238,0.0511375004759577,6.98997274738955e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F3,Tissue factor,29536,-0.00946071752101526,0.00190762539122521,-0.0131996632878167,-0.00572177175421385,7.10956565473086e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,24011,-0.0091156698814559,0.00183861501544314,-0.0127193553117245,-0.00551198445118734,7.17449401616402e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST6,Cystatin-M,28825,0.0168380415025463,0.00340405035733882,0.0101661028021622,0.0235099802029304,7.59955166414978e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL28,C-C motif chemokine 28,29322,0.0204211890048691,0.00413266772995814,0.0123211602541512,0.0285212177555871,7.79884299854425e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,24878,0.00512020348823433,0.00103697833633951,0.00308772594900888,0.00715268102745978,7.95944520315247e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,24190,0.0266446352394035,0.00540892845401414,0.0160431354695358,0.0372461350092713,8.44637157248625e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24106,0.0295290356238948,0.00599950284502279,0.0177700100476501,0.0412880612001394,8.62677987199279e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGL1,Fibrinogen-like protein 1,24946,-0.0219587825934738,0.00446720479297811,-0.0307145039877109,-0.0132030611992367,8.90940737945053e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28769,0.0171893842610948,0.00349760792937919,0.0103340727195116,0.024044695802678,8.94477287693545e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UNC5D,Netrin receptor UNC5D,24224,0.0090911085929504,0.00185219763774283,0.00546080122297444,0.0127214159629264,9.2474809122365e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,28792,0.0121554497516184,0.00248163056954879,0.00729145383530275,0.017019445667934,9.72576045595204e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",28911,0.0149142036972473,0.00304538063778023,0.008945257647198,0.0208831497472965,9.76768183725693e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,29429,0.0120430270411812,0.00245925022043419,0.00722289660913018,0.0168631574732322,9.78106733747758e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,24190,0.0234556463660129,0.00479569964195207,0.0140560750677868,0.0328552176642389,1.00982040982851e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOX9,Transcription factor SOX-9,24190,0.0093895027477102,0.00192030153873849,0.00562571173178276,0.0131532937636376,1.01690136327545e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,29727,-0.0121966246647754,0.00249679976391761,-0.0170903522020539,-0.00730289712749687,1.04017558036574e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,24106,0.0308590414199341,0.00633532423549606,0.0184418059183618,0.0432762769215064,1.11767867652119e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,29335,0.0116640519359861,0.00239824219613002,0.00696349723157122,0.0163646066404009,1.1587613893932e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QL2,Complement C1q-like protein 2,24224,0.0145266966494016,0.00301099321482302,0.00862514994834844,0.0204282433504547,1.41170990183272e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,29815,0.0106643078392467,0.00222125605809453,0.00631064596538144,0.015017969713112,1.58619952882871e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,29438,0.0106222134097403,0.00221683467839182,0.0062772174400923,0.0149672093793882,1.66252028358678e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,24235,0.0191618751243393,0.00401277218720322,0.011296841637421,0.0270269086112577,1.80558712019576e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,24788,0.0204305963608957,0.00428298968182552,0.0120359365845176,0.0288252561372737,1.85116165343479e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,24863,0.0119913381816328,0.00251384933810098,0.00706419347895488,0.0169184828843107,1.8516958082964e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,29438,0.0266826042138186,0.00559867357741314,0.0157092040020888,0.0376560044255483,1.88928817290574e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,24800,0.0267102197166131,0.00562683445553221,0.01568162418377,0.0377388152494562,2.07674411213693e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEO1,Neogenin,24863,0.00729372235917304,0.00153672562545047,0.00428174013329012,0.010305704585056,2.08349763859497e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DKKL1,Dickkopf-like protein 1,29344,-0.0284600867129572,0.00599851834003184,-0.0402171826594196,-0.0167029907664948,2.09985353887254e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,24440,0.0177429434490286,0.00375033810472002,0.0103922807637774,0.0250936061342799,2.24637812577534e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,24129,0.0130937856503381,0.00277173557620966,0.00766118392096714,0.018526387379709,2.32508409338468e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,28911,0.0160857492167984,0.00341227083227994,0.00939769838552975,0.0227738000480671,2.43925456437665e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,28792,0.0182657060934726,0.00388047693310147,0.0106599713045937,0.0258714408823514,2.52462200345056e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,24235,0.0133970693406357,0.00284718445153392,0.0078165878156292,0.0189775508656422,2.54799303260843e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NECTIN1,Nectin-1,24224,0.0106627540393509,0.00226925893173223,0.00621500653315576,0.0151105015455461,2.63154903452443e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAPS,Calcyphosin,24840,0.0310427988908887,0.00664158825397344,0.0180252859131007,0.0440603118686766,2.96936604809932e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24106,0.0162495730552496,0.00349920883308694,0.00939112374239922,0.0231080223681,3.43888749824674e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VASN,Vasorin,29060,0.00888990146504788,0.00192131722951992,0.00512411969518883,0.0126556832349069,3.72632417729125e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD276,CD276 antigen,29449,-0.0115901147301649,0.00250872591972008,-0.0165072175328162,-0.00667301192751351,3.85511589949257e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAPPA,Pappalysin-1,28926,0.0151739701213895,0.00329245860016335,0.00872075126506937,0.0216271889777097,4.06914708814494e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PKLR,Pyruvate kinase PKLR,29486,0.0206833961077235,0.00450476999617631,0.011854046915218,0.0295127453002291,4.420082985489e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,24106,-0.0141842707804571,0.00309526085179669,-0.0202509820499786,-0.00811755951093555,4.61583745337311e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,24011,0.0135822317679691,0.00296604296213494,0.00776878756218467,0.0193956759737536,4.69004255487417e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,24863,0.00864077185933025,0.00188894993938302,0.00493842997813954,0.012343113740521,4.79941830199735e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,24106,-0.0132360622988888,0.00289665861975235,-0.0189135131936034,-0.00755861140417423,4.91491153469306e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,24800,0.0139339160344977,0.00305713187013615,0.00794193756903086,0.0199258944999646,5.19292367612938e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,24235,0.0105756432410248,0.00232168529640532,0.00602514006007039,0.0151261464219793,5.26013610547777e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MELTF,Melanotransferrin,24917,0.00941402920353821,0.0020724020348805,0.00535212121517244,0.013475937191904,5.58334468157987e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYL3,Myosin light chain 3,24235,-0.0232499982373988,0.00511928668937959,-0.0332838001485828,-0.0132161963262148,5.60851376432678e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLSPN,Claspin,28714,0.011015732343048,0.00242566962755237,0.00626141987304539,0.0157700448130507,5.61313738300522e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24788,0.0142969590730839,0.00315016648105489,0.00812263277021631,0.0204712853759515,5.69281100712264e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRD1,Bromodomain-containing protein 1,24440,-0.00974215421509022,0.00215444273407485,-0.0139648619738769,-0.00551944645630352,6.15777510448879e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,29540,0.00861124075574942,0.00190634793285025,0.00487479880736292,0.0123476827041359,6.29230293241772e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,29473,0.00891153354784578,0.00198098947072376,0.0050287941852272,0.0127942729104644,6.86873586100615e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPHS1,Nephrin,24224,0.0107347458502539,0.0023890916696003,0.0060521261778373,0.0154173655226705,7.04744838703786e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24317,-0.0153177638797146,0.00342244518425031,-0.0220257564408452,-0.00860977131858402,7.65149180571834e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,28769,0.0124656168918583,0.0027915406498675,0.00699419721811798,0.0179370365655986,8.01868304820193e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFRC,Transferrin receptor protein 1,29560,0.0119082950136482,0.0026916248014844,0.00663271040273881,0.0171838796245577,9.7144639554428e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,24190,-0.0117150891934312,0.00264795170845306,-0.0169050745419992,-0.00652510384486318,9.72193876129466e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHRDL2,Chordin-like protein 2,29473,0.0164666252812123,0.00372950837569544,0.00915678886484927,0.0237764616975754,1.01262832705723e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PALM3,Paralemmin-3,24106,0.0228744334785248,0.00518061891595775,0.0127204204032477,0.033028446553802,1.01268251681396e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24440,0.021818905835983,0.00494719657069892,0.0121224005574131,0.0315154111145529,1.03640760133725e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29492,-0.0103482883777623,0.00235330154730732,-0.0149607594104847,-0.00573581734503998,1.09964315103827e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLC,Galectin-10,29421,0.0203429411503139,0.00463199239640586,0.0112642360533584,0.0294216462472694,1.12790765865839e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB2,Integrin beta-2,29269,0.00878661866970227,0.00200356024293175,0.00485964059355604,0.0127135967458485,1.16121925363941e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,28769,0.0175574029728487,0.00401690910810634,0.00968426112096029,0.0254305448247371,1.24183891566301e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,29623,0.00616966498140519,0.00141273774516281,0.00340069900088608,0.0089386309619243,1.26294043125843e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,24224,0.00664481418636647,0.00152156673167872,0.00366254339227617,0.00962708498045676,1.26437042957039e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,24096,0.0224805744844032,0.00515316079206718,0.0123803793319516,0.0325807696368549,1.29129016288634e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPARCL1,SPARC-like protein 1,29484,-0.00835514302083637,0.0019175324065544,-0.012113506537683,-0.00459677950398974,1.32159626121809e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24788,0.0296513124551806,0.00681572753875985,0.0162924864792113,0.0430101384311499,1.36416732845227e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLAMF7,SLAM family member 7,29429,0.0177301631187506,0.00408638704964582,0.00972084450144478,0.0257394817360564,1.43716408817093e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCD6,Programmed cell death protein 6,29473,-0.02121681028866,0.0048927436164663,-0.0308065877769339,-0.011627032800386,1.45327084007008e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23965,0.0264629558749139,0.00615684584997711,0.0143955380089587,0.038530373740869,1.72920857099984e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29561,-0.0135229717850855,0.00315769145712594,-0.0197120470410524,-0.00733389652911867,1.85346318480118e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,24224,0.0199714960681034,0.00466385558198855,0.0108303391274058,0.0291126530088009,1.85778737522142e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24800,0.0090562058476971,0.00211807147923848,0.00490478574838967,0.0132076259470045,1.91263011164094e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX18,Sorting nexin-18,24800,0.013376275010104,0.00313037929194584,0.00724073159789021,0.0195118184223179,1.93534098321564e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTR,Methionine synthase,24106,0.0194786861812575,0.00457798368439237,0.0105058381598485,0.0284515342026666,2.09968145550666e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UNG,Uracil-DNA glycosylase,24788,0.0102725516511568,0.0024154232784837,0.00553832202532872,0.0150067812769848,2.11793864567921e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28769,0.016013119486246,0.00376542124501894,0.00863289384600888,0.0233933451264831,2.11896957585078e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",24106,0.011717517213915,0.00276342858152965,0.00630119719411692,0.0171338372337131,2.24142831953905e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24106,-0.00933479204737439,0.00221136965021442,-0.0136690765617946,-0.00500050753295413,2.4381768187085e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRD3,Bromodomain-containing protein 3,24106,0.0141157479894932,0.00335914149218426,0.00753183066481206,0.0206996653141744,2.6529769558063e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPS10,40S ribosomal protein S10,24106,-0.0123267797588523,0.00294218900385442,-0.018093470206407,-0.00656008931129765,2.80363638724861e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACTN2,Alpha-actinin-2,24106,-0.0173654405766632,0.00415495862069106,-0.0255091594732177,-0.00922172168010877,2.9324576197774e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KEL,Kell blood group glycoprotein,28769,0.0104289015098126,0.0025063560784743,0.00551644359600299,0.0153413594236222,3.17802998990612e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,29344,0.00757428297708445,0.00182251981372088,0.00400214414219152,0.0111464218119774,3.24871050376611e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,24011,0.0162440603522885,0.00392971485457447,0.00854181923732249,0.0239463014672544,3.58261380511969e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24863,0.0197440296107464,0.00478007633488001,0.0103750799943816,0.0291129792271112,3.63183341588031e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PODXL,Podocalyxin,29344,0.004366440806481,0.00105846891507562,0.0022918417329328,0.00644103988002921,3.71365067511232e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",24190,0.0244270792467167,0.00593403313876891,0.0127963742947296,0.0360577841987038,3.86049020565031e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,24224,0.0124978738813964,0.00304593627452017,0.00652783878333683,0.0184679089794559,4.08930738934949e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCN1,Transcobalamin-1,24541,0.00981228156108028,0.00239740654450134,0.00511336473385766,0.0145111983883029,4.27423112415663e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,24011,-0.0119306933113515,0.0029155167402408,-0.0176451061222235,-0.00621628050047952,4.28812813278013e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,24011,0.0104647881862524,0.00256033619777616,0.00544652923861111,0.0154830471338936,4.37896541997955e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYO6,Unconventional myosin-VI,24863,0.0107069656340421,0.00261969376241127,0.00557236585971597,0.0158415654083681,4.38159550589299e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA6C,Semaphorin-6C,24224,0.00749986677030783,0.00183762309822241,0.00389812549779192,0.0111016080428238,4.49306431949809e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCC,Netrin receptor DCC,24190,0.00655906591799864,0.00160806577865848,0.00340725699182802,0.00971087484416926,4.54031679387241e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMBN,Ameloblastin,28926,-0.00812368616463306,0.00199665031653599,-0.0120371207850436,-0.00421025154422252,4.74102332035261e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPE,Carboxypeptidase E,29463,-0.0109432612162985,0.00269473574200549,-0.0162249432706292,-0.0056615791619677,4.89940324844975e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAA4,Serum amyloid A-4 protein,24961,0.00929935458487926,0.00229195023899524,0.00480713211644859,0.0137915770533099,4.97734284620518e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKCQ,Protein kinase C theta type,28926,0.0123424457988161,0.00304276443899754,0.00637862749838095,0.0183062640992513,4.99812967583083e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MB,Myoglobin,29815,0.0148430247976709,0.00366084029889437,0.00766777781183789,0.0220182717835038,5.03605495407997e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24235,-0.0104706746220354,0.002583430864974,-0.0155341991173844,-0.00540715012668633,5.07203509409715e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24440,0.010012924979838,0.00248877847178079,0.00513491917514767,0.0148909307845284,5.75784564104406e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REN,Renin,29473,0.0213641826091988,0.00531081329331588,0.0109549885542997,0.0317733766640979,5.76609863438298e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRP2,Neuropilin-2,29438,0.0080440891853607,0.00200102069432287,0.00412208862448787,0.0119660897462335,5.83447946642034e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28792,0.0216184405497879,0.00540431964585626,0.0110259740439096,0.0322109070556662,6.34431030986239e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28769,0.0189305713690595,0.00474738140864192,0.00962570380812129,0.0282354389299976,6.69151606124437e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29473,0.00886787816802383,0.00222488988266398,0.00450709399800244,0.0132286623380452,6.74263021398435e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,29344,-0.00737578490735439,0.00185454302044043,-0.0110106892274176,-0.00374088058729114,6.99151947616058e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOP56,Nucleolar protein 56,24106,0.0307324748138007,0.00778857779574955,0.0154668623341316,0.0459980872934698,7.97464188301029e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSN,Gelsolin,24840,-0.00525548993956393,0.00133593810130894,-0.00787392861812945,-0.00263705126099841,8.37946214109434e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYB5A,Cytochrome b5,24011,0.019930077160459,0.00507255788948921,0.00998786369706011,0.0298722906238578,8.55388951478089e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,24106,0.0110116149953594,0.0028030404393506,0.00551765573423222,0.0165055742564866,8.57320869663019e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CENPJ,Centromere protein J,24440,0.019811093613024,0.00504351750252944,0.00992579930806631,0.0296963879179817,8.58795258235224e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,29429,0.0127783822399678,0.00326603794216878,0.00637694787331698,0.0191798166066186,9.15498623539798e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,28926,0.00863208077663685,0.00220836235588665,0.00430369055909902,0.0129604709941747,9.29611794842797e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,28792,0.0207707279971717,0.00532207153952131,0.0103394677797099,0.0312019882146335,9.53214215783392e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C7,Complement component C7,24369,-0.00886839722158508,0.00227570302546292,-0.0133287751514924,-0.00440801929167776,9.76552380589333e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,24011,0.0161902066071919,0.00416549636351592,0.00802583373470071,0.0243545794796831,0.000101872050031544
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,24106,0.00887176480799455,0.00228992288437984,0.00438351595461007,0.013360013661379,0.000107230508344249
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS53,Serine protease 53,24840,0.0101049824315822,0.00261805255816911,0.00497359941757077,0.0152363654455937,0.000113798498006827
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCAN,Neurocan core protein,29689,0.0100534529353964,0.00260636182053279,0.00494498376715213,0.0151619221036407,0.000114900520162466
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FBN2,Fibrillin-2,24190,0.0163434907362283,0.00424985487660793,0.00801377517807671,0.0246732062943798,0.000120537267077727
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,24224,0.00986471571755209,0.002565594593551,0.00483615031419212,0.014893281120912,0.000120859943475849
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,24440,0.0142892051652298,0.00372754221573861,0.00698322242238214,0.0215951879080775,0.000126694792088615
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28926,0.0148412816266065,0.00388831166162022,0.00722019076983082,0.0224623724833821,0.000135422571831656
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BMP10,Bone morphogenetic protein 10,24376,-0.00763562753513017,0.00200210738172761,-0.0115597580033163,-0.00371149706694406,0.000137186223776133
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD70,CD70 antigen,29429,0.011349480939893,0.00298130316694567,0.00550612673267953,0.0171928351471066,0.000141012952858291
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,29213,-0.00961943563691533,0.00252858639995249,-0.0145754649808222,-0.00466340629300844,0.000142510380837231
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGB2A2,Mammaglobin-A,24106,-0.00838675122337926,0.00221496709409643,-0.0127280867278083,-0.00404541571895026,0.000153216403810745
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",28769,0.0143139657839455,0.00378165108307724,0.00690192966111413,0.0217260019067769,0.000153952364226444
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSB,Lupus La protein,28769,0.0156511036872661,0.00416395084759,0.00748976002598968,0.0238124473485425,0.000171126003075526
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,24096,-0.0100223903447843,0.0026674023515029,-0.01525049895373,-0.00479428173583865,0.000172120351263534
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,29576,0.00739364283700984,0.00196937793731354,0.00353366207987531,0.0112536235941444,0.000174156785883647
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCT,Secretin,24190,0.0123750596604914,0.00329648993297556,0.00591393939185927,0.0188361799291235,0.000174434495750702
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGMA,Repulsive guidance molecule A,29689,-0.00822255214242197,0.0021954587924371,-0.0125256513755987,-0.00391945290924527,0.000180551496691131
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,24096,0.0282859305779354,0.00761452372242359,0.0133614640819851,0.0432103970738856,0.000203876940522163
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,24190,0.0186239820864086,0.00501491101533719,0.00879475649634774,0.0284532076764695,0.000204692673171657
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28792,0.0324339493634733,0.00873790731387088,0.0153076510282864,0.0495602476986602,0.000206123795836481
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24863,0.0299616791130328,0.00809770395994452,0.0140901793515416,0.0458331788745241,0.000216046037513142
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29429,0.0385455370058069,0.0104628632741099,0.0180383249885515,0.0590527490230623,0.000229983611792063
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTTG1,Securin,24440,0.0107066684669788,0.00290649588004002,0.00500993654210037,0.0164034003918573,0.000230365761020951
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TEF,Thyrotroph embryonic factor,24106,0.0110361824653246,0.00300670782525201,0.00514303512783063,0.0169293298028185,0.000242579566388235
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH15,Cadherin-15,29634,0.0147904177518907,0.00403210491843822,0.00688749211175177,0.0226933433920296,0.000244727281485085
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYOM1,Myomesin-1,24096,0.0122659329162416,0.00335701530366189,0.00568618292106429,0.0188456829114189,0.000258914853600706
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,29531,0.0114844259641161,0.00315091128706558,0.00530863984146754,0.0176602120867646,0.000268064023548811
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GDF2,Growth/differentiation factor 2,29473,0.00905454103375606,0.00248895795018881,0.00417618345138599,0.0139328986161261,0.000275356016244477
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,29404,-0.00447047638527362,0.00123135055696816,-0.00688392347693122,-0.00205702929361602,0.000283301099474606
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH5,Cadherin-5,29815,-0.00769095341757765,0.002118677766998,-0.0118435618408937,-0.00353834499426157,0.000283816070098781
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28769,0.0120241352024486,0.00332229883427029,0.00551242948727885,0.0185358409176184,0.000295997503997722
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,24440,0.0177022053992186,0.00489120913537176,0.00811543549388999,0.0272889753045473,0.000296125637833172
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",23970,0.00652392865056684,0.00181201811868884,0.00297237313793672,0.010075484163197,0.000318411012964544
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,24106,-0.00696234328140288,0.0019344329603526,-0.010753831883694,-0.00317085467911178,0.000319880803379989
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24011,0.0128912039269224,0.00358613661512281,0.00586237616128172,0.0199200316925631,0.000325375017415658
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSAP,Gamma-secretase-activating protein,28792,0.0218096551975882,0.00607278542438329,0.00990699576579695,0.0337123146293794,0.000329484457826716
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EXTL1,Exostosin-like 1,24106,0.0119893916107765,0.00333839118092738,0.00544614489615889,0.0185326383253942,0.00032960089732893
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRH,Corticoliberin,28746,0.0216959253519436,0.00606584116362031,0.00980687667124778,0.0335849740326394,0.000348479762351793
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPAN1,Tetraspanin-1,28911,0.0141529104107392,0.0039669292317472,0.00637772911651471,0.0219280917049637,0.00036067737006954
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,24190,0.0210064169301498,0.00590495420629045,0.00943270668582052,0.0325801271744791,0.000375227930961984
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRING1,SREBP regulating gene protein,24011,0.0148650206358381,0.00418026477940415,0.00667170166820597,0.0230583396034702,0.000377268954263098
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRXN3,Neurexin-3,24190,0.0088044013564243,0.00248128018338675,0.00394109219698627,0.0136677105158623,0.000388416419399334
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,29449,0.0728198143553059,0.0206049747510873,0.0324340638431747,0.113205564867437,0.000409810465958463
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,28769,0.00823372629236614,0.00234127923012307,0.00364481900132492,0.0128226335834074,0.000437515101002594
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,24190,0.0255116286364298,0.0072548082301112,0.0112922045054118,0.0397310527674477,0.000438056001429693
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,29815,0.00850186739902055,0.00242563160385255,0.00374762945546955,0.0132561053425715,0.00045725728105522
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29213,0.0170839721694848,0.00487605774542834,0.00752689898844525,0.0266410453505243,0.000459624429359173
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,24096,0.0183741035351505,0.00524724109156914,0.00808951099567501,0.028658696074626,0.000463189940840724
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,24064,0.0241124837960553,0.00690244795281912,0.0105836858085298,0.0376412817835808,0.000477905255887178
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,24224,0.00719419733206289,0.00206385088171785,0.0031490496038959,0.0112393450602299,0.00049151333055944
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,24020,-0.0153567776698399,0.00440597072539992,-0.0239924802916238,-0.00672107504805607,0.000492192361995414
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,28926,0.015852601300274,0.00455354999829814,0.00692764330360962,0.0247775592969383,0.000499588204514022
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,29473,0.00625168127022365,0.00179775776569641,0.00272807604945869,0.00977528649098861,0.000506865304490736
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,28792,0.0125404924946697,0.00361209612311353,0.00546078409336717,0.0196202008959722,0.000517730636541345
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HLA_DRA,,29317,0.00873596297626219,0.0025211113694572,0.00379458469212607,0.0136773412603983,0.000530745625411662
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24106,0.0144404186177981,0.0041739610115311,0.00625945503519719,0.0226213822003991,0.000541825911066822
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,24106,-0.00819547733484986,0.00237113588449106,-0.0128429036684523,-0.00354805100124738,0.000548486116349049
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24168,0.00932933790591325,0.00270071326692235,0.00403593990274544,0.0146227359090811,0.000552469497731229
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,24961,-0.00628794142365047,0.00182264722510099,-0.00986032998484842,-0.00271555286245253,0.000561731827569793
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TLR4,Toll-like receptor 4,24224,0.00683404942677221,0.00198937814331034,0.00293486826588395,0.0107332305876605,0.000592958047926675
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB118,Beta-defensin 118,24096,0.0138562044971551,0.00405313694701263,0.00591205608101037,0.0218003529132999,0.000630397797085085
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29531,-0.0154366992096337,0.00451710188493948,-0.024290218904115,-0.00658317951515228,0.000633098857465098
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24106,0.010967678615089,0.00321409818349371,0.00466804617544134,0.0172673110547367,0.000645074790353092
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGM2,Phosphoglucomutase-2,24190,0.0144336153383546,0.00423320987908914,0.00613652397533991,0.0227307067013693,0.000651609015300467
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YY1,Transcriptional repressor protein YY1,24224,0.00667353175772378,0.00196032760554958,0.0028312896508466,0.010515773864601,0.000664428207340812
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDNRB,Endothelin receptor type B,24224,0.0109095147531404,0.00320710884764283,0.00462358141176043,0.0171954480945203,0.000670845801138386
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,METAP1,Methionine aminopeptidase 1,28769,0.0071061541995784,0.00208914790680496,0.00301142430224067,0.0112008840969161,0.000671179950919013
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFNB2,Ephrin-B2,24190,0.0137828440377584,0.00406312767193551,0.00581911380076478,0.021746574274752,0.000694509779995079
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,24933,0.0145464554492345,0.00429143762055076,0.00613523771295506,0.022957673185514,0.000700913362730442
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASPN,Asporin,24917,0.006529795656429,0.00192684347518895,0.00275318244505867,0.0103064088677993,0.000702935377009436
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MUC2,Mucin-2,24933,0.0215549494555768,0.00640261394767784,0.00900582611812824,0.0341040727930254,0.000762198966351728
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACTN4,Alpha-actinin-4,28926,0.00751797447635805,0.00223542819366661,0.00313653521677148,0.0118994137359446,0.000771716896163429
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,24096,0.0228188284013195,0.00680255225002025,0.00948582599127985,0.0361518308113592,0.000796453195127229
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,24440,-0.00664553592635518,0.00198326462048749,-0.0105327345825107,-0.0027583372701997,0.000806986661446743
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,24863,0.0179634778586487,0.00536414950638481,0.00744974482613451,0.0284772108911629,0.000812821938888127
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,24106,0.0107548321709395,0.00321767639760632,0.00444818643163113,0.0170614779102479,0.000831770989732646
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,29449,0.00917269435366201,0.00276382174350124,0.00375560373639959,0.0145897849709244,0.00090500439738493
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,24840,0.0130273806830094,0.00392550213655616,0.00533339649535932,0.0207213648706594,0.000905827438187942
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,24440,0.00902392995302676,0.00272416168490294,0.003684573050617,0.0143632868554365,0.000925828310561037
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSB,Cathepsin B,29475,-0.0121120515440176,0.00365807053692184,-0.0192818697963844,-0.00494223329165077,0.00093058550037838
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,29815,-0.00734607090616541,0.00221976375626336,-0.0116968078684416,-0.00299533394388922,0.000936093170828928
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHIT1,Chitotriosidase-1,29574,0.0350098702080475,0.0106293712238545,0.0141763026092927,0.0558434378068023,0.000989970778050067
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSC1,Hamartin,24224,0.0173134011870047,0.00526637336994725,0.00699130938190806,0.0276354929921013,0.00101211591143914
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24863,0.00740643027365677,0.00225464723305863,0.00298732169686186,0.0118255388504517,0.0010213728423117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL36G,Interleukin-36 gamma,24144,0.015584553522744,0.00476973835221857,0.0062358663523956,0.0249332406930924,0.00108699030222074
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STC2,Stanniocalcin-2,29391,0.00591673677227684,0.001812198580097,0.00236482755528673,0.00946864598926695,0.00109608873714811
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB5,Integrin beta-5,29561,-0.0085486268993335,0.00263025111245014,-0.0137039190797358,-0.00339333471893122,0.00115486102443023
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHAD,Chondroadherin,24376,0.0117983855853436,0.00363604373102302,0.0046717398725385,0.0189250312981487,0.00117674497847164
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELENOP,Selenoprotein P,24961,-0.0051350211858715,0.00158444081609955,-0.00824052518542662,-0.00202951718631638,0.00119307358518852
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,29589,0.00777554846087861,0.0024025214455984,0.00306660642750574,0.0124844904942515,0.0012117584906533
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,24190,-0.00654268944559,0.00203640859820996,-0.0105340502980815,-0.00255132859309847,0.00131593932107029
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,24096,0.0111105993502234,0.00345846287457856,0.00433201211604943,0.0178891865843974,0.00131720061136783
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,24011,0.0323650855261543,0.0100824530383146,0.0126034775710578,0.0521266934812509,0.00132890752199011
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL22,Interleukin-22,24788,0.0152281383819653,0.00474544705151538,0.00592706216099514,0.0245292146029354,0.00133367156996541
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,28926,0.00841066457184847,0.00263056324729476,0.00325476060715075,0.0135665685365462,0.00138876302953213
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL20,Interleukin-20,28926,0.0108619961116233,0.00342136947313016,0.00415611194428821,0.0175678802789584,0.00150122354659872
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMOD4,Tropomodulin-4,24011,-0.00912732789700698,0.00287693003360339,-0.0147661107628696,-0.00348854503114434,0.00151274565083249
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FSTL1,Follistatin-related protein 1,24235,0.00505826301784906,0.00159968884055396,0.00192287289036329,0.00819365314533482,0.00156866987489389
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,24933,0.00514815790594221,0.00163067753256209,0.00195202994212052,0.0083442858697639,0.0015955474232741
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPN1,Epsin-1,24440,0.00968788750641078,0.00306990915752189,0.00367086555766789,0.0157049094551537,0.00160276453171179
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH23,Cadherin-23,24840,-0.00585820554466934,0.00185999181320139,-0.00950378949854406,-0.00221262159079462,0.00163695437165322
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24440,0.0152040784478196,0.00483090931402426,0.00573549619233209,0.0246726607033072,0.00165012169782763
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,29689,-0.0280576401535946,0.0089546289650743,-0.0456087129251403,-0.010506567382049,0.00173014233035896
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28769,0.0171735320269779,0.00548364408285401,0.00642558962458404,0.0279214744293718,0.00173927976823828
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NENF,Neudesin,24788,0.0241361617223291,0.00771285999874928,0.0090189561247805,0.0392533673198777,0.00175402725756094
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29815,0.0152360254425153,0.00488547823815294,0.00566048809573553,0.0248115627892951,0.00181863697887629
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24190,0.0083344856312719,0.0026751656168296,0.00309116102228589,0.0135778102402579,0.00183846516040931
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPM1B,Protein phosphatase 1B,24224,0.0136604536510799,0.00438549816789697,0.00506487724200184,0.022256030060158,0.00184212786042127
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPTX1,Neuronal pentraxin-1,29438,0.00884582647498448,0.00283995728036882,0.0032795102054616,0.0144121427445074,0.00184262381473392
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEPTIN7,Septin-7,24440,0.0114948366166674,0.00370291462905022,0.00423712394372901,0.0187525492896059,0.00190968909423355
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24933,0.0299073961835414,0.00965151565920632,0.010990425491497,0.0488243668755858,0.00194571370474692
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,24106,0.0213052843607172,0.00688778553111777,0.00780522471972638,0.034805344001708,0.00198238395349184
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24224,0.00766211973125658,0.00248056404231649,0.00280021420831625,0.0125240252541969,0.00201152271793775
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",28769,0.00913428490565044,0.00296148243546692,0.00332977933213527,0.0149387904791656,0.00204182360090737
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,24933,0.00604870831019348,0.00196487717346627,0.0021975490501996,0.00989986757018736,0.00208330599676737
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,24011,0.00898334825536858,0.00292668286969309,0.00324704983077013,0.014719646679967,0.00214682433132287
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A14,Protein S100-A14,24863,0.0113756077994752,0.003706763195255,0.00411035193677541,0.018640863662175,0.00215094985436447
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK14,Kallikrein-14,29720,0.0098143398373974,0.00321984378835234,0.00350344601222681,0.016125233662568,0.00230511360408504
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL4,Interleukin-4,28926,0.0194660847012436,0.0064129295849882,0.00689674271466675,0.0320354266878205,0.0024039588133815
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,24235,0.00842055355385097,0.00278168183905769,0.0029684571492979,0.0138726499584041,0.00247135156372371
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24224,0.0131467099404356,0.00434555494272092,0.00462942225270263,0.0216639976281686,0.00248627787661641
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,24863,0.00985136976932283,0.0032680146117846,0.00344606113022501,0.0162566784084206,0.00257678537078062
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNR,Tenascin-R,29213,-0.00886451976824662,0.00294677869242778,-0.0146402060054051,-0.00308883353108816,0.00263018108778747
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",24224,0.00614660955660458,0.00204518946528356,0.0021380382046488,0.0101551809085604,0.00265504625300806
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29422,0.015450154936687,0.00514607733085893,0.00536384336820347,0.0255364665051705,0.00268158122157653
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSF,Cathepsin F,29561,0.00839381911518897,0.00279763880865211,0.00291044705023084,0.0138771911801471,0.00269918637323962
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECM1,Extracellular matrix protein 1,24344,0.00772669099814422,0.00257564499491383,0.00267842680811312,0.0127749551881753,0.00270336943213522
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,24096,-0.0128646293201741,0.00433787783965431,-0.0213668698858965,-0.00436238875445163,0.00302339790495014
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH12,Protocadherin-12,24863,0.00530263520132695,0.00179095690801043,0.00179235966162651,0.00881291074102739,0.00307147717930627
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBP6,Guanylate-binding protein 6,24106,-0.00957593490141611,0.00323729225455467,-0.0159210277203433,-0.00323084208248895,0.0030993523678598
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTF3,Neurotrophin-3,29429,0.00716164388996903,0.00242148534338386,0.00241553261693667,0.0119077551630014,0.00310349291471499
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SBSN,Suprabasin,24900,-0.00709920071500743,0.00241243872012414,-0.0118275806064507,-0.00237082082356411,0.00325612581143188
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",27981,0.00598318978217216,0.0020353258234693,0.00199395116817232,0.009972428396172,0.00328828838740665
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24863,0.0086973107309242,0.00296195714797241,0.00289187472089828,0.0145027467409501,0.00332415436295929
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24096,-0.0112211202260145,0.0038245732027332,-0.0187172837033716,-0.00372495674865742,0.00334989878957339
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN5,Contactin-5,29506,-0.00758291665253685,0.0025858654950403,-0.0126512130228158,-0.00251462028225787,0.0033655948268649
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,29720,-0.0116938336105861,0.00402147587688329,-0.0195759263292774,-0.00381174089189486,0.00364196519241467
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,23033,0.0108149757497088,0.00373585409750354,0.00349270171860187,0.0181372497808157,0.00379619021664722
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,28769,0.00970505544695603,0.00335734454010719,0.00312466014834594,0.0162854507455661,0.0038467993117739
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYH7B,Myosin-7B,24011,-0.00898928839868003,0.00311455603486641,-0.0150938182270182,-0.00288475857034187,0.00390249359672941
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,24224,0.0116211455019013,0.00405475576545027,0.00367382420161877,0.0195684668021838,0.00415982581529324
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,28926,0.0126021641418553,0.00440480335112695,0.00396874957364645,0.0212355787100641,0.00422603211685392
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TLR2,Toll-like receptor 2,24440,0.00461853014906454,0.00161661627197625,0.00144996225599109,0.00778709804213798,0.00428145779312513
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRND,Prion-like protein doppel,24840,0.0103130377235796,0.00361333476615032,0.00323090158192496,0.0173951738652342,0.00431864264305734
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPA33,Cell surface A33 antigen,29344,-0.0269039193776669,0.00942714328809345,-0.0453811202223301,-0.00842671853300375,0.00432193224425361
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,29815,-0.00598422808672408,0.00209858729312069,-0.0100974591812406,-0.00187099699220752,0.00435364439416224
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPSD1,Tryptase delta,24863,0.00746431974944052,0.00262308951051927,0.00232306430882275,0.0126055751900583,0.00443611120080533
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRL,Prolactin,29689,-0.0150397897132036,0.00528683722136208,-0.0254019906670733,-0.00467758875933395,0.00444751298625391
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ROBO4,Roundabout homolog 4,24235,-0.00357891501335448,0.00126104298470713,-0.00605055926338044,-0.00110727076332851,0.00454264474576942
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24235,-0.00417367815979479,0.00147067249643892,-0.00705619625281508,-0.00129116006677449,0.00454436585254263
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH3GL3,Endophilin-A3,24302,0.0166349844740048,0.00588495865019607,0.00510046551962054,0.0281695034283891,0.00470694887044417
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,24106,0.00660514674518464,0.00234875168171257,0.002001593449028,0.0112087000413413,0.00492445059293206
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDHB15,Protocadherin beta-15,24788,-0.00786630277761817,0.00280829807361984,-0.013370567001913,-0.00236203855332328,0.00509693836527409
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",29397,0.0108687592264327,0.00388529317594843,0.00325358460157379,0.0184839338512916,0.00515475670571758
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28388,0.0124389530772769,0.00446923582656087,0.0036792508572176,0.0211986552973362,0.00538546716160803
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",29473,-0.0152172539161664,0.0054801543395266,-0.0259583564216385,-0.00447615141069427,0.00549328111841746
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,24096,-0.0064708457220473,0.0023350660299715,-0.0110475751407914,-0.00189411630330316,0.00558995098701049
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,24190,0.00705757270335434,0.00255093021063204,0.00205774949051553,0.0120573959161931,0.00566757039417734
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,24788,0.010716253397616,0.00391035825581035,0.0030519512162277,0.0183805555790043,0.00613937075725115
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HBZ,Hemoglobin subunit zeta,24917,0.0200713797132677,0.00741258835716035,0.00554270653323339,0.034600052893302,0.00677888153122689
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRNN,Cornulin,28575,0.012627620748607,0.00467490940039065,0.00346479832384135,0.0217904431733727,0.00691414061187807
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EBI3_IL27,Interleukin-27,29669,0.00582904180361481,0.00215897127989952,0.00159745809501176,0.0100606255122179,0.00693962555751243
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRD2,Bromodomain-containing protein 2,24096,0.00655598757830224,0.0024422843769018,0.0017691101995747,0.0113428649570298,0.00727170056216011
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,28911,0.0113027458830526,0.00422984922276977,0.00301224140642387,0.0195932503596814,0.00754116527616259
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,29344,-0.00622850890952172,0.00234169733333639,-0.010818235682861,-0.0016387821361824,0.00782233810880911
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,24440,0.0161477222878461,0.00607123215336857,0.00424810726724369,0.0280473373084485,0.00782587901603654
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYL4,Myosin light chain 4,24235,0.00969473410366513,0.00364530107737898,0.00254994399200234,0.0168395242153279,0.00783046558706662
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,24224,-0.00407478928675689,0.00153661997235324,-0.00708656443256924,-0.00106301414094453,0.00801191286515029
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,24011,0.00545474845079618,0.00205899973667658,0.00141910896691009,0.00949038793468227,0.00807300353753728
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24106,-0.00758110228479816,0.00286303090068206,-0.013192642850135,-0.00196956171946132,0.00810392961690873
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17C,Interleukin-17C,28926,0.013019265655707,0.00491783324186219,0.00338031250165714,0.0226582188097569,0.00811673867837461
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,24224,0.0171757392499577,0.00649271050124247,0.00445002666752242,0.0299014518323929,0.00816499640838876
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17F,Interleukin-17F,28926,0.0141355798964187,0.00535034034313009,0.00364891282388377,0.0246222469689537,0.00824633018488919
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24096,0.010712788596598,0.00406897016970845,0.00273760706396944,0.0186879701292266,0.00847380125375755
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,24440,0.00759118891035692,0.00288400328329755,0.00193854247509372,0.0132438353456201,0.00848945743731538
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GH2,Growth hormone variant,28792,0.030429617772163,0.0115644183065575,0.00776335789131025,0.0530958776530158,0.00851007086110166
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANK2,Ankyrin-2,24106,0.013291447893636,0.00506396749656694,0.0033660716003648,0.0232168241869072,0.00867774366847976
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,24011,0.0158469348077753,0.0060714203304078,0.00394695096017596,0.0277469186553746,0.00905754402825192
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24440,0.0102001444140264,0.0039156645509997,0.00252544189406701,0.0178748469339858,0.00919410126304198
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH4,Cadherin-4,24096,0.0088082100159023,0.0033860102164499,0.00217162999166049,0.0154447900401441,0.00929134643964424
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24106,-0.0106601559599448,0.00411464926266011,-0.0187248685147586,-0.00259544340513099,0.00958160479181964
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24106,-0.0072836539717212,0.00281650481705475,-0.0128040034131485,-0.00176330453029389,0.00971377909259602
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,24268,0.00621450480397972,0.00240869539750037,0.00149346182487899,0.0109355477830804,0.00988501783214895
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,24096,0.0138434893609117,0.00538334747936781,0.00329212830135075,0.0243948504204726,0.0101306969111589
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,24054,0.0153486850695346,0.00598135581864838,0.00362522766498376,0.0270721424740854,0.0102912772685387
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",24011,0.0165873375064017,0.0064960298486516,0.00385511900304459,0.0293195560097589,0.0106720506805297
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,24840,0.00700027051572039,0.00274396018069904,0.00162210856155027,0.0123784324698905,0.0107425684707095
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,24933,0.00383958424196312,0.00150815468203862,0.000883601065167423,0.00679556741875882,0.010906162186881
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24235,-0.00465632893986937,0.00183141153889818,-0.00824589555610981,-0.00106676232362894,0.0110130303721769
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,24096,0.0210503200996764,0.00833215071104643,0.00471930470602545,0.0373813354933274,0.0115302721179368
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCG3,Secretogranin-3,29492,0.00586321835659897,0.00232222525424657,0.00131165685827568,0.0104147798549223,0.0115807084356961
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C8B,Complement component C8 beta chain,24961,0.00536689200677808,0.00212871613483883,0.00119460838249398,0.00953917563106219,0.0117021377957038
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,24106,0.00859223927657251,0.00341132700023909,0.0019060383561039,0.0152784401970411,0.0117840431556999
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,29561,-0.00506695091699231,0.00202068034629123,-0.00902748439572312,-0.0011064174382615,0.0121625611505858
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAD1,Glutamate decarboxylase 1,24011,-0.00458147759345766,0.00182737490816404,-0.00816313241345918,-0.00099982277345614,0.0121779375320779
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28769,0.00830067359153374,0.00331828313031816,0.00179683865611015,0.0148045085269573,0.0123724800344165
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBX2,Chromobox protein homolog 2,24106,-0.00706211665021009,0.0028279279934947,-0.0126048555174597,-0.00151937778296048,0.012521770827576
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,29720,0.0104713828425401,0.00420080046741624,0.0022378139264043,0.018704951758676,0.0126825900888556
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSP90B1,Endoplasmin,28621,0.0116786353306987,0.004690031075679,0.00248617442236784,0.0208710962390295,0.0127764314504196
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,29164,0.00584312423261954,0.002348068013068,0.00124091092700627,0.0104453375382328,0.0128345232838542
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL11,Interleukin-11,28926,0.0108270492655137,0.0043601689802522,0.00228111806421936,0.019372980466808,0.01302744728014
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,24224,0.0114244394307546,0.00460412376615287,0.00240035684909499,0.0204485220124143,0.0130953383434851
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,29657,0.0109965783392252,0.00444880415689394,0.00227692219171302,0.0197162344867373,0.0134488390632254
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,24917,0.00525408216754186,0.00212568875549522,0.00108773220677124,0.00942043212831249,0.0134535607768731
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24096,0.0128186188060842,0.00518620398399593,0.00265365899745215,0.0229835786147162,0.0134549746514646
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,28769,0.00559494763896598,0.002273041670622,0.00113978596454685,0.0100501093133851,0.0138440183524304
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HRAS,GTPase Hras,24416,0.0170325437686932,0.00692431407236444,0.00346088818685892,0.0306041993505275,0.0139076794232333
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24224,0.00838170831648532,0.00343423046484709,0.00165061660538503,0.0151128000275856,0.0146685207118172
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH17,Cadherin-17,29473,-0.011553538239758,0.0047468340103316,-0.0208573329000079,-0.00224974357950807,0.0149411194759332
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,24011,0.0148993185551008,0.00612853816536293,0.00288738375098942,0.0269112533592121,0.0150587758264519
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,24224,0.00396523055208634,0.0016375824780208,0.000755568895165575,0.00717489220900711,0.0154684574704853
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",28911,0.0142476229124775,0.00588921170765645,0.00270476796547088,0.0257904778594841,0.0155576094805764
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24376,-0.0108633388309971,0.00449927947883801,-0.0196819266095196,-0.00204475105247457,0.0157657917957377
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24788,0.010544597877617,0.00437559118620491,0.00196843915265542,0.0191207566025787,0.0159655275288697
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP4,Caspase-4,24440,0.0284685134626661,0.0118282720083879,0.00528510032622586,0.0516519265991064,0.01609950293997
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CGN,Cingulin,24190,0.00675610888267319,0.00280750496331901,0.00125339915456792,0.0122588186107785,0.0161160417512017
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK15,Kallikrein-15,24749,0.00866936607419482,0.00363107286336465,0.00155246326200011,0.0157862688863895,0.0169685816270872
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAG,S-arrestin,24096,-0.00886908699567784,0.00371632045132762,-0.01615307508028,-0.00158509891107572,0.0170161827866483
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,28911,0.0130208096415907,0.00546153374374757,0.00231620350384546,0.0237254157793359,0.0171276445547147
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN2,Contactin-2,29720,0.00738048369500414,0.0031164637108049,0.00127221482182653,0.0134887525681817,0.0178800816648931
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA12,Carbonic anhydrase 12,29344,-0.00537736076900397,0.00227696867201498,-0.00984021936615334,-0.000914502171854605,0.0182012191566743
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNF75D,Zinc finger protein 75D,24440,0.00996593910213392,0.00422296568008073,0.00168892636917569,0.0182429518350921,0.0182857855585686
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",24840,-0.00991175440494919,0.00420500659097218,-0.0181535673232547,-0.00166994148664371,0.018424431814994
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,24011,-0.00420478489894395,0.00178556227717051,-0.00770448696219815,-0.000705082835689748,0.0185366952505108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,24440,0.0129132115521333,0.00548894243026193,0.00215488438881989,0.0236715387154467,0.0186512442581039
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,24440,0.012296970878959,0.00523727215172745,0.00203191746157317,0.0225620242963448,0.0188838482903877
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,24190,0.0103002883686702,0.00442443986992697,0.00162838622361335,0.0189721905137271,0.0199180015183952
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,24933,-0.00821938999699623,0.00353124715351914,-0.0151406344178937,-0.00129814557609872,0.019940429131952
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",24106,0.00647894483601353,0.00278418115864887,0.00102194976506174,0.0119359399069653,0.0199705414406444
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYL6B,Myosin light chain 6B,24190,0.0149384227560786,0.00645576845046491,0.00228511659316738,0.0275917289189898,0.020677979448822
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,24190,0.00813869152746886,0.00353489643066721,0.00121029452336113,0.0150670885315766,0.0213219390080515
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEBP1,Heme-binding protein 1,28911,0.00855449180113736,0.00372491279946913,0.00125366271417786,0.0158553208880969,0.0216509085816592
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29512,0.00779616790637367,0.00342985219575877,0.00107365760268647,0.0145186782100609,0.0230313381199882
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24946,0.00687302086020477,0.00302511806799851,0.00094378944692769,0.0128022522734818,0.0230959360666742
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MATN3,Matrilin-3,29164,-0.0050969458080061,0.00224557842796093,-0.00949827952680952,-0.000695612089202669,0.0232288317669878
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL15,Interleukin-15,29429,0.00519274475509794,0.00228808408340175,0.000708099951630504,0.00967738955856538,0.0232467920302031
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,24190,0.00474282039202297,0.0020905277420725,0.000645386017560863,0.00884025476648508,0.0232941842039873
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,24011,0.0100451727201662,0.00444451283719503,0.00133392755926394,0.0187564178810685,0.0238221647435284
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLNS1A,Methylosome subunit pICln,24190,0.00530620948197818,0.00235810946543496,0.000684314929725665,0.0099281040342307,0.0244454320216174
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,24096,0.00931585532821259,0.00414834368940734,0.00118510169697421,0.017446608959451,0.0247334985307368
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,24224,0.00508954897882978,0.00227230020083161,0.000635840585199813,0.00954325737245974,0.0251114910947554
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,24800,0.00732158786726495,0.00326901653633088,0.000914315456056424,0.0137288602784735,0.0251198010978033
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28926,0.0184049986669794,0.00824140643079039,0.00225184206263028,0.0345581552713286,0.0255410611856462
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTRC,Chymotrypsin-C,29451,0.00989043954647628,0.00445944909004956,0.00114991932997915,0.0186309597629734,0.0265718952328004
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,29815,0.00379208952708889,0.00171814358128153,0.000424528107777099,0.00715965094640068,0.0273156905527619
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDHR1,Cadherin-related family member 1,28769,0.00658728364249637,0.00298746139817732,0.000731859302068835,0.0124427079829239,0.0274635955229785
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP53BP1,TP53-binding protein 1,24224,0.0134943820315687,0.0061343627335178,0.00147103107387381,0.0255177329892636,0.0278303772406666
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A16,Protein S100-A16,28717,-0.00944190956036347,0.00429888186909467,-0.017867718023789,-0.00101610109693792,0.028073865642431
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,24543,0.0012442222369447,0.000569495726233462,0.000128010613527114,0.00236043386036229,0.0289144938168607
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,28911,0.00931941871959809,0.00427071877235356,0.000948809925785117,0.0176900275134111,0.0291052845583774
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,29074,-0.00577947708472088,0.00266114867352766,-0.0109953284848351,-0.000563625684606673,0.0298789707899574
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24106,-0.00311330948801284,0.00143380905858944,-0.00592357524284814,-0.000303043733177538,0.0299140204481688
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COPE,Coatomer subunit epsilon,28769,0.0071832077597405,0.00330974081761807,0.000696115757209089,0.0136702997622719,0.029990516460705
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRP2BP,LRP2-binding protein,24190,0.0126143475968446,0.00581732625885,0.00121238812949859,0.0240163070641906,0.0301372361944653
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,24746,0.00613304764677914,0.00283116488914802,0.000583964464049016,0.0116821308295093,0.0303006185833926
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RLN1,Prorelaxin H1,24863,-0.0104608153077237,0.00482957766663739,-0.019926787534333,-0.000994843081114459,0.0303214549098619
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,24096,0.00857467774329105,0.0039609663849906,0.000811183628709473,0.0163381718578726,0.0304132269519601
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24788,0.00716704649596935,0.00332818569313787,0.000643802537419133,0.0136902904545196,0.0312937738969387
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDSN,Corneodesmosin,29671,0.00650046808291329,0.00302763228314708,0.00056630880794502,0.0124346273578816,0.0317976417358029
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,24011,0.00809909105670856,0.00379684339341697,0.000657278005611286,0.0155409041078058,0.0329256802572677
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB5,Serpin B5,28911,0.00725484916880482,0.00340244947221589,0.000586048203261678,0.013923650134348,0.0329952798183365
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OBP2B,Odorant-binding protein 2b,29132,-0.00919702538666601,0.00437260567608917,-0.0177673325118008,-0.000626718261531236,0.0354456353450978
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPT,Microtubule-associated protein tau,28769,0.00776790754143817,0.00369670910191815,0.000522357701678592,0.0150134573811978,0.0356230177503898
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,29377,-0.00373072704856902,0.00178079044483231,-0.00722107632044035,-0.000240377776697695,0.0361809820894722
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,24106,0.00695368739516338,0.00332614792963374,0.000434437453081257,0.0134729373372455,0.0365732415908302
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,24190,-0.00541750721085373,0.00259695417330161,-0.0105075373905249,-0.00032747703118258,0.0369799828686014
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,24224,-0.00429546442984645,0.00206012495496873,-0.00833330934158516,-0.00025761951810773,0.0370751730881668
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,28792,0.00674599960525615,0.00323984572902318,0.000395901976370724,0.0130960972341416,0.0373332194788172
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,24840,-0.00992461295153393,0.00477177123105879,-0.0192772845644092,-0.000571941338658693,0.0375486711182605
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,24190,0.00728165970877698,0.00353125931100469,0.000360391459207792,0.0142029279583462,0.0392129243150821
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRX,Cone-rod homeobox protein,28911,0.0154413336833866,0.00750155221698223,0.000738291338101394,0.0301443760286717,0.039558924811183
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,29385,0.00329467549425842,0.0016076364110452,0.000143708128609836,0.00644564285990701,0.0404327655178722
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTNNA1,Catenin alpha-1,24096,-0.00505530008845121,0.00247257603547434,-0.00990154911798092,-0.000209051058921499,0.0409103024383141
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,24190,0.0111369669237703,0.00546121269497692,0.00043299004161558,0.0218409438059251,0.0414324832825225
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,24733,-0.0038774093797221,0.00190138102398071,-0.0076041161867243,-0.000150702572719906,0.041434745052975
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OPTC,Opticin,29344,0.00642739832392968,0.00315431725631082,0.000244936501560475,0.0126098601462989,0.0415937837394523
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL5,Interleukin-5,28926,0.0202199759320171,0.00993008808400758,0.000757003287362192,0.0396829485766719,0.0417360294680086
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD99,CD99 antigen,29438,-0.00278496612228244,0.00137408127006648,-0.00547816541161274,-9.17668329521461e-05,0.0426934929527709
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,24106,0.00630273303324714,0.00312636207090747,0.000175063374268503,0.0124304026922258,0.0438114858427242
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB7,Integrin beta-7,29720,0.00645028100209027,0.00320113135836563,0.00017606353969363,0.0127244984644869,0.0439135973123022
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24224,0.00396274214027302,0.00197077281134188,0.000100027430042943,0.00782545685050311,0.0443623617246353
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,24106,0.00455485196887062,0.00228406594121874,7.80827240818849e-05,0.00903162121365935,0.0461429992793958
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBP2,Retinol-binding protein 2,29344,-0.0106832015350335,0.005365442590602,-0.0211994690126134,-0.000166934057453558,0.0464777462757724
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,28926,0.00827166862452014,0.004154731755479,0.000128394383781304,0.016414942865259,0.0465009299249623
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28911,-0.00428782460281363,0.0021543168625399,-0.00851028565339184,-6.53635522354298e-05,0.0465628186892088
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,28769,0.00764617855724208,0.00384312128132693,0.000113660845841303,0.0151786962686429,0.0466472132934121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP1B4,Protein ATP1B4,24011,-0.00586957987791656,0.00295186970274393,-0.0116552444952947,-8.39152605384523e-05,0.0467757331346443
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24440,0.0088113989510494,0.00443204286466066,0.000124594936314502,0.0174982029657843,0.0468104142145464
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JCHAIN,Immunoglobulin J chain,28926,0.00849493382084978,0.00430196415887234,6.30840694600034e-05,0.0169267835722396,0.0483157888978491
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24106,0.00674333490129274,0.00341869555361312,4.26916162110363e-05,0.0134439781863745,0.0485653768068618
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24917,0.00379257478979529,0.0019262771034897,1.70716669554679e-05,0.00756807791263511,0.0489799519600695
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGR,Progesterone receptor,24224,0.0138692362412613,0.00714650313315349,-0.000137909899719561,0.0278763823822421,0.052305970074109
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GUK1,Guanylate kinase,24106,-0.0054550282972359,0.00281468611807213,-0.0109718130886573,6.17564941854743e-05,0.0526276699711662
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCAM,Basal cell adhesion molecule,29438,0.00322842681989949,0.00168149384030265,-6.73011070936973e-05,0.00652415474689267,0.054870662842709
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DBH,Dopamine beta-hydroxylase,24914,-0.0146082568279865,0.00766117010613957,-0.0296241502360201,0.000407636580047015,0.0565590428033156
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPTX2,Neuronal pentraxin-2,24933,-0.0043986114667611,0.00233397108496758,-0.00897319479329756,0.000175971859775349,0.0594949368007997
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24011,0.00349944401996612,0.00186228540105956,-0.000150635366110612,0.00714952340604285,0.060241225100465
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,28926,0.0039323707515729,0.00209297691854941,-0.000169864008783942,0.00803460551192975,0.0602762652273293
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,24096,0.00737261017143566,0.00394925424964271,-0.000367928157864058,0.0151131485007354,0.0619366297250237
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,24190,0.00465825369576775,0.00250960807002383,-0.000260578121478959,0.00957708551301446,0.0634418021893652
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24961,-0.00251916810123042,0.00136147367307682,-0.00518765650046099,0.000149320298000157,0.0642786081711816
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EXOSC10,Exosome component 10,24106,0.00785581614007149,0.00425851291865442,-0.000490869180491167,0.0162025014606341,0.0650887632807469
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1A,Interleukin-1 alpha,28926,0.00713845479829542,0.00388762321922902,-0.000481286711393455,0.0147581963079843,0.0663383049059942
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESR1,Estrogen receptor,24224,0.0074224534470759,0.00404260504029646,-0.000501052431905163,0.015345959326057,0.0663614766733496
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTO1,Protein LTO1 homolog,28926,0.00527545493954641,0.00287500676752994,-0.000359558324812267,0.0109104682039051,0.0665253621166748
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24863,0.00484107477492012,0.00265287110153774,-0.000358552584093845,0.0100407021339341,0.0680366385909257
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29576,-0.0054004140458189,0.00297219980102836,-0.0112259256558345,0.000425097564196682,0.0692309946619025
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,24096,0.0115349052924383,0.00642394216773045,-0.0010560213563134,0.0241258319411899,0.072568836230257
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,24440,-0.00551161952889804,0.00308268462413826,-0.011553681392209,0.000530442334412949,0.0737999446530183
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL13,Interleukin-13,28926,0.00601037057116953,0.00336543969721017,-0.0005858912353624,0.0126066323777015,0.0741243970334229
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,24416,0.0124828056773199,0.00705420197365066,-0.00134343019103541,0.0263090415456752,0.0768136150166697
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24840,-0.0031549647407846,0.00180194177502657,-0.00668677061983667,0.000376841138267473,0.0799807564311123
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPON2,Spondin-2,29306,-0.00425998623699877,0.00243492717380849,-0.0090324434976634,0.000512471023665864,0.0802093449883616
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOLR3,Folate receptor gamma,29456,0.0228901404491082,0.0130942538341865,-0.00277459706589733,0.0485548779641137,0.080456140074266
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24863,0.00291829103303667,0.00167063785986289,-0.000356159172294589,0.00619274123836794,0.0806822286820179
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MILR1,Allergin-1,28926,0.00613182145117552,0.00352308990003775,-0.000773434752898467,0.0130370776552495,0.0817877015975669
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,29589,-0.00556774564510124,0.00320529590742661,-0.0118501256236574,0.000714634333454924,0.0823895063728662
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,28792,0.00592558824717917,0.00342269780323429,-0.000782899447160037,0.0126340759415184,0.0834156797958306
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24788,0.0105400246166198,0.00609751169678527,-0.00141109830907928,0.022491147542319,0.0838971079353894
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF5,Fibroblast growth factor 5,28926,-0.00399207494520614,0.00231217462603328,-0.00852393721223138,0.000539787321819093,0.0842599838548557
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,24224,0.00839573017037742,0.00486468131903278,-0.00113904521492682,0.0179305055556817,0.0843864245138566
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,29589,-0.00362396320655702,0.00210867670237022,-0.00775696954320264,0.000509043130088602,0.0856984380480868
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,28926,0.00447000678149914,0.00260103927713381,-0.000628030201683139,0.00956804376468141,0.0857076976028756
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,29429,-0.00671250736313775,0.00391641776965112,-0.0143886861916539,0.000963671465378448,0.0865501736747937
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,24946,0.00313842935553374,0.00183541987608376,-0.000458993601590439,0.00673585231265792,0.0872922836338921
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,24840,0.00336965266058795,0.0019716433616644,-0.000494768328274271,0.00723407364945017,0.0874527235096585
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24106,-0.00571680732503966,0.00336030856569712,-0.012303012113806,0.000869397463726696,0.0889043549989452
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,24863,0.00403086397843647,0.00237272584201365,-0.000619678671910276,0.00868140662878322,0.0893632498575549
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IKZF2,Zinc finger protein Helios,28792,0.0107392060916317,0.00638504626836128,-0.00177548459435643,0.0232538967776198,0.0925931055283414
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYH4,Myosin-4,24106,-0.00548666513565056,0.00327714622421065,-0.0119098717351034,0.000936541463802312,0.0941002674212758
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAT1,Diamine acetyltransferase 1,24106,-0.00590704492344349,0.00353867996220274,-0.0128428576493609,0.00102876780247388,0.0950750491672007
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,24917,-0.00458639386746846,0.00275901983176817,-0.00999407273773407,0.000821285002797148,0.0964597609640456
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,24224,0.00475744914216695,0.00286559042487669,-0.000859108090591357,0.0103740063749253,0.0968874615475891
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABO,Histo-blood group ABO system transferase,24946,0.0167761364882347,0.0101163318840375,-0.00305187400447884,0.0366041469809483,0.097265055044595
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24106,-0.00437918740110444,0.00264218403052665,-0.00955786810093666,0.00079949329872779,0.0974492360304095
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,24096,0.00584717213687638,0.00353466357256992,-0.00108076846536066,0.0127751127391134,0.0980923501133317
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,28769,0.00755385023122368,0.00457226945572952,-0.00140779790200618,0.0165154983644535,0.0985249130598943
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",24096,0.00975239051839609,0.00590976692004413,-0.00183075264489042,0.0213355336816826,0.0989118551157903
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,24917,-0.00408944103918173,0.00248196927996035,-0.00895410082790401,0.000775218749540553,0.0994351149970861
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLSTN1,Calsyntenin-1,28769,0.00593197226566534,0.00360893843458239,-0.00114154706611614,0.0130054915974468,0.100251399817145
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOA4,Apolipoprotein A-IV,24961,-0.00411307614430747,0.00250355868923848,-0.00902005117521489,0.000793898886599954,0.100417916109296
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24440,0.00743961557786345,0.0045345154294711,-0.00144803466389992,0.0163272658196268,0.100880086943119
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK1,Kallikrein-1,29194,-0.0145842551664404,0.00890065014432131,-0.0320295294493101,0.00286101911642941,0.101315572406303
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEG1,Protein LEG1 homolog,23598,-0.00801721999389539,0.00491947594547297,-0.0176593928470224,0.00162495285923162,0.103180419452496
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK3,Prostate-specific antigen,24933,-0.0101162435334542,0.00622448251517055,-0.0223162292631885,0.00208374219628008,0.104125254781898
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,24106,0.00693863802762541,0.0042801778734976,-0.00145051060442988,0.0153277866596807,0.105007192539013
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,24096,0.00878020483755267,0.00543755070651698,-0.00187739454722061,0.019437804222326,0.106381139632705
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP15,Matrix metalloproteinase-15,24917,0.00556149138539307,0.00344608416289537,-0.00119283357388186,0.012315816344668,0.10657084436077
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCL2,Phosducin-like protein 2,24011,0.00598826117635148,0.00372584003005334,-0.00131438528255307,0.013290907635256,0.108018297760947
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,24106,-0.00572357438242644,0.00356721891887333,-0.0127153234634182,0.00126817469856527,0.108618743852069
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23489,0.00563734576150116,0.00351417463227761,-0.00125043651776295,0.0125251280407653,0.108689270317652
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD109,CD109 antigen,29438,-0.00376130964815626,0.00235725042480973,-0.00838152048078332,0.000858901184470803,0.110581202890264
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF12,Fibroblast growth factor 12,24224,0.00522259718531283,0.00328591364474667,-0.00121779355839064,0.0116629879290163,0.111985504263112
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24961,0.00206894339585982,0.0013080340451958,-0.000494803332723942,0.00463269012444359,0.113726219315216
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,24788,0.00614175279033859,0.00389034220246797,-0.00148331792649862,0.0137668235071758,0.114413549249555
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,24840,-0.00299009048780829,0.00189709519700235,-0.00670839707393289,0.000728216098316315,0.115005936342778
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,24800,0.0162496692651365,0.0103388878354888,-0.0040145508924216,0.0365138894226946,0.116032025474477
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGAX,Integrin alpha-X,24440,0.00589697048099481,0.00376229869095035,-0.00147713495326789,0.0132710759152575,0.117037685023101
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCLN,Nicalin,28926,0.00567622337912609,0.00365501273574548,-0.00148760158293506,0.0128400483411872,0.120434825277276
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD200,OX-2 membrane glycoprotein,29429,0.0028742439038467,0.00185092184329059,-0.000753562909002853,0.00650205071669624,0.120464579056389
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29556,-0.0033882954059538,0.00218291495302178,-0.00766680871387648,0.000890217901968882,0.120627847894465
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDAC8,Histone deacetylase 8,24224,0.00664100001603877,0.0043062602719199,-0.00179927011692424,0.0150812701490018,0.123044533693588
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,24224,0.00809260300086267,0.00528775490687459,-0.00227139661661152,0.0184566026183369,0.125920387374729
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24106,0.00550691668564444,0.00360014664325405,-0.0015493707351335,0.0125632041064224,0.126119791470098
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,29641,-0.00241938246082154,0.0015833909212685,-0.0055228286665078,0.000684063744864716,0.126529308097589
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGN,Secretagogin,28926,-0.00469476095140566,0.00308009768420957,-0.0107317524124564,0.00134223050964509,0.127463528903858
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29213,0.00303969263657646,0.00199569897940159,-0.000871877363050669,0.00695126263620358,0.127739063417007
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMCN2,Hemicentin-2,24338,-0.00614982192590132,0.00404763555751299,-0.0140831876186268,0.00178354376682413,0.128684506302602
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RUVBL1,RuvB-like 1,28792,0.0109577573750513,0.00723057344077325,-0.00321416656886424,0.0251296813189669,0.129662996715957
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,28911,-0.00362037644748402,0.00239689357217684,-0.00831828784895063,0.00107753495398259,0.130940790639767
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,28769,0.00716357984766481,0.00475703921426254,-0.00216021701228978,0.0164873767076194,0.132106286945162
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRR1B,Cornifin-B,24440,0.00902032836859181,0.00601391248025465,-0.0027669400927073,0.0208075968298909,0.133650603001138
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PFDN4,Prefoldin subunit 4,24011,0.00562804333245908,0.00375946665316104,-0.00174051130773655,0.0129965979726547,0.134397983510107
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNF830,Zinc finger protein 830,24788,-0.00832187576227658,0.00556203135335002,-0.0192234572148426,0.00257970569028946,0.13461594815853
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24096,0.00593838236455397,0.0039754881408814,-0.00185357439157358,0.0137303391206815,0.135254276339666
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24800,-0.0180633360771834,0.0121082088042847,-0.0417954253335814,0.00566875317921454,0.135757593160704
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24011,0.0060343843596018,0.00405154670187974,-0.00190664717608249,0.0139754158952861,0.136394515350754
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,29731,-0.00478865154880443,0.00324327293470734,-0.0111454665008308,0.00156816340322196,0.139823697528932
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,29815,-0.00326238683655501,0.00220970752542356,-0.00759341358638519,0.00106863991327516,0.139850187245461
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28911,0.00321106731546164,0.00218997322013254,-0.00108128019599813,0.00750341482692141,0.142588700134391
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,24946,0.0033031858145766,0.00225370473688759,-0.00111407546972307,0.00772044709887628,0.142751016061013
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOH,Beta-2-glycoprotein 1,29438,0.00366364547055646,0.00251053228573778,-0.0012569978094896,0.00858428875060251,0.144490413667742
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,28792,0.00325134595099886,0.00222876331539042,-0.00111703014716638,0.00761972204916409,0.144627861607315
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,29689,-0.00296809341181096,0.00203513697974401,-0.00695696189210921,0.0010207750684873,0.144734184878139
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TEX101,Testis-expressed protein 101,24190,0.0051925680800139,0.00356276417881761,-0.00179044971046862,0.0121755858704964,0.145003842981086
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24190,-0.00645929570270952,0.00443315541867771,-0.0151482803233178,0.00222968891789879,0.145117646148672
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SKIV2L,Helicase SKI2W,24106,0.00406835420743279,0.00281020735620813,-0.00143965221073514,0.00957636062560072,0.147712287948421
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GKN1,Gastrokine-1,28109,0.00283954805027969,0.0019633110027143,-0.00100854151504034,0.00668763761559971,0.148102610962468
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PI16,Peptidase inhibitor 16,24946,-0.00248698508963043,0.00172043725481154,-0.00585904210906105,0.000885071929800179,0.14831488384355
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RELB,Transcription factor RelB,24224,0.00497245749498746,0.00346631726245851,-0.00182152433943123,0.0117664393294061,0.151440457540088
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL36A,Interleukin-36 alpha,24224,0.00584767199072358,0.00408772153185737,-0.00216426221171686,0.013859606193164,0.152573398348982
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",24788,0.0043122219053867,0.00304222358127873,-0.00165053631391961,0.010274980124693,0.156361857631994
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MBL2,Mannose-binding protein C,24605,-0.0107244758797063,0.00756975465647205,-0.0255611950063915,0.00411224324697895,0.156567697198647
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYBB2,Beta-crystallin B2,24840,0.00683982609063717,0.00485108436054992,-0.00266829925604067,0.016347951437315,0.158564558485714
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCIN,Adseverin,24096,0.00728010846380463,0.00517112513221736,-0.0028552967953414,0.0174155137229507,0.159191838730041
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24106,-0.00500515310881171,0.00356540104507508,-0.0119933391571589,0.00198303293953545,0.160387701102127
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCLRE1C,Protein artemis,24011,-0.0030583455545505,0.00218457092515812,-0.00734010456786042,0.00122341345875942,0.161533613091439
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,24011,0.00547385459030434,0.0039116928917454,-0.00219306347751664,0.0131407726581253,0.161718898816715
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,24788,0.0050660203495763,0.00365430834806183,-0.00209642401262488,0.0122284647117775,0.1656633922221
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL25,Interleukin-25,23908,0.00336322111495012,0.00242925275896138,-0.00139811429261418,0.00812455652251443,0.166228329271873
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOP1,DNA topoisomerase 1,24800,-0.010988785815191,0.0079503457513689,-0.0265714634878741,0.00459389185749199,0.166929785511859
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACE,Angiotensin-converting enzyme,24946,-0.00253329770309886,0.00183633234751091,-0.00613250910422025,0.00106591369802253,0.167740061201553
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,24096,-0.00332502933193579,0.00241472479141615,-0.00805788992311144,0.00140783125923986,0.168531027470322
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUOX2,Dual oxidase 2,28911,0.0068393418450216,0.00499105875493161,-0.00294313331464436,0.0166218170046876,0.170598039448715
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,24106,-0.00484244809783031,0.00353443443029099,-0.0117699395812006,0.00208504338554003,0.170675565208957
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",24235,0.00813497797093892,0.00595410117184524,-0.00353506032587775,0.0198050162677556,0.171863325626889
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,28926,0.0037603070877703,0.00275705129647025,-0.0016435134533114,0.00916412762885199,0.172613674717254
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL2,Interleukin-2,28926,-0.00300856066465199,0.00220591205866744,-0.00733214829964017,0.00131502697033618,0.172621472955391
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,24440,0.00417024205365574,0.00306651748058072,-0.00184013220828248,0.010180616315594,0.173865357060925
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",24106,-0.00455558967423557,0.00335633359687319,-0.011134003524107,0.00202282417563589,0.174695018112499
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,24440,0.00631352174326808,0.00465364284606843,-0.00280761823502604,0.0154346617215622,0.174894248140672
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,24440,0.00351152333335529,0.00258874842024781,-0.00156242357033042,0.00858547023704101,0.174966662283559
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DKK3,Dickkopf-related protein 3,29815,-0.00278314163865705,0.00205375817545193,-0.00680850766254283,0.00124222438522872,0.175381400114998
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PXDNL,Peroxidasin-like protein,24788,0.00549765916012316,0.0040614991880215,-0.00246287924839898,0.0134581975686453,0.175875286771799
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAPN3,Calpain-3,24788,-0.00360413705283638,0.00266288935113077,-0.0088234001810527,0.00161512607537993,0.175918331599386
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,24011,-0.00538157029401938,0.00398949589532683,-0.01320098224886,0.00243784166082122,0.177370601714401
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VCAN,Versican core protein,29689,0.00281009393981352,0.00209678691064683,-0.00129960840505427,0.00691979628468132,0.180193673816052
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PALLD,Palladin,24224,0.00375081733511825,0.00280259252849928,-0.00174226402074035,0.00924389869097684,0.180798702410929
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TG,Thyroglobulin,24788,0.0104707255163488,0.00783635740985701,-0.0048885350069709,0.0258299860396686,0.1815051597583
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,24096,0.00794814482365599,0.00596191147588922,-0.00373720166908688,0.0196334913163989,0.182493954437255
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,24011,0.00312819949831973,0.00234878713135856,-0.00147542327914305,0.00773182227578251,0.182926701118449
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24096,-0.00570267330611022,0.00432054550500149,-0.0141709424959131,0.00276559588369269,0.186882090367277
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,28329,0.00439901945878793,0.00334203761517652,-0.00215137426695806,0.0109494131845339,0.188094532273016
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF9,Fibroblast growth factor 9,23965,0.0037586247823048,0.00286572800536634,-0.00185820210821323,0.00937545167282282,0.189675252685898
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCUN1D1,DCN1-like protein 1,24096,0.00691150717631044,0.00527414942137435,-0.00342582568958328,0.0172488400422042,0.190056270122662
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,28769,0.00467151965321332,0.00356720719716086,-0.00232020645322196,0.0116632457596486,0.190350655352511
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL24,Interleukin-24,28926,0.00445120793323436,0.003405077730041,-0.002222744417646,0.0111251602841147,0.191146184944153
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPT1,Translationally-controlled tumor protein,28926,0.00593284528997908,0.00456136977702552,-0.00300743947299094,0.0148731300529491,0.193381166701282
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,29561,0.00249252653606855,0.00192422772169337,-0.00127895979845045,0.00626401287058755,0.195213552490573
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,24440,-0.00757756651949103,0.0058587554362806,-0.019060727174601,0.00390559413561894,0.19589369983178
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,24054,0.00311427109788633,0.00241551493170053,-0.0016201381682467,0.00784868036401937,0.197313740599932
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,24106,0.00334981493373985,0.00263325870216709,-0.00181137212250764,0.00851100198998734,0.203343591001038
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NLGN1,Neuroligin-1,24190,0.00608301651280968,0.00481224809453547,-0.00334898975247985,0.0155150227780992,0.206217234900194
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF6,Fibroblast growth factor 6,24224,0.00363066619688043,0.00289055415921925,-0.0020348199551893,0.00929615234895016,0.209111763652327
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,24106,-0.00338090362981701,0.00269813596098688,-0.0086692501133513,0.00190744285371728,0.21019908343806
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,24440,0.00646089175078329,0.00516201315541161,-0.00365665403382347,0.01657843753539,0.210719442143107
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACHE,Acetylcholinesterase,24376,0.00288602982706589,0.00231922732872152,-0.0016596557372283,0.00743171539136007,0.213366997120605
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,24190,-0.00326527151092987,0.00265897995064308,-0.00847687221419029,0.00194632919233056,0.219452692971417
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MLLT1,Protein ENL,24011,0.00592731029381129,0.0048581078139556,-0.00359458102154169,0.0154492016091643,0.222444189974507
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOX2,Transcription factor SOX-2,24822,0.00203801221722923,0.00167118124764299,-0.00123750302815103,0.00531352746260949,0.222664552461966
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,24440,0.00571457808320814,0.00470873924918251,-0.00351455084518958,0.0149437070116059,0.224908012192901
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INSL4,Early placenta insulin-like peptide,24788,0.00437391624121673,0.00360822819800418,-0.00269821102687146,0.0114460435093049,0.225445056347753
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHH,Sonic hedgehog protein,24224,-0.00363760217720597,0.00301752874311055,-0.00955195851370265,0.00227675415929072,0.228025792414586
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM171A2,Protein FAM171A2,24863,0.0133809909100621,0.0111128392415377,-0.00840017400335175,0.035162155823476,0.228561662729326
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24440,0.00416442047938689,0.00346525277309921,-0.00262747495588756,0.0109563159146613,0.2294661310537
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24096,0.00455601986177307,0.003822038764786,-0.00293517611720749,0.0120472158407536,0.233257638855628
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBM19,Probable RNA-binding protein 19,24106,-0.00399600863351767,0.00335816387700957,-0.0105780098324564,0.00258599256542108,0.234082273620923
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OTOA,Otoancorin,24096,0.0044932572537844,0.00378065081699098,-0.00291681834751792,0.0119033328550867,0.234653015737834
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD177,CD177 antigen,29408,0.0105411480799546,0.00894351748818537,-0.00698814619688872,0.0280704423567979,0.23855285131824
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,29390,-0.00240560843681224,0.00204124794946077,-0.00640645441775536,0.00159523754413087,0.238607321621332
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,24235,-0.00502613848978097,0.00427608739024415,-0.0134072697746595,0.00335499279509756,0.239843904798897
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF3,Fibroblast growth factor 3,24224,0.00245825265679491,0.00210744803746319,-0.00167234549663294,0.00658885081022276,0.243440228480912
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAP1,Antigen peptide transporter 1,24440,0.00490023447625359,0.00421709706417161,-0.00336527576952277,0.01316574472203,0.245249931042395
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,29344,-0.00193699306395079,0.00167501943078316,-0.00522003114828578,0.0013460450203842,0.247526855394302
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A3,Protein S100-A3,24788,0.00360141024674712,0.00311688877094689,-0.00250769174430879,0.00971051223780303,0.247917193640032
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,24224,0.00438725476103711,0.0038215371637134,-0.00310295807984115,0.0118774676019154,0.250965853971888
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LXN,Latexin,29112,-0.00536564019120537,0.00469498837052815,-0.0145678173974405,0.00383653701502979,0.253112689819938
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,24096,0.00473434950676036,0.00415512582877303,-0.00340969711763479,0.0128783961311555,0.254547775518628
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRTG,Protogenin,29720,0.0019807819749374,0.0017403488456845,-0.00143030176260422,0.00539186571247901,0.255066087625699
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,24863,0.00603971567729925,0.00531016790343043,-0.00436821341342439,0.0164476447680229,0.255387527205687
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TJP3,Tight junction protein ZO-3,24096,-0.00342093145166996,0.00301496215392302,-0.00933025727335908,0.00248839437001917,0.256532642614385
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,24096,-0.00229851580522309,0.00203287045434361,-0.00628294189573657,0.00168591028529039,0.25820316683877
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAGE2A,G antigen 2A,24011,0.0050217483902815,0.00446351628744554,-0.00372674353311176,0.0137702403136748,0.260572512458328
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G1B,Phospholipase A2,29782,0.00333836243446377,0.00300711013855383,-0.00255557343710174,0.00923229830602927,0.266940623301319
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC4A1,Band 3 anion transport protein,24933,-0.00361418221750614,0.00327377047579195,-0.0100307723500584,0.00280240791504608,0.269611799621147
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,24376,0.00248350512911199,0.00226025459906592,-0.00194659388505722,0.0069136041432812,0.271878258795096
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,24096,0.00355775670705325,0.00324695024548738,-0.00280626577410202,0.00992177918820852,0.273211154788462
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,24800,0.0038412149945476,0.00351186697057709,-0.0030420442677835,0.0107244742568787,0.274061465377497
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REST,RE1-silencing transcription factor,24011,-0.00268446874893188,0.00246248954163413,-0.00751094825053477,0.00214201075267101,0.275660564831709
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,24235,0.00319722886018279,0.00294063192677045,-0.00256640971628729,0.00896086743665287,0.276933132178333
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24190,0.00425399317456644,0.00391373486261804,-0.00341692715616492,0.0119249135052978,0.277074366635718
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,29588,-0.00183762415400688,0.00169330266317963,-0.00515649737383896,0.00148124906582519,0.277828305104478
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,24190,0.00317766861961868,0.00293556926797866,-0.00257604714561949,0.00893138438485685,0.279054088137662
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMEM25,Transmembrane protein 25,24863,-0.00343067439321368,0.00316950722968321,-0.00964290856339278,0.00278155977696542,0.279085364105352
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,24106,0.00854967171124728,0.00795448187058267,-0.00704111275509475,0.0241404561775893,0.282464089630136
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNC,Tenascin,29589,-0.00355099706378989,0.00332979014373172,-0.0100773857455041,0.00297539161792427,0.28623679575366
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCAN,Brevican core protein,29213,0.00252621653355882,0.00237420498288299,-0.00212722523289183,0.00717965830000948,0.287325586435986
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OMP,Olfactory marker protein,24096,0.00369132285962308,0.00347475621018254,-0.00311919931233469,0.0105018450315809,0.288098499177805
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,24224,-0.00314686501269931,0.0029642297401282,-0.00895675530335058,0.00266302527795197,0.288421970985206
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,24190,0.00516763877274372,0.00489110887721736,-0.0044189346266023,0.0147542121720897,0.290733384401711
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,29152,-0.00207433868880296,0.00196778086388273,-0.00593118918201312,0.0017825118044072,0.291822408869023
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSLNL,Mesothelin-like protein,24190,-0.00276263125820693,0.00265065981185139,-0.00795792448943565,0.0024326619730218,0.297309519407368
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNW1,Interferon omega-1,24106,-0.00262352833479337,0.00253004259481284,-0.00758241182062654,0.00233535515103981,0.29976944466669
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KHDC3L,KH domain-containing protein 3,24011,-0.00491718219300118,0.00474674302473518,-0.0142207985214821,0.00438643413547977,0.30025617984172
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LCN15,Lipocalin-15,24863,0.00450574712377706,0.00436755647354285,-0.00405466356436692,0.013066157811921,0.302250710365667
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNL2,Interferon lambda-2,24096,0.00445984192283325,0.00435779423589678,-0.00408143477952444,0.0130011186251909,0.306120872842848
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,29525,0.00350013590041203,0.00343476624486107,-0.00323200593951566,0.0102322777403397,0.308196241373676
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRR4,Proline-rich protein 4,24198,0.00498452813761834,0.00489167956309309,-0.00460316380604412,0.0145722200812808,0.308222218544577
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSTN,Osteocrin,24190,0.0029925798005014,0.00294186670129832,-0.00277347893404331,0.00875863853504611,0.309050208349588
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNPO1,Transportin-1,24440,0.00249352964470317,0.00248786752020576,-0.00238269069490011,0.00736974998430646,0.316220290114242
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL31,Interleukin-31,24224,0.00400384218017193,0.00399519435661746,-0.00382673875879829,0.0118344231191421,0.316274139170071
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,24011,0.00445833340033457,0.00444999037980623,-0.00426364774408565,0.0131803145447548,0.316414147703476
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPSG1,Tryptase gamma,24224,0.00187030901005462,0.00187698093379427,-0.00180857362018216,0.0055491916402914,0.319043744334963
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24096,-0.00319029269224877,0.00320731698300966,-0.0094766339789477,0.00309604859445016,0.319896058323974
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24106,-0.00463640883538408,0.00470320911501481,-0.0138546987008131,0.00458188103004495,0.324242700753497
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,24096,-0.00369480008518122,0.00374952101852732,-0.0110438612814948,0.00365426111113232,0.324434639095812
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,23970,0.00334820207785189,0.00340127344890302,-0.00331829388199803,0.0100146980377018,0.324930482320828
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA4,Carbonic anhydrase 4,29815,-0.00162952070324229,0.00165888107496558,-0.00488092761017484,0.00162188620369025,0.325959507761127
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRG2,Bone marrow proteoglycan,24933,-0.00356100530005466,0.00362624195157916,-0.0106684395251498,0.0035464289250405,0.326104531612505
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB1,Integrin beta-1,29469,0.00148566636822582,0.00151610947337711,-0.0014859081995933,0.00445724093604495,0.32713353654178
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,28769,0.00431036502216855,0.00441275293588744,-0.00433863073217083,0.0129593607765079,0.328677745133701
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24106,0.00427803628486683,0.00439289796332677,-0.00433204372325364,0.0128881162929873,0.33013937568257
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,24224,-0.00411692834864605,0.00426197261949712,-0.0124703946828604,0.00423653798556831,0.334069938751956
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGFR,Epidermal growth factor receptor,29815,-0.00109979412904537,0.00114369976068775,-0.00334144565999336,0.00114185740190263,0.336252908160824
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24190,-0.00346873264402815,0.00360916816643126,-0.0105427022502334,0.00360523696217712,0.336516917806861
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CORO6,Coronin-6,24096,-0.00253280540386494,0.0026450677234348,-0.00771713814179716,0.00265152733406727,0.338295366875199
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,29033,0.0114670756135112,0.0120046841310671,-0.0120621052833804,0.0349962565104028,0.339476043325744
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24106,-0.00225556566964896,0.00236294166118169,-0.00688693132556508,0.00237579998626716,0.339810670643425
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLI2,Zinc finger protein GLI2,24224,-0.00223267495052311,0.00234204204737618,-0.00682307736338042,0.0023577274623342,0.340446253788739
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FZD10,Frizzled-10,24190,0.00403584409440595,0.00423707278901421,-0.0042688185720619,0.0123405067608738,0.340849128828982
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24190,0.00519581515063023,0.00546886814721115,-0.00552316641790363,0.0159147967191641,0.342085477643394
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LMOD1,Leiomodin-1,24863,-0.0023560489186788,0.0024880404860083,-0.00723260827125507,0.00252051043389747,0.343673674899185
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITM2A,Integral membrane protein 2A,29429,0.00398762657211047,0.00421153644427628,-0.00426698485867103,0.012242238002892,0.343731069819853
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,24224,-0.00811990015446404,0.00862699198570801,-0.0250288044464517,0.00878900413752366,0.346601356966848
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,24224,0.00310399514753775,0.00330942416023628,-0.00338247620652537,0.00959046650160087,0.348291768676692
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,24190,0.0034054225995277,0.00363438021232624,-0.00371796261663173,0.0105288078156871,0.348766737359137
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDAC9,Histone deacetylase 9,24096,0.00427489489458303,0.00456380355547088,-0.00467016007413989,0.013219949863306,0.348924532555301
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNF174,Zinc finger protein 174,24224,0.00246340526278184,0.00265459750773671,-0.00273960585238211,0.0076664163779458,0.353428784662257
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYTH3,Cytohesin-3,24011,0.00477542457768499,0.00515031090580516,-0.00531918479769313,0.0148700339530631,0.35382635292814
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24788,0.00289747436567314,0.00313132452162969,-0.00323992169672107,0.00903487042806734,0.354808963251898
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24106,0.00340452017965451,0.00368500635123131,-0.00381809226875887,0.0106271326280679,0.355555716865345
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,24106,-0.00318652420499685,0.00348522179938665,-0.0100175589317947,0.00364451052180097,0.360570503853325
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,28792,0.00195282269431935,0.002138204400291,-0.002238057930251,0.0061437033188897,0.361092282218053
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK4,Kallikrein-4,29720,-0.0040107244392106,0.00439422406302788,-0.0126234036027452,0.00460195472432405,0.361393847285635
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24106,-0.00275901988771771,0.00304284054799014,-0.00872298736177839,0.00320494758634296,0.364561257365634
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,24096,0.00279665339367891,0.00308618247171728,-0.00325226425088697,0.00884557103824479,0.364846813636163
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSCA,Prostate stem cell antigen,24800,0.0164886812438022,0.0182092799618569,-0.0192015074814374,0.0521788699690418,0.365204178459287
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RRP15,RRP15-like protein,24096,0.00578136185926522,0.00640711059617776,-0.00677657490924319,0.0183392986277736,0.366887820706927
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,24011,-0.00312769629303169,0.00347065201977394,-0.00993017425178862,0.00367478166572523,0.367499506564898
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,24190,0.004914444673213,0.00550140579219964,-0.0058683106794983,0.0156972000259243,0.371701646416456
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,24440,0.00393883091761965,0.00442554191288967,-0.0047352312316441,0.0126128930668834,0.373462686808676
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,24096,-0.00258263877197868,0.00290286944517278,-0.00827226288451734,0.00310698534055997,0.373644054384278
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MET,Hepatocyte growth factor receptor,29502,-0.00122502640561333,0.00138010985624282,-0.00393004172384926,0.00147998891262259,0.374747247774244
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29689,0.00290534872038699,0.0032806277696471,-0.00352468170812133,0.00933537914889531,0.37583621797803
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,24096,0.0024864894626327,0.00282664377739842,-0.0030537323410682,0.0080267112663336,0.379051535861944
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,24224,0.0025653423958855,0.00292353114324149,-0.00316477864486783,0.00829546343663882,0.380234259753111
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,24190,-0.00253126680059671,0.00289721975552085,-0.00820981752141757,0.00314728392022415,0.382296740497636
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BMP4,Bone morphogenetic protein 4,29164,-0.0028200425923536,0.00323004943150918,-0.00915093947811159,0.00351085429340439,0.382634928224888
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBM25,RNA-binding protein 25,24011,-0.00284365785095664,0.00326249168230937,-0.00923814154828301,0.00355082584636973,0.383423624887427
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24800,-0.00423383024771181,0.00494661927561514,-0.0139292040279175,0.00546154353249387,0.392059265384773
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28296,-0.00223359748264406,0.00263754874960496,-0.00740319303186979,0.00293599806658167,0.397088156785083
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24011,-0.00261192307716672,0.00310766941671268,-0.00870295513392357,0.00347910897959013,0.40064965307289
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29360,-0.0038891166805676,0.00465549957764541,-0.0130138958527526,0.00523566249161739,0.403509929900269
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYOC,Myocilin,29438,0.00266525475840579,0.00319062123440092,-0.00358836286102001,0.00891887237783158,0.403532869860905
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LMOD2,Leiomodin-2,24096,0.00370488042646625,0.00445830346630715,-0.00503339436749576,0.0124431552204283,0.405978035687911
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTF,Ciliary neurotrophic factor,24096,-0.0019912251293527,0.00240182661907141,-0.00669880530273266,0.00271635504402726,0.407086506107988
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,24190,0.00246327160857442,0.00298520439361131,-0.00338772900290375,0.00831427222005258,0.409288834334762
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24011,0.0048377270485455,0.00589349114968979,-0.00671351560484648,0.0163889697019375,0.411734567641184
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD93,Complement component C1q receptor,28348,0.0018028652471914,0.00219828885574538,-0.00250578091006954,0.00611151140445234,0.412153410414674
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPTN,Neuroplastin,28792,0.00463358985109396,0.00570502129827759,-0.00654825189353011,0.015815431595718,0.416686458492406
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH22,Cadherin-22,24440,-0.00161603220695499,0.00200818031829271,-0.0055520656308087,0.00232000121689872,0.420986423226642
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TUBB3,Tubulin beta-3 chain,24096,-0.00158024019404143,0.00197997857338776,-0.00546099819788143,0.00230051780979858,0.424814676828499
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,29815,-0.00160684195564202,0.00201444398219557,-0.00555515216074535,0.0023414682494613,0.425074013841824
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,24235,0.0146826748025139,0.0184920533321109,-0.0215617497284234,0.0509270993334512,0.427203699437053
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,24096,-0.00240203818776519,0.0030260614884612,-0.00833311870514915,0.00352904232961876,0.427329203338855
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOS,Proto-oncogene c-Fos,23965,0.00196579797613898,0.00249243362886267,-0.00291937193643185,0.00685096788870981,0.43029152172937
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RYR1,Ryanodine receptor 1,24106,-0.00187616905290399,0.00239455170034992,-0.00656949038558984,0.00281715227978186,0.433331990801121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24096,0.00180525234939518,0.00230682672442037,-0.00271612803046873,0.0063266327292591,0.433887623930532
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGLON5,IgLON family member 5,24011,0.00511813881817999,0.0065541863730183,-0.00772806647293587,0.0179643441092959,0.43487128759276
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,24440,0.00435452233416714,0.00559031187811938,-0.00660248894694685,0.0153115336152811,0.43602210002622
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL21R,Interleukin-21 receptor,24224,0.00300308634251345,0.00386344868147562,-0.00456927307317877,0.0105754457582057,0.436985163761972
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TTN,Titin,24106,-0.00366316328438462,0.00471324155836067,-0.0129011167387715,0.00557479017000229,0.43704441522547
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKAP12,A-kinase anchor protein 12,24376,-0.00117248189157113,0.00151246524150481,-0.00413691376492055,0.00179194998177829,0.438221654553662
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24096,0.00267719621111101,0.00345693195806649,-0.00409839042669932,0.00945278284892134,0.438676559811266
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEB,Nebulin,24106,0.00205512686566296,0.00266088466269821,-0.00316020707322553,0.00727046080455146,0.439916382873989
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,24011,0.00221153708536516,0.00286432264781892,-0.00340253530435992,0.00782560947509025,0.440064135393766
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PMCH,Pro-MCH,24106,0.00452499769537367,0.00587170779545568,-0.00698354958371947,0.0160335449744668,0.440925397868939
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,24011,0.00429331681183446,0.00560147916255858,-0.00668558234678036,0.0152722159704493,0.443409430107366
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMY2B,Alpha-amylase 2B,27580,0.00260995291604331,0.00341682811739228,-0.00408703019404556,0.00930693602613218,0.444961646501653
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP350,Centrosome-associated protein 350,24011,0.00198089675089251,0.00259782538328942,-0.00311084100035476,0.00707263450213978,0.44575653087665
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24011,0.00336282445273213,0.0044813757370592,-0.0054206719919039,0.0121463208973682,0.45302117494515
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24106,0.00364467332669284,0.00486885272306098,-0.00589827801050668,0.0131876246638924,0.454124192347577
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD82,CD82 antigen,24440,-0.00217835504532719,0.002922877179171,-0.00790719431650234,0.00355048422584797,0.456111058458753
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAND5,DAN domain family member 5,24224,0.0028400324324018,0.00382057291862891,-0.00464829048811086,0.0103283553529145,0.457275507282398
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,29438,0.00174967738952022,0.00236864421997628,-0.00289286528163328,0.00639222006067372,0.460105359055048
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCP11,T-complex protein 11 homolog,24440,-0.0030546197985142,0.00417169968095917,-0.0112311511731942,0.00512191157616577,0.464038712110216
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24096,-0.00162710866056987,0.00224879334444038,-0.00603474361567302,0.00278052629453328,0.469350649024006
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLHL41,Kelch-like protein 41,24863,0.00252072386673351,0.00348790863883384,-0.00431557706538082,0.00935702479884784,0.469868851315647
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24106,0.0043694438877162,0.00605772797035983,-0.00750370293418908,0.0162425907096215,0.470731478935992
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24224,0.00147662657603243,0.00207387685483987,-0.00258817205945372,0.00554142521151858,0.476463797439158
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,24011,-0.00232569908045688,0.00328802295919519,-0.00877022408047945,0.00411882591956569,0.479371734144531
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",24863,0.00180494502536185,0.00256230454420681,-0.0032171718812835,0.00682706193200719,0.481176286767299
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF7,Fibroblast growth factor 7,24011,0.00388739493216619,0.00557682323143108,-0.00704317860143872,0.0148179684657711,0.485770367583594
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,24106,0.00481469132848477,0.00691468643009557,-0.00873809407450256,0.0183674767314721,0.486248128131414
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH6,Cadherin-6,29473,0.00186662792830886,0.0026809660283124,-0.00338806548718346,0.00712132134380117,0.486276527909352
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA11,Serpin A11,29815,-0.00197783887758838,0.00285750457892453,-0.00757854785228046,0.00362287009710371,0.488844773414953
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRR5,Proline-rich protein 5,24224,0.00231294950061958,0.00334488441431944,-0.00424302395144653,0.00886892295268569,0.489265161795997
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,24106,0.00352725650166226,0.00511470160721277,-0.00649755864847477,0.0135520716517993,0.490432944403604
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHGA,Chromogranin-A,24933,0.00416802202128498,0.00614523320534287,-0.00787663506118703,0.016212679103757,0.497617677540999
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRN1,Neuritin,24863,-0.00169628354470195,0.00250632689524257,-0.00660868425937738,0.00321611716997348,0.498538777825585
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENG,Endoglin,29815,0.000803083221207891,0.0012013278593387,-0.00155151938309595,0.00315768582551174,0.503822024835539
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24096,0.00279668335666827,0.00419098256339054,-0.00541764246757719,0.0110110091809137,0.504580719727971
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,24190,0.00310685110073723,0.00470252745184288,-0.00611010270487481,0.0123238049063493,0.508825857657662
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GJA8,Gap junction alpha-8 protein,24011,0.00278843792345845,0.00436888118883629,-0.00577456920666069,0.0113514450535776,0.523317118463502
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAG,Myelin-associated glycoprotein,24190,0.00212659938465179,0.00333831349689422,-0.00441649506926088,0.00866969383856447,0.524112595482694
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,29589,-0.00259353155357563,0.00407255220581086,-0.0105757338769649,0.00538867076981365,0.524239210843946
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPLX2,Complexin-2,24011,-0.0013650353831047,0.00216145116203269,-0.00560147966068877,0.00287140889447938,0.527695782399336
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HCG22,Protein PBMUCL2,24106,-0.0024542641425307,0.0038915235456233,-0.0100816502919524,0.00517312200689096,0.528262807002979
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,29473,-0.00124495368138607,0.0019903680039412,-0.00514607496911082,0.00265616760633867,0.531654882840041
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,28792,-0.00143682075523526,0.00231850895070855,-0.00598109829862403,0.00310745678815351,0.53544864618694
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP13,Collagenase 3,28769,-0.00141069505362425,0.0022877384626047,-0.00589466244032945,0.00307327233308095,0.53748169825752
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24190,-0.00204976669966195,0.00333057570514125,-0.0085776950817388,0.00447816168241489,0.538270532796501
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NGF,Beta-nerve growth factor,29213,0.000516556616541512,0.000849669581701812,-0.00114879576359404,0.00218190899667706,0.543225369043495
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL9,Interleukin-9,24440,0.00238967059239891,0.00398877709614876,-0.00542833251605266,0.0102076737008505,0.549112721779595
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BEX3,Protein BEX3,24011,-0.00198579726320123,0.00331679961821725,-0.00848672451490705,0.00451512998850459,0.549372710180647
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,24096,-0.00263778071625369,0.00442148212564401,-0.0113038856825159,0.00602832425000857,0.550791485499381
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA8,Carbonic anhydrase-related protein,24224,0.00113657008590743,0.00191172104214666,-0.00261040315670003,0.00488354332851489,0.552165136521054
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PITHD1,PITH domain-containing protein 1,23965,0.00332507436915804,0.00560316824455811,-0.00765713539017586,0.0143072841284919,0.552900663775628
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29082,0.0024596834031266,0.0041515000293501,-0.00567725665439961,0.0105966234606528,0.553533388369104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,24190,0.0015098333946899,0.00257777451788245,-0.0035426046603597,0.0065622714497395,0.558074555220718
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,24800,0.00206976911988867,0.00353516126749829,-0.00485914696440798,0.00899868520418533,0.558229789445915
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CX3CL1,Fractalkine,29213,-0.00136835024909362,0.00235897159770719,-0.00599193458059971,0.00325523408241247,0.561877150869401
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,24106,-0.00161255163342296,0.0027945725200204,-0.00708991377266295,0.00386481050581703,0.563924713789739
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,24715,-0.00112243878569303,0.00196859768697968,-0.00498089025217321,0.00273601268078714,0.568566401341634
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,24096,0.00240504130259417,0.00422579783539538,-0.00587752245478078,0.0106876050599691,0.569271144103191
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,24190,0.00261389477026434,0.0046299472377572,-0.00646080181573978,0.0116885913562685,0.572376588841019
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,24106,0.00278966203287312,0.00496190077642661,-0.00693566348892303,0.0125149875546693,0.573973813964395
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NLGN2,Neuroligin-2,24096,-0.00186238458864594,0.00334524803833112,-0.00841907074377492,0.00469430156648305,0.577720225919866
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,29344,0.00250248542994507,0.00458888025871892,-0.00649171987714402,0.0114966907370342,0.585526022460488
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ISM2,Isthmin-2,24933,0.00167678531373852,0.00307837147160153,-0.00435682277060048,0.00771039339807751,0.585965549613374
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,24224,0.00345160015697421,0.00636789209900881,-0.00902946835708306,0.0159326686710315,0.587801572753238
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24190,-0.00119736136275483,0.00223163716628416,-0.00557137020867178,0.00317664748316213,0.591590720347503
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EVI2B,Protein EVI2B,24011,0.00152204935391682,0.00288572323384144,-0.00413396818441241,0.00717806689224604,0.597892108443567
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA9,Carbonic anhydrase 9,29720,-0.00164942286381462,0.00319361043586788,-0.00790889931811566,0.00461005359048642,0.605525902791855
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPGN,Epigen,24788,-0.00173329827848162,0.00336807934808005,-0.00833473380071852,0.00486813724375528,0.60681959063141
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COMMD9,COMM domain-containing protein 9,24788,-0.00142477162472515,0.00276881031327469,-0.00685163983874355,0.00400209658929325,0.606851837661838
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29589,0.00156238257036744,0.0030495741873387,-0.00441478283681642,0.0075395479775513,0.608425223128005
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24788,-0.00274785386125755,0.00538004120588239,-0.013292734624787,0.00779702690227193,0.609530959928529
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24190,-0.00175346640170209,0.00344690741535594,-0.00850940493579974,0.00500247213239555,0.610962161386226
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,24788,0.00161654803087644,0.00318825619164273,-0.00463243410474331,0.00786553016649619,0.612136852882627
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,24106,-0.00200913038576424,0.00398087910710176,-0.00981165343568369,0.00579339266415521,0.613777582716701
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,24096,0.00272070188385426,0.00541906326260127,-0.00790066211084423,0.0133420658785527,0.615628999997053
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPHS2,Podocin,24224,-0.00362854434556056,0.00725177353864094,-0.0178420204812968,0.0105849317901757,0.616821604734681
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MUCL3,Mucin-like protein 3,24011,-0.00153246076270482,0.00307921725340616,-0.00756772657938089,0.00450280505397125,0.618715101266559
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UPK3A,Uroplakin-3a,24096,0.00170501437066593,0.00346669590277055,-0.00508970959876434,0.00849973834009621,0.622846186631258
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STEAP4,Metalloreductase STEAP4,24096,0.00253596334761838,0.00521488467494749,-0.0076852106152787,0.0127571373105155,0.626763671647057
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCN,Decorin,28911,0.00077233741467298,0.00160041320824984,-0.00236447247349671,0.00390914730284267,0.629393196931646
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24011,0.00190014882931009,0.00403130748665046,-0.0060012138445248,0.00980151150314499,0.637396509246563
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,24917,0.000867860425004513,0.00186084695915602,-0.00277939961494128,0.00451512046495031,0.640948134836063
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASQ2,Calsequestrin-2,24106,0.00157566647569241,0.00343165658580569,-0.00515038043248674,0.00830171338387156,0.6461261274467
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,24190,0.00116389859969142,0.00255136089213393,-0.00383676874889109,0.00616456594827393,0.648259349020907
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,24011,0.00207472302643198,0.00462828306571985,-0.00699671178237892,0.0111461578352429,0.653961994357092
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,24106,-0.00109626294768146,0.00247809568664925,-0.005953330493514,0.00376080459815108,0.658217350999622
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24933,-0.000783335413249311,0.00177892330387802,-0.00427002508885024,0.00270335426235161,0.659692932608213
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AOC3,Membrane primary amine oxidase,29589,-0.000926576100309801,0.00210767912763366,-0.00505762719047177,0.00320447498985217,0.660216182895292
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,24440,0.00261687990693823,0.00598016743513054,-0.00910424826591763,0.0143380080797941,0.661685155052727
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPAN7,Tetraspanin-7,24096,0.00289680438421982,0.00663012491797912,-0.0100982404550193,0.0158918492234589,0.662176543534956
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24106,0.000785259773662921,0.00181663713838332,-0.00277534901756838,0.00434586856489423,0.665556242729086
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPO,Lactoperoxidase,28447,0.00180261112567201,0.00420665536006866,-0.00644243338006257,0.0100476556314066,0.668280118066247
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMA1,Laminin subunit alpha-1,24106,-0.00160930413464007,0.00379399665620494,-0.00904553758080174,0.00582692931152161,0.671444746233502
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,24440,0.00159909170975846,0.00379470646193918,-0.00583853295564233,0.00903671637515926,0.67346626421149
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24235,-0.00117023571701349,0.00282034083546418,-0.00669810375452327,0.0043576323204963,0.678198978471615
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28792,-0.00102156348217821,0.00247638724019281,-0.00587528247295612,0.00383215550859969,0.679960149431148
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,24190,-0.00124098644161235,0.00303219475775496,-0.00718408816681207,0.00470211528358738,0.682345132006483
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EVPL,Envoplakin,24440,-0.000962955317405059,0.00238487900227983,-0.00563731816187352,0.0037114075270634,0.686381470553711
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBLN1,Cerebellin-1,24096,0.0027150149989339,0.00672502489185451,-0.0104660337891009,0.0158960637869687,0.686423533207372
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",24011,-0.00134433879151691,0.00342973764743969,-0.0080666245804987,0.00537794699746487,0.695087194704456
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24224,-0.00116636407413869,0.00311379866654196,-0.00726940946056092,0.00493668131228355,0.707976758681969
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,H2AP,Huntingtin-interacting protein M,24011,-0.00134765231677349,0.00359802326047291,-0.00839977790730038,0.00570447327375341,0.70799584767895
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,24224,0.00125147986903951,0.00339322284499014,-0.00539923690714117,0.00790219664522018,0.712267006295433
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RTKN2,Rhotekin-2,24106,-0.00133135282014432,0.0036344530557597,-0.00845488080943333,0.00579217516914468,0.714133634584054
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBQLN3,Ubiquilin-3,24106,0.00128072062421692,0.00353341986564623,-0.00564478231244968,0.00820622356088352,0.71701206842154
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24863,0.000752351673326931,0.00207974146329504,-0.00332394159473135,0.00482864494138521,0.717540066938097
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,24399,0.00135475526476676,0.0038166477289197,-0.00612587428391586,0.00883538481344938,0.722623022765651
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,29209,-0.000832263775834331,0.00234963951521171,-0.00543755722564929,0.00377302967398063,0.723184717593373
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,24917,0.000728729712598503,0.00208078653429599,-0.00334961189462164,0.00480707131981865,0.726177767431959
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,24440,0.000981845170172708,0.00282065988802215,-0.0045466482103507,0.00651033855069611,0.727775149262048
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,28911,0.000807701242991048,0.00233447035022948,-0.00376786064345874,0.00538326312944084,0.729353442102469
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRG3,Proteoglycan 3,24933,0.00120676127464472,0.00349359682574841,-0.00564068850382217,0.00805421105311161,0.729780901070435
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,24011,-0.000758344071573711,0.00223951590475386,-0.00514779524489127,0.00363110710174385,0.734899247157357
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPAN15,Tetraspanin-15,24106,0.00117985919883753,0.00355104677298562,-0.00578019247621429,0.00813991087388935,0.739698298564697
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACRV1,Acrosomal protein SP-10,24224,0.00176349960491242,0.00538910415548673,-0.00879914453984157,0.0123261437496664,0.743493526270196
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,24440,-0.0010199614671285,0.00313933599696387,-0.00717306002117768,0.00513313708692068,0.745261660548541
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAD2,Glutamate decarboxylase 2,24224,-0.00103205807576034,0.00325277430971018,-0.00740749572279229,0.00534337957127162,0.751029725897958
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MORN4,MORN repeat-containing protein 4,24011,0.001747736923069,0.00551050592793185,-0.00905285469567742,0.0125483285418154,0.751121535446354
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB116,Beta-defensin 116,24096,-0.00171675498407213,0.00543315581078941,-0.0123657403732194,0.00893223040507511,0.752022325497339
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,24106,-0.00167626276560256,0.00536128742677239,-0.0121843861220764,0.00883186059087132,0.754541320509125
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FRMD7,FERM domain-containing protein 7,24190,0.000733729210544715,0.00235948749363779,-0.00389086627698535,0.00535832469807478,0.755826307530342
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,24096,0.0010893879764531,0.00351907827332921,-0.00580800543927215,0.00798678139217834,0.756893479080948
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24096,-0.00137060659089102,0.00457541200523391,-0.0103384141211495,0.00759720093936744,0.764516022784038
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PFDN6,Prefoldin subunit 6,24190,0.00133278639846202,0.00460346804453245,-0.00769001096882158,0.0103555837657456,0.772187567039542
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24863,0.000531610445147639,0.00183730083619536,-0.00306949919379526,0.00413272008409054,0.77232119468529
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24011,0.00110637215450291,0.00386474885076594,-0.00646853559299834,0.00868127990200416,0.774671723898252
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,24106,0.000734586834358175,0.00261707658794843,-0.00439488327802074,0.0058640569467371,0.778950704834857
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100G,Protein S100-G,24863,0.000910296348269941,0.00325696363431587,-0.00547335237498917,0.00729394507152905,0.779869351096058
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24096,0.00112505824733952,0.00403427697899143,-0.00678212463148368,0.00903224112616271,0.780343291176985
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBR1,T-box brain protein 1,24190,0.000930222730391613,0.0033998153441667,-0.00573341534417512,0.00759386080495835,0.784386854241428
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL3,Interleukin-3,24011,0.00113431557909125,0.00425249848808861,-0.00720058145756242,0.00946921261574492,0.789670897537016
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,24011,0.00090087587137647,0.00344210702325309,-0.00584565389419958,0.00764740563695252,0.793537859207897
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK12,Kallikrein-12,28792,0.0024449003383163,0.00968523128714058,-0.0165381529844792,0.0214279536611118,0.800705936206506
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,24190,0.00121849728125101,0.00488050275584827,-0.00834728812021159,0.0107842826827136,0.802847508642062
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BSND,Barttin,24011,-0.000593887545234162,0.00238001452226593,-0.00525871600887538,0.00407094091840706,0.802952154388141
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWF,von Willebrand factor,29815,0.0012625748809726,0.00506147127179688,-0.00865790881174928,0.0111830585736945,0.803015826821094
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24106,0.000807035107746774,0.00328898653851834,-0.00563937850774918,0.00725344872324273,0.806168166106406
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEZ6,Seizure protein 6 homolog,24190,-0.00053488721392762,0.00219699069574751,-0.00484098897759275,0.00377121454973751,0.807648363181057
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HK2,Hexokinase-2,28911,0.000458548345423358,0.0019194565904058,-0.003303586571772,0.00422068326261872,0.811188792507262
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPP1,Osteopontin,29752,0.000738719299720609,0.00321703297607586,-0.00556666533338809,0.0070441039328293,0.818382800681646
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDAN1,Codanin-1,24840,0.000361303843477761,0.00158278087461831,-0.00274094667077412,0.00346355435772964,0.819437020604415
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,24011,0.00141472772642041,0.00656852587326298,-0.011459582985175,0.0142890384380159,0.829473055524149
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,24096,0.00103740805367062,0.00498390808425919,-0.0087310517914774,0.0108058678988186,0.835112419509455
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TEX33,Testis-expressed protein 33,24440,0.000566674867723581,0.00274050186848077,-0.00480470879449873,0.00593805852994589,0.836185140721575
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESPL1,Separin,24011,-0.000774693584101854,0.00389474942979513,-0.00840840246650031,0.0068590152982966,0.842337046427276
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",24863,0.000578801612381287,0.00294006704714886,-0.00518372980003049,0.00634133302479306,0.843933379431065
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NXPE4,NXPE family member 4,24106,0.000471890676279527,0.00241372367915496,-0.00425900773486419,0.00520278908742324,0.845000690234867
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24106,-0.000507400662769929,0.00260606497478242,-0.00561528801334348,0.00460048668780362,0.845629510051007
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTP1,Glutathione S-transferase P,28599,0.000942515241830206,0.00487300250556677,-0.00860856966908067,0.0104936001527411,0.846634786774718
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAGLN3,Transgelin-3,24011,0.000780342281176097,0.00424324408241082,-0.0075364161203491,0.0090971006827013,0.854091666319363
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MN1,Transcriptional activator MN1,24190,-0.00074194741665802,0.00416588396122883,-0.00890707998066652,0.00742318514735048,0.858645277626427
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28792,0.000390244483455011,0.00224771381348187,-0.00401527459096946,0.00479576355787949,0.862166589048054
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,24011,-0.000460198931019829,0.00284253294417661,-0.00603156350160598,0.00511116563956632,0.87138794742009
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24106,-0.000722854973098818,0.00461982765814737,-0.00977771718306766,0.00833200723687002,0.875665489584516
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29340,-0.00201389621524015,0.0129575097526793,-0.0274106153304915,0.0233828229000112,0.87648885120144
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24440,0.000773437551012593,0.00502380490782638,-0.00907322006832712,0.0106200951703523,0.87764685539752
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHPK,Sedoheptulokinase,24440,0.00042866623946517,0.00291523955414662,-0.00528520328666221,0.00614253576559255,0.883099112336598
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCUN1D2,DCN1-like protein 2,24011,0.000821721998889093,0.00563479458518335,-0.0102224753880703,0.0118659193858485,0.88405683073061
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,24096,-0.000682629996519279,0.00493718898161435,-0.0103595204004834,0.00899426040744484,0.890033812568409
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,24400,-0.000509919618516491,0.00371499667085002,-0.00779131309338253,0.00677147385634955,0.890826595093308
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,24933,-0.000279318648787903,0.00208615560937511,-0.00436818364316312,0.00380954634558731,0.893489398059267
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28792,0.00114379719467797,0.00862003412829768,-0.0157514696967855,0.0180390640861414,0.8944390330132
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLGAP5,Disks large-associated protein 5,24863,-0.000429665419035934,0.00362895855536458,-0.00754242418755051,0.00668309334947865,0.905752397590867
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",24106,-0.000326139075501277,0.00279273853051159,-0.005799906595304,0.00514762844430144,0.907034495288648
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23965,-0.000401421832149666,0.00367849786742229,-0.00761127765229736,0.00680843398799802,0.913103020051556
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,24096,-0.000223750628215647,0.00211744257813655,-0.00437393808136328,0.00392643682493198,0.915844887205832
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,24096,0.000541490855989537,0.00515948116404664,-0.00957109222554189,0.010654073937521,0.916415849063631
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24011,0.00024653809702918,0.00238931467307937,-0.00443651866220638,0.00492959485626474,0.917818115456354
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPA,Apolipoprotein(a),24479,0.0011942297948159,0.0125016095897813,-0.0233089250011555,0.0256973845907873,0.923897756161706
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHC1,SHC-transforming protein 1,24011,0.000747235486510093,0.00819407174220167,-0.0153131451282052,0.0168076161012254,0.927340628212915
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP73,Tumor protein p73,24190,0.000195808496177275,0.00243300279010049,-0.00457287697241968,0.00496449396477423,0.935856027388802
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24190,0.000229800165190612,0.00291638391536513,-0.00548631230892504,0.00594591263930626,0.937195325587135
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",24917,-0.00038209913484259,0.00488936199104265,-0.00996524863728618,0.009201050367601,0.937710095277943
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,24011,0.000200376096965028,0.00259496096043779,-0.00488574738549305,0.00528649957942311,0.938451256256688
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,29576,0.000101672903371347,0.00142872894385969,-0.00269863582659365,0.00290198163333635,0.943268361920408
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24106,0.000297747400814551,0.00428099826882329,-0.00809300920607909,0.00868850400770819,0.944551673604926
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24800,0.000157800494086786,0.00240231589408395,-0.00455073865831775,0.00486633964649132,0.947627694845169
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLINT1,Clathrin interactor 1,24011,0.0002015893104939,0.00334956929358327,-0.0063635665049293,0.0067667451259171,0.952009867621243
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WIF1,Wnt inhibitory factor 1,29720,0.000136209846982477,0.00237865160465635,-0.00452594729814398,0.00479836699210893,0.954335703711716
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,24224,-0.000360779969065859,0.00636221827343263,-0.0128307277849938,0.0121091678468621,0.954779359070421
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF20,Fibroblast growth factor 20,24224,0.000159563007864388,0.00308255842061849,-0.00588225149654785,0.00620137751227662,0.958717826146014
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,29429,-8.72749212199998e-05,0.00169585014402844,-0.00341114120351575,0.00323659136107575,0.95895628304547
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNLZ,DNL-type zinc finger protein,24096,0.000322418418463445,0.00635747082925642,-0.0121382244068791,0.012783061243806,0.959553133942317
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERVV_1,,24106,0.000152728151607075,0.00323951173544363,-0.00619671484986243,0.00650217115307658,0.962397715890339
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IDS,Iduronate 2-sulfatase,29781,-2.26577010977302e-05,0.000620397143437118,-0.00123863610223448,0.00119332070003902,0.97086695167891
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24933,8.47856374198875e-05,0.00277872620164801,-0.00536151771781021,0.00553108899264999,0.975658639371193
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,24011,8.75356286580294e-05,0.00287207627005698,-0.00554173386065365,0.00571680511796971,0.97568595661227
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,24391,0.00010310027902747,0.00354316997193628,-0.00684151286596763,0.00704771342402257,0.976786417174984
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24190,-8.776167686301e-05,0.00346678969236791,-0.00688266947390411,0.00670714612017809,0.979803942404058
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,24011,-0.000102518260212576,0.00445160858488599,-0.00882767108658911,0.00862263456616396,0.98162694376322
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",24106,-4.09968763992905e-05,0.00274952530020098,-0.00543006646479321,0.00534807271199462,0.988103683489732
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,24190,-2.32009719939136e-05,0.00224111705824363,-0.00441579040615143,0.0043693884621636,0.991740201524183
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,24096,2.60819548868279e-05,0.00440379925969655,-0.00860536459411841,0.00865752850389206,0.995274523157849
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMEM132A,Transmembrane protein 132A,24235,-1.50462071123513e-05,0.00439106598778101,-0.00862153554316314,0.00859144312893844,0.997266042236229
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,24011,5.44998525668193e-06,0.00212396856220182,-0.00415752839665889,0.00416842836717225,0.997952696147903
